Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
I-kappaB kinase/NF-kappaB signaling (GO:0007249),9/57,0.0019476099239263613,1,0,0,3.157894736842105,19.708902120645355,IKBKB;NFKBIA;IRAK1BP1;IRAK2;BCL3;RBCK1;CD14;UBA52;MAP3K14
hippo signaling (GO:0035329),6/30,0.0032536223155712174,1,0,0,4,22.91194537865016,LATS1;MOB1B;WWTR1;LATS2;MAP3K14;AJUBA
regulation of DNA binding (GO:0051101),8/52,0.004036933812583697,1,0,0,3.076923076923077,16.96083025367454,PRKN;NFKBIA;ID2;ID1;BCL3;RSF1;HDAC8;NME1
Golgi to lysosome transport (GO:0090160),3/8,0.005774732022768516,1,0,0,7.5,38.65697569976054,AP4M1;EHD3;ANKFY1
cellular defense response (GO:0006968),8/56,0.006396436021663812,1,0,0,2.8571428571428568,14.434326615263213,SPN;NCR2;CXCL9;GNLY;ADORA2B;PRF1;CCR6;ZNF148
negative regulation of lipid storage (GO:0010888),4/16,0.006976160030101439,1,0,0,5,24.82628326271881,CRP;ABCA1;NFKBIA;IL6
prostaglandin metabolic process (GO:0006693),5/25,0.007123209459613566,1,0,0,4,19.777587553293714,CD74;HPGD;ABHD16A;ACOX1;AKR1C3
negative regulation of lipid localization (GO:1905953),3/9,0.008342411451160579,1,0,0,6.666666666666666,31.90935307720135,CRP;NFKBIA;IL6
positive regulation of protein processing (GO:0010954),4/17,0.008766901403579476,1,0,0,4.705882352941176,22.2906910717708,GSN;ASTL;HPN;ANGPTL8
positive regulation of chemotaxis (GO:0050921),7/48,0.009381035119053851,1,0,0,2.9166666666666665,13.618106740609136,CXCL9;IL6;RARRES2;MET;CXCL5;CCR2;CCL26
regulation of lipid metabolic process (GO:0019216),11/100,0.011272773307998182,1,0,0,2.1999999999999997,9.867802785301508,ABCA1;PANK2;ACOX1;RARRES2;ID2;ANGPTL8;RORA;NR1D1;CD36;NPAS2;PPARD
organic substance transport (GO:0071702),10/87,0.011430916732415513,1,0,0,2.2988505747126435,10.279157701909751,SLC22A23;ABCA1;CUBN;SLCO2A1;NME4;APOA4;SLC50A1;ABCC11;RHBG;RHCE
vesicle transport along microtubule (GO:0047496),4/19,0.01318872540853091,1,0,0,4.2105263157894735,18.224812421427043,CLN3;KIF13A;BICDL1;PAFAH1B1
regulation of macrophage derived foam cell differentiation (GO:0010743),5/29,0.013506098212759996,1,0,0,3.4482758620689657,14.843496469201975,CRP;ABCA1;NFKBIA;PRKCH;CD36
regulation of cellular metabolic process (GO:0031323),6/41,0.01547935582050457,1,0,0,2.9268292682926824,12.19975031809441,ANKRD13C;PRKN;PANK2;ANGPTL8;FLOT1;TBC1D16
vacuolar acidification (GO:0007035),4/20,0.015846713681637082,1,0,0,4,16.579172555417852,CLN3;DMXL1;DMXL2;ATP6V0D2
regulation of lipoprotein lipase activity (GO:0051004),4/20,0.015846713681637082,1,0,0,4,16.579172555417852,APOH;ANGPTL8;APOA4;PCSK6
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),4/20,0.015846713681637082,1,0,0,4,16.579172555417852,BCL3;EP300;USP28;TP73
striated muscle cell development (GO:0055002),4/20,0.015846713681637082,1,0,0,4,16.579172555417852,TMOD3;TMOD2;LMOD1;MYOZ3
secondary alcohol metabolic process (GO:1902652),5/31,0.017804675725432068,1,0,0,3.225806451612903,12.994497338628113,ABCA1;OSBPL5;LCAT;APOA4;PPARD
prostanoid metabolic process (GO:0006692),3/12,0.01953037772410442,1,0,0,5,19.678920967843133,HPGD;ACOX1;AKR1C3
positive regulation of cell cycle arrest (GO:0071158),9/82,0.02105745765548775,1,0,0,2.195121951219512,8.474269387337754,MED25;PCNA;PRMT1;CNOT2;ID2;EP300;GTSE1;UBA52;TP73
cellular glucose homeostasis (GO:0001678),5/33,0.02292040460454417,1,0,0,3.0303030303030303,11.441599195115412,ERN1;TRA2B;PCK1;FOXO1;GCK
negative regulation of macrophage derived foam cell differentiation (GO:0010745),3/13,0.02446267254220388,1,0,0,4.615384615384615,17.125877967461363,CRP;ABCA1;NFKBIA
sensory perception of taste (GO:0050909),3/13,0.02446267254220388,1,0,0,4.615384615384615,17.125877967461363,TAS1R2;TAS1R1;CD36
positive regulation of alpha-beta T cell proliferation (GO:0046641),3/13,0.02446267254220388,1,0,0,4.615384615384615,17.125877967461363,IL23A;EBI3;CCR2
negative regulation of interleukin-10 production (GO:0032693),3/13,0.02446267254220388,1,0,0,4.615384615384615,17.125877967461363,IL23A;DLL1;AGER
cellular response to amyloid-beta (GO:1904646),4/23,0.025734894590821872,1,0,0,3.4782608695652173,12.730112841155169,GRM5;ADRB2;CD36;AGER
lysosomal transport (GO:0007041),8/72,0.026917281476999108,1,0,0,2.222222222222222,8.033303921239105,AP4M1;PRKN;EHD3;KIF13A;ANKFY1;ADRB2;NAGPA;GPRASP1
regulation of fat cell differentiation (GO:0045598),8/72,0.026917281476999108,1,0,0,2.222222222222222,8.033303921239105,IL6;LMO3;RARRES2;RORA;CREBL2;NR1D1;FOXO1;PPARD
positive regulation of cellular biosynthetic process (GO:0031328),14/159,0.02855413663371373,1,0,0,1.761006289308176,6.2620564119984055,GUCY2C;HSP90AB1;PCNA;YTHDF3;EPO;AGXT2;PRMT1;CIRBP;APOA4;NR1D1;GCK;IL6;BCL3;CD36
positive regulation of NIK/NF-kappaB signaling (GO:1901224),5/35,0.02890077475508324,1,0,0,2.8571428571428568,10.125391074539182,PTP4A3;TNFSF15;TNFRSF10B;CD14;AGER
regulation of chromosome organization (GO:0033044),4/24,0.02969412469495944,1,0,0,3.333333333333333,11.722686914871057,PIF1;RMI2;MKI67;HDAC8
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),3/14,0.030000982735417972,1,0,0,4.285714285714286,15.027964885753896,PRKN;CD74;TAF9B
neuromuscular process controlling balance (GO:0050885),3/14,0.030000982735417972,1,0,0,4.285714285714286,15.027964885753896,CLN3;USH1C;PAFAH1B1
Golgi to vacuole transport (GO:0006896),3/14,0.030000982735417972,1,0,0,4.285714285714286,15.027964885753896,AP4M1;EHD3;ANKFY1
fatty acid transport (GO:0015908),3/14,0.030000982735417972,1,0,0,4.285714285714286,15.027964885753896,SLC25A17;SLCO2A1;PPARD
regulation of response to DNA damage stimulus (GO:2001020),5/36,0.032227243715029656,1,0,0,2.7777777777777777,9.541508627909957,ANKLE1;PARG;ARMT1;FEM1B;NPAS2
glutamate receptor signaling pathway (GO:0007215),5/36,0.032227243715029656,1,0,0,2.7777777777777777,9.541508627909957,GRIA2;CLN3;GRM5;GRIK3;GRIN2B
negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,IGBP1;FOXO1
activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,ANGPT1;ADRB2
platelet dense granule organization (GO:0060155),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,ABCA1;F2RL3
regulation of glucokinase activity (GO:0033131),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,PRKN;MIDN
ammonium transmembrane transport (GO:0072488),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,RHBG;RHCE
regulation of glial cell apoptotic process (GO:0034350),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,PRKCH;DLL1
cellular response to bacterial lipopeptide (GO:0071221),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,CD14;CD36
mitochondrial RNA processing (GO:0000963),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,ELAC2;HSD17B10
cellular response to cold (GO:0070417),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,NFKBIA;FOXO1
negative regulation of myeloid cell apoptotic process (GO:0033033),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,EPO;APOH
response to amyloid-beta (GO:1904645),4/25,0.03399335307152362,1,0,0,3.1999999999999997,10.821088868398542,GRM5;ADRB2;CD36;AGER
positive regulation of alpha-beta T cell activation (GO:0046635),3/15,0.03614002285058795,1,0,0,4,13.281417446154263,IL23A;EBI3;CCR2
negative regulation of signal transduction by p53 class mediator (GO:1901797),3/15,0.03614002285058795,1,0,0,4,13.281417446154263,PRKN;CD74;SNAI2
regulation of T cell mediated cytotoxicity (GO:0001914),3/15,0.03614002285058795,1,0,0,4,13.281417446154263,IL23A;STX7;AGER
regulation of cell junction assembly (GO:1901888),3/15,0.03614002285058795,1,0,0,4,13.281417446154263,PRKCH;FLOT1;SNAI2
lipid transport (GO:0006869),9/91,0.03805819725018905,1,0,0,1.9780219780219779,6.465439353425976,SLCO1C1;ABCA1;SLC25A17;OSBPL5;SLCO2A1;SLC10A3;NME4;APOA4;PPARD
regulation of NF-kappaB import into nucleus (GO:0042345),4/26,0.038635239533284925,1,0,0,3.076923076923077,10.01104762372913,NFKBIA;IL23A;BCL3;AGER
response to endoplasmic reticulum stress (GO:0034976),10/106,0.03938499007877461,1,0,0,1.8867924528301887,6.102585844774594,ERN1;PRKN;TMX3;WFS1;FLOT1;TXNDC11;TNFRSF10B;CHAC1;ATF6;ATF3
positive regulation of epithelial cell apoptotic process (GO:1904037),3/16,0.04287015534900723,1,0,0,3.75,11.81092265495912,IL6;GSN;AKR1C3
postsynaptic membrane organization (GO:0001941),3/16,0.04287015534900723,1,0,0,3.75,11.81092265495912,DNAJA3;LRP4;GPHN
regulation of bicellular tight junction assembly (GO:2000810),3/16,0.04287015534900723,1,0,0,3.75,11.81092265495912,IKBKB;PRKCH;SNAI2
regulation of energy homeostasis (GO:2000505),3/16,0.04287015534900723,1,0,0,3.75,11.81092265495912,CD36;DLL1;FOXO1
T cell migration (GO:0072678),3/16,0.04287015534900723,1,0,0,3.75,11.81092265495912,CXCL9;CCR6;CCL26
defense response to Gram-positive bacterium (GO:0050830),7/65,0.043014194656866074,1,0,0,2.1538461538461537,6.776484851151335,CRP;IL6;DMBT1;RARRES2;DEFA4;LALBA;MBL2
cellular response to glucose stimulus (GO:0071333),4/27,0.04362093265098386,1,0,0,2.962962962962963,9.280646332348267,ERN1;TRA2B;PCK1;AGER
regulation of myosin-light-chain-phosphatase activity (GO:0035507),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,IKBKB;PPP1R12A
rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,XPO1;RPSA
positive regulation of glutamate receptor signaling pathway (GO:1900451),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,RELN;ADRB2
negative regulation of glial cell apoptotic process (GO:0034351),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,PRKCH;DLL1
mitochondrial DNA metabolic process (GO:0032042),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,MGME1;PRIMPOL
regulation of mitochondrial fusion (GO:0010635),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,PRKN;VAT1
regulation of lymphocyte migration (GO:2000401),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,SPN;CCR6
molybdopterin cofactor metabolic process (GO:0043545),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,MOCOS;GPHN
lymphatic endothelial cell differentiation (GO:0060836),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,ACVRL1;SOX18
tRNA 3'-end processing (GO:0042780),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,ELAC2;HSD17B10
glycosphingolipid catabolic process (GO:0046479),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,NEU4;NEU1
negative regulation of cell adhesion mediated by integrin (GO:0033629),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,PDE3B;SNAI2
"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,UTP20;RPSA
molybdopterin cofactor biosynthetic process (GO:0032324),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,MOCOS;GPHN
detection of molecule of bacterial origin (GO:0032490),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,C4B;DMBT1
regulation of transcription involved in cell fate commitment (GO:0060850),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,CHD5;RORA
marginal zone B cell differentiation (GO:0002315),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,DOCK10;DLL1
leucine metabolic process (GO:0006551),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,IVD;BCAT2
protein export from nucleus (GO:0006611),4/28,0.04895013769244342,1,0,0,2.8571428571428568,8.619865991683946,CRB1;ANKLE1;XPO1;STRADB
reverse cholesterol transport (GO:0043691),3/17,0.05017800549335433,1,0,0,3.5294117647058822,10.56062995015536,ABCA1;LCAT;APOA4
RNA stabilization (GO:0043489),3/17,0.05017800549335433,1,0,0,3.5294117647058822,10.56062995015536,THRAP3;CIRBP;PABPC1
regulation of protein localization to membrane (GO:1905475),3/17,0.05017800549335433,1,0,0,3.5294117647058822,10.56062995015536,PRKN;GSN;STX7
regulation of T cell migration (GO:2000404),3/17,0.05017800549335433,1,0,0,3.5294117647058822,10.56062995015536,SPN;AIRE;CCR6
positive chemotaxis (GO:0050918),3/17,0.05017800549335433,1,0,0,3.5294117647058822,10.56062995015536,LGALS3;ANGPT1;MET
cellular response to nutrient levels (GO:0031669),6/54,0.05175964311269336,1,0,0,2.222222222222222,6.580321164119916,HSPA8;RRAGB;USP33;AKR1C3;GAS2L1;FOXO1
"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",8/82,0.05220786888704381,1,0,0,1.951219512195122,5.7610186351061445,PCNA;PRMT1;CNOT2;BCL3;EP300;GTSE1;UBA52;TP73
positive regulation of viral transcription (GO:0050434),5/41,0.05234904272896249,1,0,0,2.4390243902439024,7.194686897103624,HPN;EP300;RSF1;NELFA;POLR2L
cholesterol metabolic process (GO:0008203),7/68,0.05279047635145934,1,0,0,2.0588235294117645,6.0558739225566685,ABCA1;OSBPL5;LCAT;APOA4;CYP46A1;SCARF1;PPARD
TRIF-dependent toll-like receptor signaling pathway (GO:0035666),4/29,0.05462119016329882,1,0,0,2.758620689655172,8.020229995291032,IKBKB;UBE2D2;CD14;UBA52
MyD88-dependent toll-like receptor signaling pathway (GO:0002755),4/29,0.05462119016329882,1,0,0,2.758620689655172,8.020229995291032,IRAK2;CD14;CD36;UBA52
response to UV (GO:0009411),9/98,0.056454519179306425,1,0,0,1.836734693877551,5.279363146414378,MSH6;PCNA;BCL3;CIRBP;EP300;ERCC5;USP28;TP73;PRIMPOL
late endosome to vacuole transport (GO:0045324),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,TMEM50B;LEPROTL1
mRNA cleavage (GO:0006379),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,ERN1;RNASE4
T-helper 17 cell differentiation (GO:0072539),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,IL6;RORA
amyloid fibril formation (GO:1990000),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,GSN;CD36
positive regulation of steroid biosynthetic process (GO:0010893),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,GUCY2C;NR1D1
desmosome organization (GO:0002934),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,PKP2;SNAI2
regulation of microvillus organization (GO:0032530),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,TWF2;USH1C
T-helper cell lineage commitment (GO:0002295),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,SPN;IL6
positive regulation of tumor necrosis factor biosynthetic process (GO:0042535),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,SPN;CCR2
negative regulation of centriole replication (GO:0046600),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,RBM14;MDM1
amyloid precursor protein catabolic process (GO:0042987),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,PSENEN;CLN3
late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,TMEM50B;LEPROTL1
short-chain fatty acid catabolic process (GO:0019626),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,MMAA;PCK1
positive regulation of lipoprotein lipase activity (GO:0051006),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,APOH;APOA4
mammary gland epithelial cell differentiation (GO:0060644),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,LATS1;ID2
immunoglobulin mediated immune response (GO:0016064),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,CD74;GAPT
response to leptin (GO:0044321),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,NR1D1;GCK
interleukin-1 beta secretion (GO:0050702),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,ABCA1;CD36
glucan biosynthetic process (GO:0009250),3/18,0.058047017485584544,1,0,0,3.333333333333333,9.488339835095955,NHLRC1;NR1D1;UBA52
establishment or maintenance of apical/basal cell polarity (GO:0035088),3/18,0.058047017485584544,1,0,0,3.333333333333333,9.488339835095955,SCARF1;PARD3B;CRB3
acute-phase response (GO:0006953),3/18,0.058047017485584544,1,0,0,3.333333333333333,9.488339835095955,CRP;IL6;MBL2
glycogen biosynthetic process (GO:0005978),3/18,0.058047017485584544,1,0,0,3.333333333333333,9.488339835095955,NHLRC1;NR1D1;UBA52
blood vessel endothelial cell migration (GO:0043534),3/18,0.058047017485584544,1,0,0,3.333333333333333,9.488339835095955,SOX18;ID1;ROBO1
anion transport (GO:0006820),6/56,0.059923284693461636,1,0,0,2.142857142857143,6.031478835629902,SLC22A23;SLC26A7;SLC4A1;LRRIQ4;ABCC11;SLC17A2
regulation of ARF protein signal transduction (GO:0032012),4/30,0.06063113352204076,1,0,0,2.6666666666666665,7.474524702251736,GIT2;ARAP2;ARFGAP1;AGFG1
MyD88-independent toll-like receptor signaling pathway (GO:0002756),4/30,0.06063113352204076,1,0,0,2.6666666666666665,7.474524702251736,IKBKB;UBE2D2;CD14;UBA52
regulation of developmental growth (GO:0048638),4/30,0.06063113352204076,1,0,0,2.6666666666666665,7.474524702251736,LATS1;LATS2;NRCAM;DLL1
response to unfolded protein (GO:0006986),5/43,0.06205452849740553,1,0,0,2.325581395348837,6.4645157873716,PRKN;HSPA8;PACRG;HSP90AB1;DNAJB4
regulation of Rho protein signal transduction (GO:0035023),6/57,0.06427597956822549,1,0,0,2.1052631578947367,5.77804060142804,ABCA1;ARAP2;MET;GPR18;ROBO1;F2RL3
regulation of protein ubiquitination (GO:0031396),9/101,0.06584023577812598,1,0,0,1.782178217821782,4.848458866115323,LATS1;PRKN;HSP90AB1;ANGPT1;WFS1;NXN;FEM1B;ADRB2;HDAC8
protein targeting to lysosome (GO:0006622),3/19,0.06645795649124922,1,0,0,3.157894736842105,8.561639256247336,AP4M1;HSPA8;NAGPA
regulation of long-term synaptic potentiation (GO:1900271),3/19,0.06645795649124922,1,0,0,3.157894736842105,8.561639256247336,CALB1;RELN;AGER
protein heterotetramerization (GO:0051290),3/19,0.06645795649124922,1,0,0,3.157894736842105,8.561639256247336,CD74;LRP4;GRIN2B
triglyceride biosynthetic process (GO:0019432),3/19,0.06645795649124922,1,0,0,3.157894736842105,8.561639256247336,GPAT4;AGMO;PCK1
regulation of protein export from nucleus (GO:0046825),4/31,0.06697579978121662,1,0,0,2.5806451612903225,6.976577863571356,XPO1;AKAP8L;ANP32B;GTSE1
cofactor biosynthetic process (GO:0051188),4/31,0.06697579978121662,1,0,0,2.5806451612903225,6.976577863571356,PANK2;MOCOS;GPHN;CIAO1
nucleobase-containing small molecule interconversion (GO:0015949),4/31,0.06697579978121662,1,0,0,2.5806451612903225,6.976577863571356,AK2;NME4;AK8;NME1
cholesterol transport (GO:0030301),5/44,0.06726261217595207,1,0,0,2.2727272727272725,6.134433491895637,ABCA1;OSBPL5;LCAT;APOA4;CD36
very-low-density lipoprotein particle remodeling (GO:0034372),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,LCAT;APOA4
secretory granule organization (GO:0033363),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,ABCA1;F2RL3
RNA destabilization (GO:0050779),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,YTHDF3;DXO
vacuolar proton-transporting V-type ATPase complex assembly (GO:0070072),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,DMXL1;DMXL2
response to UV-C (GO:0010225),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,BCL3;ERCC5
positive regulation of protein maturation (GO:1903319),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,ASTL;ANGPTL8
regulation of organ growth (GO:0046620),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,LATS1;LATS2
regulation of T-helper 1 type immune response (GO:0002825),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,IL23A;CCR2
oligosaccharide catabolic process (GO:0009313),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,NEU4;NEU1
sterol catabolic process (GO:0016127),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,CYP46A1;SCARF1
negative regulation of catenin import into nucleus (GO:0035414),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,WWTR1;SNAI2
regulation of mast cell activation (GO:0033003),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,CD226;CRLF2
regulation of mast cell activation involved in immune response (GO:0033006),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,FES;UNC13D
mature B cell differentiation involved in immune response (GO:0002313),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,DOCK10;DLL1
sphingomyelin metabolic process (GO:0006684),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,CLN3;SGMS2
regulation of leukocyte mediated cytotoxicity (GO:0001910),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,AGER;PIK3R6
ionotropic glutamate receptor signaling pathway (GO:0035235),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,GRIA2;CLN3
interleukin-1 beta production (GO:0032611),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,ABCA1;CD36
interleukin-1 secretion (GO:0050701),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,ABCA1;CD36
myeloid leukocyte mediated immunity (GO:0002444),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,IL6;CXCL5
regulation of natural killer cell activation (GO:0032814),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,IL23A;MICA
positive regulation of cell activation (GO:0050867),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,RPS6KA1;AGER
regulation of bile acid biosynthetic process (GO:0070857),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,GUCY2C;NR1D1
regulation of leukocyte degranulation (GO:0043300),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,FES;UNC13D
cholesterol catabolic process (GO:0006707),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,CYP46A1;SCARF1
B cell homeostasis (GO:0001782),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,DOCK10;GAPT
proton-transporting V-type ATPase complex assembly (GO:0070070),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,DMXL1;DMXL2
positive regulation of triglyceride lipase activity (GO:0061365),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,APOH;APOA4
protein polymerization (GO:0051258),5/45,0.07270586423397986,1,0,0,2.222222222222222,5.825184964955028,PRKN;TPPP3;GSN;MAP7D3;CASQ2
sterol metabolic process (GO:0016125),6/59,0.073523209939382,1,0,0,2.0338983050847457,5.308788083641293,ABCA1;OSBPL5;LCAT;APOA4;CYP46A1;PPARD
neuromuscular junction development (GO:0007528),3/20,0.07538936106098607,1,0,0,2.9999999999999996,7.755267341732064,DNAJA3;LRP4;GPHN
vesicle cytoskeletal trafficking (GO:0099518),3/20,0.07538936106098607,1,0,0,2.9999999999999996,7.755267341732064,CLN3;BICDL1;PAFAH1B1
regulation of transport (GO:0051049),3/20,0.07538936106098607,1,0,0,2.9999999999999996,7.755267341732064,PRKN;RSC1A1;FES
regulation of DNA metabolic process (GO:0051052),5/46,0.07838227433911542,1,0,0,2.1739130434782608,5.535124934351927,ACVRL1;PIF1;CCDC88A;PARG;HDAC8
protein stabilization (GO:0050821),12/152,0.07911183137441752,1,0,0,1.5789473684210524,4.0056202744672404,PRKN;MORC3;COG7;HSP90AB1;WDR81;WFS1;USP33;FLOT1;EP300;CREBL2;TAF9B;GTSE1
negative regulation of neurogenesis (GO:0050768),4/33,0.08064706826013496,1,0,0,2.4242424242424243,6.103449276278521,SOX2;ID2;ID1;DLL1
establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),4/33,0.08064706826013496,1,0,0,2.4242424242424243,6.103449276278521,SYNE4;SCARF1;PARD3B;CRB3
regulation of cytokine-mediated signaling pathway (GO:0001959),8/90,0.0808316388583679,1,0,0,1.7777777777777777,4.4717987912343435,IKBKB;CD74;HSP90AB1;IRAK2;RBCK1;UBA52;AGPAT2;IFNA10
"DNA-templated transcription, initiation (GO:0006352)",14/186,0.08358490608613982,1,0,0,1.5053763440860215,3.7361819937223957,WWTR1;CCNC;RORA;RSF1;NR1D1;MED25;NR5A2;TAF1B;THRAP3;POLR1E;TAF9B;TAF2;PPARD;POLR2L
response to glucose (GO:0009749),5/47,0.08428928588938157,1,0,0,2.127659574468085,5.26276705761003,ERN1;INS-IGF2;TRA2B;PCK1;GCK
"positive regulation of gene expression, epigenetic (GO:0045815)",5/47,0.08428928588938157,1,0,0,2.127659574468085,5.26276705761003,TAF1B;EP300;POLR1E;SLC50A1;POLR2L
epoxygenase P450 pathway (GO:0019373),3/21,0.08481794993785322,1,0,0,2.8571428571428568,7.049280242253078,CYP2B6;CYP2S1;CYP2C19
cellular response to hexose stimulus (GO:0071331),3/21,0.08481794993785322,1,0,0,2.8571428571428568,7.049280242253078,ERN1;TRA2B;PCK1
sterol transport (GO:0015918),3/21,0.08481794993785322,1,0,0,2.8571428571428568,7.049280242253078,OSBPL5;LCAT;CD36
branched-chain amino acid catabolic process (GO:0009083),3/21,0.08481794993785322,1,0,0,2.8571428571428568,7.049280242253078,IVD;HSD17B10;BCAT2
cellular response to misfolded protein (GO:0071218),3/21,0.08481794993785322,1,0,0,2.8571428571428568,7.049280242253078,RNF126;POMT1;ANKZF1
peptidyl-serine dephosphorylation (GO:0070262),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,PPP2R2B;PPP2R2D
regulation of chromatin organization (GO:1902275),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,PARG;MKI67
T cell chemotaxis (GO:0010818),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,CXCL9;CCL26
glycoprotein catabolic process (GO:0006516),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,NEU4;EDEM2
primary alcohol catabolic process (GO:0034310),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,AKR1C3;SULT1A2
regulation of histone phosphorylation (GO:0033127),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,RPS6KA4;AKAP8L
positive regulation of circadian rhythm (GO:0042753),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,THRAP3;RORA
actin filament capping (GO:0051693),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,GSN;TWF2
cardiovascular system development (GO:0072358),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,NXN;SOX18
negative regulation of centrosome duplication (GO:0010826),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,RBM14;MDM1
regulation of podosome assembly (GO:0071801),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,KIF9;GSN
negative regulation by host of viral process (GO:0044793),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,CRP;PRKN
ceramide catabolic process (GO:0046514),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,NEU4;NEU1
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,IL23A;CCR2
"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",2/10,0.08609691405925976,1,0,0,4,9.809126838186547,THRAP3;TRA2B
sequestering of actin monomers (GO:0042989),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,GSN;TWF2
positive regulation of nuclease activity (GO:0032075),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,ERN1;PCNA
thyroid hormone generation (GO:0006590),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,IYD;DIO3
positive regulation of leukocyte migration (GO:0002687),4/34,0.08796002427126849,1,0,0,2.352941176470588,5.719700793788988,LGALS3;CXCL9;IL6;CXCL5
negative regulation of DNA binding (GO:0043392),4/34,0.08796002427126849,1,0,0,2.352941176470588,5.719700793788988,NFKBIA;ID2;ID1;RSF1
"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",6/62,0.08873881335310585,1,0,0,1.9354838709677418,4.687854010251747,PCNA;PRMT1;CNOT2;EP300;GTSE1;UBA52
tRNA processing (GO:0008033),6/62,0.08873881335310585,1,0,0,1.9354838709677418,4.687854010251747,CTU2;METTL1;ELAC2;DDX1;ADAT1;HSD17B10
nuclear export (GO:0051168),8/92,0.08919814687860968,1,0,0,1.7391304347826086,4.20329567741818,CRB1;NXF2;ANKLE1;XPO1;STRADB;SRSF1;IGFLR1;POM121L12
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),5/48,0.0904238200779985,1,0,0,2.0833333333333335,5.006765728864707,MSH6;BCL3;EP300;USP28;TP73
ribonucleoprotein complex assembly (GO:0022618),12/156,0.09171348535222464,1,0,0,1.5384615384615385,3.675516693961087,ISY1;SAMD15;HSP90AB1;SNRPD2;SCAF11;OGFOD1;DDX1;MRTO4;SRSF1;CIRBP;RPSA;RSL24D1
organic anion transport (GO:0015711),10/124,0.09227027017297251,1,0,0,1.6129032258064515,3.8436020795588095,SLCO1C1;SLC22A23;SLC25A17;OSBPL5;SLCO2A1;CA7;SLC26A7;SLC4A1;SLC16A2;ABCC11
signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431),6/63,0.09416438282354153,1,0,0,1.9047619047619047,4.500406229636559,PCNA;PRMT1;CNOT2;EP300;GTSE1;UBA52
regulation of natural killer cell mediated cytotoxicity (GO:0042269),3/22,0.09471898702745883,1,0,0,2.727272727272727,6.427747642616689,CD226;PIK3R6;MICA
acylglycerol homeostasis (GO:0055090),3/22,0.09471898702745883,1,0,0,2.727272727272727,6.427747642616689,ANGPTL8;APOA4;RORA
branched-chain amino acid metabolic process (GO:0009081),3/22,0.09471898702745883,1,0,0,2.727272727272727,6.427747642616689,IVD;HSD17B10;BCAT2
positive regulation of biosynthetic process (GO:0009891),3/22,0.09471898702745883,1,0,0,2.727272727272727,6.427747642616689,CREBL2;APOA4;CD36
negative regulation of protein import into nucleus (GO:0042308),3/22,0.09471898702745883,1,0,0,2.727272727272727,6.427747642616689,WWTR1;SNAI2;CABP1
cellular response to unfolded protein (GO:0034620),3/22,0.09471898702745883,1,0,0,2.727272727272727,6.427747642616689,PRKN;HSPA8;PACRG
positive regulation of RNA splicing (GO:0033120),3/22,0.09471898702745883,1,0,0,2.727272727272727,6.427747642616689,ERN1;THRAP3;TRA2B
endothelial cell migration (GO:0043542),4/35,0.09558057758683013,1,0,0,2.2857142857142856,5.366367183732389,PTP4A3;SOX18;PXN;ID1
carbohydrate catabolic process (GO:0016052),4/35,0.09558057758683013,1,0,0,2.2857142857142856,5.366367183732389,NEU4;NEU1;GCK;DERA
glycerophospholipid metabolic process (GO:0006650),6/64,0.09976385224519034,1,0,0,1.875,4.321780056051918,PIGC;AGK;LCAT;APOA4;PIGW;PAFAH1B1
isotype switching (GO:0045190),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,MSH6;CCR6
regulation of myeloid leukocyte mediated immunity (GO:0002886),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,FES;UNC13D
regulation of tumor necrosis factor biosynthetic process (GO:0042534),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,SPN;CCR2
regulation of vascular endothelial growth factor signaling pathway (GO:1900746),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,DLL1;ROBO1
modulation by host of viral process (GO:0044788),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,CRP;PC
"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,UTP20;RPSA
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,ATF6;ATF3
internal protein amino acid acetylation (GO:0006475),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,EP300;PCK1
stress granule assembly (GO:0034063),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,OGFOD1;CIRBP
regulation of chromatin binding (GO:0035561),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,MED25;BTAF1
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,CD74;TAF9B
response to thyroid hormone (GO:0097066),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,HPN;GAS2L1
carbohydrate derivative catabolic process (GO:1901136),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,NEU4;DERA
regulation of receptor biosynthetic process (GO:0010869),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,ANKRD13C;NR1D1
response to corticosteroid (GO:0031960),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,IL6;AKR1C3
alcohol catabolic process (GO:0046164),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,CYP46A1;SCARF1
spinal cord development (GO:0021510),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,RELN;DLL1
fatty acid beta-oxidation (GO:0006635),5/50,0.10336068197068972,1,0,0,2,4.5390612819119465,SLC25A17;ACOX1;IVD;ECI2;PPARD
mRNA catabolic process (GO:0006402),4/36,0.10349974906541197,1,0,0,2.222222222222222,5.040413535040945,ERN1;THRAP3;MRTO4;DXO
cell cycle G2/M phase transition (GO:0044839),10/127,0.10391551943251265,1,0,0,1.574803149606299,3.565633107235882,LATS1;PPP1R12A;CEP164;AKAP8L;CNTRL;USH1C;AJUBA;UBA52;TAF2;PAFAH1B1
exogenous drug catabolic process (GO:0042738),3/23,0.10506660809461679,1,0,0,2.6086956521739126,5.877810696891578,CYP2B6;CYP2S1;CYP2C19
neuronal action potential (GO:0019228),3/23,0.10506660809461679,1,0,0,2.6086956521739126,5.877810696891578,SCN10A;KCNA2;KCNMB4
microtubule polymerization or depolymerization (GO:0031109),3/23,0.10506660809461679,1,0,0,2.6086956521739126,5.877810696891578,TPPP3;KIF2A;MAP7D3
cellular amino acid catabolic process (GO:0009063),3/23,0.10506660809461679,1,0,0,2.6086956521739126,5.877810696891578,IVD;HSD17B10;BCAT2
regulation of interleukin-8 secretion (GO:2000482),3/23,0.10506660809461679,1,0,0,2.6086956521739126,5.877810696891578,CRP;MAPKBP1;CD14
regulation of androgen receptor signaling pathway (GO:0060765),3/23,0.10506660809461679,1,0,0,2.6086956521739126,5.877810696891578,KDM5D;EP300;PIAS2
cellular response to reactive oxygen species (GO:0034614),6/65,0.10553500656937817,1,0,0,1.8461538461538463,4.1514693512884095,IL6;MPV17L;PXN;AKR1C3;FOXO1;ANKZF1
negative regulation of cell adhesion (GO:0007162),6/65,0.10553500656937817,1,0,0,1.8461538461538463,4.1514693512884095,ACVRL1;SPN;ADAMDEC1;ANGPT1;PDE3B;SNAI2
positive regulation of binding (GO:0051099),7/81,0.11013078353458117,1,0,0,1.728395061728395,3.812989320340752,PRKN;MED25;TERT;USP33;FLOT1;MET;NME1
protein catabolic process (GO:0030163),7/81,0.11013078353458117,1,0,0,1.728395061728395,3.812989320340752,PRKN;CLN3;ATE1;HSPA8;NEU4;NR1D1;PSMB8
protein monoubiquitination (GO:0006513),4/37,0.11170784333278796,1,0,0,2.1621621621621623,4.739174827095357,PRKN;RNF126;ZNF598;RNF40
sodium-independent organic anion transport (GO:0043252),4/37,0.11170784333278796,1,0,0,2.1621621621621623,4.739174827095357,SLCO1C1;SLC22A23;SLCO2A1;SLC16A2
organic cyclic compound biosynthetic process (GO:1901362),4/37,0.11170784333278796,1,0,0,2.1621621621621623,4.739174827095357,GUCY2C;DHRS11;MOCOS;GPHN
drug catabolic process (GO:0042737),3/24,0.11583411237416653,1,0,0,2.5,5.388990442839107,CYP2B6;CYP2S1;CYP2C19
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),3/24,0.11583411237416653,1,0,0,2.5,5.388990442839107,CD74;SNAI2;TAF9B
cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),3/24,0.11583411237416653,1,0,0,2.5,5.388990442839107,IKBKB;IRAK2;UBA52
triglyceride metabolic process (GO:0006641),5/52,0.11715876376056604,1,0,0,1.9230769230769231,4.123510209226117,GPAT4;APOH;AGMO;APOA4;PNPLA5
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,CD74;TAF9B
entry of bacterium into host cell (GO:0035635),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,MET;UBA52
positive regulation of skeletal muscle tissue development (GO:0048643),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,FLOT1;DLL1
phospholipid efflux (GO:0033700),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,ABCA1;APOA4
positive regulation of T-helper 1 type immune response (GO:0002827),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,IL23A;CCR2
regulation of cholesterol homeostasis (GO:2000188),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,RORA;NR1D1
eye photoreceptor cell development (GO:0042462),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,USH1C;MAPRE2
regulation of skeletal muscle tissue development (GO:0048641),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,FLOT1;DLL1
regulation of mononuclear cell migration (GO:0071675),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,LGALS3;RARRES2
positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,ERN1;ATF6
"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,CD74;SNAI2
endosome transport via multivesicular body sorting pathway (GO:0032509),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,TMEM50B;LEPROTL1
regulation of cellular pH (GO:0030641),4/38,0.12019452718952628,1,0,0,2.1052631578947367,4.4603027132352775,CLN3;SLC9A8;SLC26A7;SLC4A1
steroid metabolic process (GO:0008202),8/99,0.12224070691787418,1,0,0,1.6161616161616161,3.3967889625023044,GUCY2C;CUBN;CYP2B6;DHRS11;UGT2B15;AKR1C3;CYP46A1;CYP2C19
protein sumoylation (GO:0016925),6/68,0.12385227423087532,1,0,0,1.7647058823529411,3.685880753701308,PCNA;BCL11A;CDCA8;PIAS2;SENP1;NUP37
monocarboxylic acid transport (GO:0015718),5/53,0.12436826089881091,1,0,0,1.8867924528301887,3.9330344692443866,SLCO1C1;SLC25A17;SLC10A3;SLC16A2;PPARD
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),9/116,0.12671365698695553,1,0,0,1.5517241379310345,3.205591149587074,CD74;IL6;GRM5;INS-IGF2;RELN;ANGPT1;EPO;IL23A;OSM
regulation of neuron differentiation (GO:0045664),7/84,0.12675522288040375,1,0,0,1.6666666666666665,3.442495718671272,SOX2;CCDC88A;ID2;ID1;NRCAM;DLL1;ATOH1
"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,IKBKB;IRAK2;UBA52
misfolded or incompletely synthesized protein catabolic process (GO:0006515),3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,RNF126;POMT1;ANKZF1
regulation of interleukin-10 production (GO:0032653),3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,IL23A;DLL1;AGER
positive regulation of leukocyte mediated cytotoxicity (GO:0001912),3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,IL23A;STX7;CD226
positive regulation of Rho protein signal transduction (GO:0035025),3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,GPR18;ROBO1;F2RL3
positive regulation of nitric oxide biosynthetic process (GO:0045429),3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,HSP90AB1;AGXT2;CD36
positive regulation of nitric oxide metabolic process (GO:1904407),3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,HSP90AB1;AGXT2;CD36
positive regulation of fat cell differentiation (GO:0045600),4/39,0.1289489055490016,1,0,0,2.051282051282051,4.201721095583098,LMO3;RARRES2;CREBL2;PPARD
negative regulation of cell differentiation (GO:0045596),11/150,0.13139432092217368,1,0,0,1.4666666666666666,2.976676843999461,ABCA1;NFKBIA;CRP;IL6;HPN;PKP2;SNAI2;RORA;ANP32B;DLL1;FOXO1
protein localization to cell periphery (GO:1990778),9/117,0.13158332870735787,1,0,0,1.5384615384615385,3.120176845647289,AP4M1;IKBKB;MRAP;TSPAN15;EHD3;PKP2;FLOT1;PIGW;CRB3
action potential (GO:0001508),5/54,0.13177730633611895,1,0,0,1.8518518518518516,3.7530404709585476,CLN3;SCN10A;CATSPER4;KCNA2;KCNMB4
glycosphingolipid metabolic process (GO:0006687),5/54,0.13177730633611895,1,0,0,1.8518518518518516,3.7530404709585476,UGCG;CLN3;NEU4;NEU1;ESYT1
regulation of peptidyl-tyrosine phosphorylation (GO:0050730),7/85,0.13256322548057173,1,0,0,1.6470588235294117,3.3282044747059696,CD74;IL6;RELN;INS-IGF2;ANGPT1;IL23A;OSM
mitochondrial genome maintenance (GO:0000002),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,MGME1;PIF1
"Notch receptor processing, ligand-dependent (GO:0035333)",2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,PSENEN;DLL1
renal absorption (GO:0070293),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,GSN;AKR1C3
endoplasmic reticulum tubular network organization (GO:0071786),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,RTN3;ATL2
positive regulation of T cell mediated cytotoxicity (GO:0001916),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,IL23A;STX7
tricarboxylic acid metabolic process (GO:0072350),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,IDH3G;ACO2
positive regulation of cholesterol efflux (GO:0010875),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,ABCA1;NFKBIA
positive regulation of endothelial cell chemotaxis (GO:2001028),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,FGF18;MET
poly(A)+ mRNA export from nucleus (GO:0016973),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,ENY2;NXF2
B cell activation involved in immune response (GO:0002312),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,MSH6;GAPT
neuron fate commitment (GO:0048663),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,ID2;DLL1
cellular response to low-density lipoprotein particle stimulus (GO:0071404),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,ABCA1;CD36
triglyceride-rich lipoprotein particle remodeling (GO:0034370),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,LCAT;APOA4
regulation of cAMP-dependent protein kinase activity (GO:2000479),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,PRKAR2A;ADRB2
high-density lipoprotein particle assembly (GO:0034380),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,ABCA1;APOA4
amyloid precursor protein metabolic process (GO:0042982),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,PSENEN;CLN3
endothelial cell differentiation (GO:0045446),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,ACVRL1;SOX18
detection of calcium ion (GO:0005513),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,CASQ2;KCNMB4
regulation of cellular carbohydrate metabolic process (GO:0010675),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,PRKN;RORA
"nucleotide-excision repair, DNA incision (GO:0033683)",4/40,0.1379595947094308,1,0,0,2,3.961588857315027,PCNA;ERCC5;BIVM-ERCC5;UBA52
regulation of cellular localization (GO:0060341),4/40,0.1379595947094308,1,0,0,2,3.961588857315027,GSN;KCNMB4;NR1D1;LINC00598
positive regulation of Ras protein signal transduction (GO:0046579),4/40,0.1379595947094308,1,0,0,2,3.961588857315027,EPO;GPR18;ROBO1;F2RL3
cytoskeleton-dependent intracellular transport (GO:0030705),3/26,0.1385193121264188,1,0,0,2.3076923076923075,4.561720443090936,CCDC88A;KIF13A;KIF1A
tRNA methylation (GO:0030488),3/26,0.1385193121264188,1,0,0,2.3076923076923075,4.561720443090936,METTL1;HSD17B10;TARBP1
regulation of cellular catabolic process (GO:0031329),5/55,0.13937991022954382,1,0,0,1.8181818181818181,3.582821649166955,PRKN;RRAGB;USP33;ULK3;EP300
fat cell differentiation (GO:0045444),5/55,0.13937991022954382,1,0,0,1.8181818181818181,3.582821649166955,WNT5B;BBS9;EP300;FOXO1;PSMB8
Notch signaling pathway (GO:0007219),5/55,0.13937991022954382,1,0,0,1.8181818181818181,3.582821649166955,PSENEN;EP300;SNAI2;UBA52;DLL1
defense response to Gram-negative bacterium (GO:0050829),6/71,0.14360927069584972,1,0,0,1.6901408450704225,3.2799871526003956,IL6;DMBT1;IL23A;RARRES2;DEFA4;LALBA
positive regulation of growth (GO:0045927),6/71,0.14360927069584972,1,0,0,1.6901408450704225,3.2799871526003956,WFS1;BRAT1;RPS6KA1;HPN;TAF9B;HDGFL2
cellular response to peptide (GO:1901653),4/41,0.14721479282726987,1,0,0,1.951219512195122,3.7382684546071134,GRM5;ADRB2;CD36;AGER
spliceosomal complex assembly (GO:0000245),4/41,0.14721479282726987,1,0,0,1.951219512195122,3.7382684546071134,SNRPD2;SCAF11;DDX1;SRSF1
regulation of cellular response to stress (GO:0080135),8/104,0.14927432324369838,1,0,0,1.5384615384615385,2.9261070310469814,PRKN;HSPA8;ARMT1;HSP90AB1;EP300;AJUBA;NPAS2;NUP37
regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,LATS1;KDM5D;EP300
regulation of cilium assembly (GO:1902017),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,CCDC88A;CROCC;EVI5L
regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,PPP2R1B;TERT;SNAI2
protein targeting to vacuole (GO:0006623),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,AP4M1;TMEM50B;NAGPA
regulation of vascular endothelial growth factor production (GO:0010574),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,IL6;RORA;CCR2
regulation of blood vessel diameter (GO:0097746),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,CRP;KCNMB4;UTS2
negative regulation of organelle assembly (GO:1902116),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,RBM14;EVI5L;MDM1
cellular response to topologically incorrect protein (GO:0035967),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,PRKN;HSPA8;PACRG
regulation of cell differentiation (GO:0045595),9/121,0.15201804550713838,1,0,0,1.487603305785124,2.802281719449235,LGALS3;HSP90AB1;PLEKHB2;FES;RPS6KA1;SNAI2;NR1D1;ANP32B;DLL1
negative regulation of hydrogen peroxide-induced cell death (GO:1903206),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,GPR37L1;MET
intermediate filament organization (GO:0045109),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,PKP2;KRT20
ubiquinone metabolic process (GO:0006743),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,COQ8A;COQ10B
regulation of lipase activity (GO:0060191),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,ANGPTL8;PCSK6
regulation of phosphate metabolic process (GO:0019220),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,IGBP1;IKBKB
positive regulation of response to cytokine stimulus (GO:0060760),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,CD74;AGPAT2
glucuronate metabolic process (GO:0019585),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,UGT2B15;UGT1A3
negative regulation of secretion (GO:0051048),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,CD74;VAMP3
cellular response to osmotic stress (GO:0071470),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,EPO;SERPINB6
quinone biosynthetic process (GO:1901663),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,COQ8A;COQ10B
necroptotic process (GO:0070266),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,MLKL;CD14
regulation of transferase activity (GO:0051338),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,FEM1B;LDB2
regulation of histone modification (GO:0031056),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,PARG;AKAP8L
"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,ERN1;DDX1
regulation of protein modification by small protein conjugation or removal (GO:1903320),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,PRKN;HSP90AB1
positive regulation of inflammatory response (GO:0050729),6/73,0.1575316394218323,1,0,0,1.643835616438356,3.03802020110663,NFKBIA;IL6;IL23A;OSM;CCR2;CCL26
transcription-coupled nucleotide-excision repair (GO:0006283),6/73,0.1575316394218323,1,0,0,1.643835616438356,3.03802020110663,ISY1;PCNA;EP300;ERCC5;UBA52;POLR2L
regulation of protein complex assembly (GO:0043254),6/73,0.1575316394218323,1,0,0,1.643835616438356,3.03802020110663,LATS1;HSPA8;KIF9;GSN;TAL1;AJUBA
nucleic acid phosphodiester bond hydrolysis (GO:0090305),6/73,0.1575316394218323,1,0,0,1.643835616438356,3.03802020110663,ANKLE1;PCNA;DDX1;DXO;ERCC5;UBA52
acute inflammatory response (GO:0002526),3/28,0.16255339603696525,1,0,0,2.142857142857143,3.893033014692501,CRP;IL6;MBL2
lytic vacuole organization (GO:0080171),3/28,0.16255339603696525,1,0,0,2.142857142857143,3.893033014692501,ABCA1;CLN3;NAGPA
regulation of NIK/NF-kappaB signaling (GO:1901222),3/28,0.16255339603696525,1,0,0,2.142857142857143,3.893033014692501,PTP4A3;CD14;AGER
triglyceride homeostasis (GO:0070328),3/28,0.16255339603696525,1,0,0,2.142857142857143,3.893033014692501,ANGPTL8;RORA;APOA4
nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),3/28,0.16255339603696525,1,0,0,2.142857142857143,3.893033014692501,IKBKB;IRAK2;UBA52
protein K63-linked deubiquitination (GO:0070536),3/28,0.16255339603696525,1,0,0,2.142857142857143,3.893033014692501,USP20;USP33;ABRAXAS2
transcription elongation from RNA polymerase I promoter (GO:0006362),3/28,0.16255339603696525,1,0,0,2.142857142857143,3.893033014692501,TAF1B;POLR1E;POLR2L
positive regulation of response to external stimulus (GO:0032103),7/90,0.16349418407909133,1,0,0,1.5555555555555556,2.8170766721365488,NFKBIA;IL23A;APOH;RARRES2;SCARF1;CCR2;CCL26
regulation of small GTPase mediated signal transduction (GO:0051056),10/140,0.16350553449103974,1,0,0,1.4285714285714284,2.587012055885183,ARHGAP11B;PLEKHG2;RELN;ARHGEF19;ARAP2;TRIP10;OCRL;RHOU;A2M;RHOBTB2
positive regulation of interferon-gamma production (GO:0032729),4/43,0.16640981850387015,1,0,0,1.8604651162790697,3.336375343076965,IL23A;EBI3;CD14;CCR2
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),4/43,0.16640981850387015,1,0,0,1.8604651162790697,3.336375343076965,BCL3;EP300;USP28;TP73
modification-dependent protein catabolic process (GO:0019941),10/141,0.16866989291733908,1,0,0,1.4184397163120568,2.524555702946532,FBXW4;PRKN;RNF146;RNF126;WDR81;UBE2D2;USP33;RLIM;UBA52;RNF40
regulation of mast cell degranulation (GO:0043304),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,FES;UNC13D
ubiquinone biosynthetic process (GO:0006744),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,COQ8A;COQ10B
fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,ACOX1;ECI2
maintenance of protein location in nucleus (GO:0051457),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,MORC3;BCL3
positive regulation of small GTPase mediated signal transduction (GO:0051057),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,RELN;EPO
positive regulation of CREB transcription factor activity (GO:0032793),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,RPS6KA4;RELN
G-protein coupled glutamate receptor signaling pathway (GO:0007216),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,GRM5;GRIK3
negative regulation of insulin secretion (GO:0046676),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,PRKN;MIDN
regulation of centriole replication (GO:0046599),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,RBM14;MDM1
positive regulation of phosphoprotein phosphatase activity (GO:0032516),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,PPP1R12A;HSP90AB1
fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,ACOX1;IVD
positive regulation of acute inflammatory response (GO:0002675),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,IL6;OSM
ganglioside metabolic process (GO:0001573),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,NEU4;NEU1
vasculature development (GO:0001944),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,ACVRL1;SOX18
positive regulation of cellular response to insulin stimulus (GO:1900078),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,INS-IGF2;RARRES2
positive regulation of NF-kappaB import into nucleus (GO:0042346),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,IL23A;AGER
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,GSN;TNFRSF10B
positive regulation of protein export from nucleus (GO:0046827),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,ANP32B;GTSE1
cytoplasmic sequestering of protein (GO:0051220),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,LATS1;NFKBIA
regulation of peptide secretion (GO:0002791),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,CD74;ARFIP1
"DNA-templated transcription, elongation (GO:0006354)",8/108,0.17280406327587397,1,0,0,1.4814814814814814,2.6008843089787628,PBRM1;TAF1B;POLR1E;NELFA;SSRP1;TAF9B;TAF2;POLR2L
vacuolar transport (GO:0007034),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,CLN3;TMEM50B;ATP6V0D2
positive regulation of myeloid cell differentiation (GO:0045639),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,PRMT1;FES;TAL1
regulation of chromosome segregation (GO:0051983),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,RMI2;MKI67;LINC00598
coenzyme biosynthetic process (GO:0009108),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,PANK2;MAT2B;GPHN
B cell proliferation (GO:0042100),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,IFNK;GAPT;IFNA10
nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,PNLDC1;CNOT2;PABPC1
ribosomal small subunit biogenesis (GO:0042274),4/44,0.17632454152329277,1,0,0,1.8181818181818181,3.155325447401995,TSR3;SNU13;RPSA;RPS24
sprouting angiogenesis (GO:0002040),4/44,0.17632454152329277,1,0,0,1.8181818181818181,3.155325447401995,ACVRL1;ANGPT1;DLL1;ROBO1
regulation of T cell activation (GO:0050863),4/44,0.17632454152329277,1,0,0,1.8181818181818181,3.155325447401995,LGALS3;GSN;SIRPG;CCR2
regulation of intracellular pH (GO:0051453),4/44,0.17632454152329277,1,0,0,1.8181818181818181,3.155325447401995,CLN3;SLC9A8;SLC26A7;SLC4A1
positive regulation of viral process (GO:0048524),4/44,0.17632454152329277,1,0,0,1.8181818181818181,3.155325447401995,PC;RSF1;NELFA;POLR2L
regulation of cellular macromolecule biosynthetic process (GO:2000112),37/631,0.17786751334428186,1,0,0,1.172741679873217,2.0249921894298164,ZNF793;ACVRL1;ZNF132;AIRE;RORA;ZNF3;ZNF7;SOX2;RPS6KA4;ZNF829;GRM5;ZNF607;ZNF429;EP300;ZNF600;HIVEP2;PATZ1;ZNF223;ZNF200;TRAPPC2;ZNF341;WWTR1;ZNF284;ANKRD30A;ASCC1;BCL11A;PRMT1;SSRP1;CCDC88A;UBTFL1;PTP4A3;NR5A2;ZSCAN21;ZNF74;IFNK;AJUBA;ZNF311
transcription initiation from RNA polymerase II promoter (GO:0006367),11/160,0.17813353768333626,1,0,0,1.375,2.3721799725993202,WWTR1;MED25;NR5A2;THRAP3;CCNC;RORA;NR1D1;TAF9B;TAF2;PPARD;POLR2L
transforming growth factor beta receptor signaling pathway (GO:0007179),6/76,0.17945756311992533,1,0,0,1.5789473684210524,2.712341867627267,ACVRL1;HPGD;PXN;ID1;DUSP15;UBA52
G2/M transition of mitotic cell cycle (GO:0000086),9/126,0.1796039438966585,1,0,0,1.4285714285714284,2.4528588057423217,LATS1;PPP1R12A;CEP164;CNTRL;USH1C;AJUBA;UBA52;TAF2;PAFAH1B1
transcription from RNA polymerase II promoter (GO:0006366),29/485,0.18322708810911384,1,0,0,1.1958762886597938,2.029436714541456,TCERG1;INTS13;SRSF1;RORA;CCNC;MED18;SOX18;SHOX;IGFLR1;NELFA;HIVEP2;ZNF148;TAF9B;ATOH1;POLR2L;GTF2A1L;WWTR1;PBRM1;INTS2;NR1D1;SSRP1;PAX1;MED25;NR5A2;THRAP3;TBPL1;IRF9;TAF2;PPARD
ribosomal large subunit assembly (GO:0000027),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,SAMD15;MRTO4;RSL24D1
negative regulation of stress-activated MAPK cascade (GO:0032873),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,PRKN;IGBP1;FOXO1
beta-catenin-TCF complex assembly (GO:1904837),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,PYGO2;TERT;EP300
acylglycerol catabolic process (GO:0046464),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,ABHD16A;APOA4;PNPLA5
regulation of leukocyte chemotaxis (GO:0002688),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,CXCL9;IL6;CXCL5
positive regulation of cation channel activity (GO:2001259),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,RELN;STAC;ADRB2
regulation of protein polymerization (GO:0032271),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,LATS1;TPPP3;PLEKHG2
nuclear envelope organization (GO:0006998),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,INTS13;ANKLE1;AKAP8L
positive regulation of reactive oxygen species biosynthetic process (GO:1903428),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,HSP90AB1;AGXT2;CD36
positive regulation of T cell proliferation (GO:0042102),5/61,0.18868988871127926,1,0,0,1.6393442622950818,2.733853134392278,IL6;IL23A;EBI3;AGER;CCR2
positive regulation of leukocyte chemotaxis (GO:0002690),5/61,0.18868988871127926,1,0,0,1.6393442622950818,2.733853134392278,CXCL9;IL6;RARRES2;CXCL5;CCR2
regulation of actin nucleation (GO:0051125),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,GSN;ARFIP1
dendritic cell chemotaxis (GO:0002407),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,CCR6;CCR2
Notch receptor processing (GO:0007220),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,PSENEN;DLL1
regulation of dopamine secretion (GO:0014059),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,PRKN;KCNA2
glucose 6-phosphate metabolic process (GO:0051156),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,GCK;DERA
activation of NF-kappaB-inducing kinase activity (GO:0007250),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,TNFSF15;TNFRSF10B
regulation of exosomal secretion (GO:1903541),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,PRKN;SDC4
neuromuscular process (GO:0050905),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,CLN3;PAFAH1B1
positive regulation of mRNA processing (GO:0050685),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,THRAP3;TRA2B
positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,PRKCH;CD226
positive regulation of macrophage derived foam cell differentiation (GO:0010744),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,PRKCH;CD36
positive regulation of cilium assembly (GO:0045724),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,CCDC88A;CROCC
regulation of steroid metabolic process (GO:0019218),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,PANK2;RORA
negative regulation of peptide hormone secretion (GO:0090278),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,PRKN;MIDN
positive regulation of leukocyte activation (GO:0002696),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,CD226;CRLF2
programmed necrotic cell death (GO:0097300),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,MLKL;CD14
regulation of mRNA stability (GO:0043488),9/128,0.19123050260387423,1,0,0,1.40625,2.3263252855899506,HSPA8;XPO1;YTHDF3;THRAP3;APEX1;CIRBP;PABPC1;UBA52;PSMB8
positive regulation of NF-kappaB transcription factor activity (GO:0051092),9/128,0.19123050260387423,1,0,0,1.40625,2.3263252855899506,RPS6KA4;NFKBIA;IKBKB;PRKCH;IRAK2;RBCK1;CD36;UBA52;AGER
extracellular matrix disassembly (GO:0022617),6/78,0.19471584243590756,1,0,0,1.5384615384615385,2.5172523099552775,KIF9;HPN;FLOT1;MMP19;MMP8;A2M
maturation of SSU-rRNA (GO:0030490),4/46,0.19672429496904084,1,0,0,1.7391304347826086,2.82774269288294,TSR3;SNU13;UTP20;RPS24
aminoglycan biosynthetic process (GO:0006023),4/46,0.19672429496904084,1,0,0,1.7391304347826086,2.82774269288294,EXT2;SDC4;B3GNT6;XYLT1
regulation of actin filament-based process (GO:0032970),5/62,0.19745752815386772,1,0,0,1.6129032258064515,2.616502846917968,CCDC88A;ARHGEF19;TWF2;RHOU;RHOBTB2
regulation of T cell proliferation (GO:0042129),5/62,0.19745752815386772,1,0,0,1.6129032258064515,2.616502846917968,SPN;LGALS3;IL6;SDC4;IL23A
central nervous system development (GO:0007417),14/217,0.19889285650945024,1,0,0,1.2903225806451613,2.0838567854868852,CHST8;PRKN;CNTN6;ROGDI;GRIN2B;DLL1;NPAS2;RELN;NRCAM;DSCAML1;SH3GL2;ATOH1;NKX2-2;SH3GL1
positive regulation of MAPK cascade (GO:0043410),18/289,0.19973411560636045,1,0,0,1.2456747404844288,2.0064932830185316,CD74;ANGPT1;TIE1;OSM;TNFRSF10B;GPR37L1;ADRB2;AGER;PIK3R6;ROBO1;SOX2;MOS;IL6;INS-IGF2;FGF18;CD36;MET;CCL26
alpha-amino acid metabolic process (GO:1901605),3/31,0.20065196718317338,1,0,0,1.9354838709677418,3.1087420224475646,CKM;IYD;KYAT3
organelle transport along microtubule (GO:0072384),3/31,0.20065196718317338,1,0,0,1.9354838709677418,3.1087420224475646,CLN3;BICDL1;PAFAH1B1
lysosome organization (GO:0007040),3/31,0.20065196718317338,1,0,0,1.9354838709677418,3.1087420224475646,ABCA1;CLN3;NAGPA
termination of RNA polymerase I transcription (GO:0006363),3/31,0.20065196718317338,1,0,0,1.9354838709677418,3.1087420224475646,TAF1B;POLR1E;POLR2L
protein destabilization (GO:0031648),3/31,0.20065196718317338,1,0,0,1.9354838709677418,3.1087420224475646,PRKN;GSN;EP300
protein localization to plasma membrane (GO:0072659),9/130,0.20317246774459144,1,0,0,1.3846153846153846,2.206661629625701,IKBKB;MRAP;TSPAN15;EHD3;KIF13A;PKP2;FLOT1;PIGW;CRB3
ribosomal large subunit biogenesis (GO:0042273),5/63,0.20636211070548938,1,0,0,1.5873015873015872,2.504956879983314,SAMD15;MRTO4;HEATR3;SNU13;RSL24D1
myofibril assembly (GO:0030239),4/47,0.20718336704116536,1,0,0,1.7021276595744679,2.679406036964871,TMOD3;TMOD2;LMOD1;MYOZ3
negative regulation of cellular biosynthetic process (GO:0031327),4/47,0.20718336704116536,1,0,0,1.7021276595744679,2.679406036964871,MPV17L;AKR1C3;SNAI2;GCK
positive regulation of tumor necrosis factor production (GO:0032760),4/47,0.20718336704116536,1,0,0,1.7021276595744679,2.679406036964871,SPN;IL23A;CD14;CCR2
positive regulation of organelle assembly (GO:1902117),4/47,0.20718336704116536,1,0,0,1.7021276595744679,2.679406036964871,CCDC88A;SDC4;CNOT2;CROCC
histone H4 acetylation (GO:0043967),4/47,0.20718336704116536,1,0,0,1.7021276595744679,2.679406036964871,TADA3;CHD5;EP300;JADE3
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),4/47,0.20718336704116536,1,0,0,1.7021276595744679,2.679406036964871,CD226;SCARF1;NECTIN3;CRB3
high-density lipoprotein particle remodeling (GO:0034375),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,LCAT;APOA4
positive regulation of cholesterol transport (GO:0032376),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,ABCA1;NFKBIA
cellular glucuronidation (GO:0052695),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,UGT2B15;UGT1A3
positive regulation of nitrogen compound metabolic process (GO:0051173),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,WFS1;HPN
preassembly of GPI anchor in ER membrane (GO:0016254),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,PIGC;PIGW
regulation of lipid catabolic process (GO:0050994),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,RARRES2;PDE3B
negative regulation of interleukin-8 production (GO:0032717),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,MAPKBP1;BCL3
regulation of receptor recycling (GO:0001919),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,TBC1D16;VAMP3
heterocycle biosynthetic process (GO:0018130),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,MOCOS;GPHN
defense response to fungus (GO:0050832),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,RARRES2;DEFA4
positive regulation by host of viral transcription (GO:0043923),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,HPN;EP300
regulation of nucleic acid-templated transcription (GO:1903506),35/607,0.21318581415864177,1,0,0,1.1532125205930805,1.7823950389376173,ZNF793;ACVRL1;ZNF132;AIRE;RORA;ZNF3;ZNF7;SOX2;RPS6KA4;ZNF829;ZNF607;ZNF429;EP300;ZNF600;HIVEP2;PATZ1;ZNF223;ZNF200;TRAPPC2;ZNF341;WWTR1;ZNF284;ANKRD30A;ASCC1;BCL11A;PRMT1;SSRP1;UBTFL1;PTP4A3;NR5A2;ZSCAN21;ZNF74;IFNK;AJUBA;ZNF311
phosphatidylcholine biosynthetic process (GO:0006656),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,CHKB;GPAT4;LCAT
microtubule bundle formation (GO:0001578),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,TPPP3;RSPH9;MAPRE2
negative regulation of fat cell differentiation (GO:0045599),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,IL6;RORA;FOXO1
regulation of nitric oxide biosynthetic process (GO:0045428),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,HSP90AB1;AGXT2;CD36
mismatch repair (GO:0006298),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,MSH6;PCNA;TP73
positive regulation of protein polymerization (GO:0032273),5/64,0.21539586226514373,1,0,0,1.5625,2.3988714437251204,TPPP3;FES;LMOD1;MET;CCL26
positive regulation of endocytosis (GO:0045807),5/64,0.21539586226514373,1,0,0,1.5625,2.3988714437251204,TF;SIRPG;FLOT1;ANKFY1;DLL1
glucose metabolic process (GO:0006006),5/64,0.21539586226514373,1,0,0,1.5625,2.3988714437251204,PC;BRAT1;PCK1;SLC25A11;PPARD
negative regulation of neuron differentiation (GO:0045665),5/64,0.21539586226514373,1,0,0,1.5625,2.3988714437251204,SOX2;ID2;ID1;PTPN9;DLL1
peptidyl-lysine modification (GO:0018205),8/115,0.21759147223531877,1,0,0,1.391304347826087,2.1219282850272605,GCSH;PCNA;BCL11A;EP300;CDCA8;PIAS2;SENP1;NUP37
protein K48-linked ubiquitination (GO:0070936),4/48,0.21779787247025076,1,0,0,1.6666666666666665,2.540313061339135,PRKN;RNF146;RNF126;UBE2D2
regulation of cell cycle arrest (GO:0071156),4/48,0.21779787247025076,1,0,0,1.6666666666666665,2.540313061339135,MED25;HSP90AB1;ID2;TP73
glycoprotein metabolic process (GO:0009100),4/48,0.21779787247025076,1,0,0,1.6666666666666665,2.540313061339135,NEU4;B3GNT6;EDEM2;PCSK6
anterograde trans-synaptic signaling (GO:0098916),15/240,0.22212953151061135,1,0,0,1.25,1.8806182399904328,GABRB3;GRIA2;DTNA;OR11H4;HTR3D;PCDHB11;GRIN2B;GRM5;NOVA1;MPZ;KCNMB4;UTS2;ZACN;BSN;PAFAH1B1
glycolipid metabolic process (GO:0006664),5/65,0.2245509341987312,1,0,0,1.5384615384615385,2.2979272602185437,UGCG;NEU4;NEU1;ESYT1;PIGW
iron-sulfur cluster assembly (GO:0016226),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,BOLA2;CIAO1
regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,IFNK;IFNA10
maintenance of protein localization in organelle (GO:0072595),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,MORC3;BCL3
negative regulation of fibroblast proliferation (GO:0048147),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,MORC3;MED25
regulation of chemokine production (GO:0032642),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,IL6;SNAI2
prostaglandin biosynthetic process (GO:0001516),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,CD74;AKR1C3
regulation of cholesterol efflux (GO:0010874),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,ABCA1;NFKBIA
positive regulation of p38MAPK cascade (GO:1900745),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,PRMT1;AGER
regulation of cAMP-mediated signaling (GO:0043949),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,CXCL9;PDE3B
positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,IFNK;IFNA10
regulation of cellular response to growth factor stimulus (GO:0090287),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,TMEM204;PCSK6
establishment of epithelial cell polarity (GO:0090162),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,SYNE4;CYTH1
mRNA destabilization (GO:0061157),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,ZC3H12D;YTHDF3
"retrograde transport, endosome to Golgi (GO:0042147)",6/82,0.22659177650802834,1,0,0,1.4634146341463412,2.172593007559255,RNF126;EHD3;HEATR5A;ANKFY1;BET1L;VAMP3
negative regulation of binding (GO:0051100),6/82,0.22659177650802834,1,0,0,1.4634146341463412,2.172593007559255,NFKBIA;BTAF1;USP33;ID2;ID1;RSF1
intracellular pH reduction (GO:0051452),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,DMXL1;DMXL2;ATP6V0D2
glycogen metabolic process (GO:0005977),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,NHLRC1;NR1D1;UBA52
positive regulation of cytokine-mediated signaling pathway (GO:0001961),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,PRKN;CD74;AGPAT2
protein acetylation (GO:0006473),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,EP300;PCK1;FOXO1
entry into host cell (GO:0030260),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,GPR15;MET;UBA52
negative regulation of mitochondrion organization (GO:0010823),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,PRKN;VAT1;MPV17L
response to exogenous dsRNA (GO:0043330),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,FLOT1;IFNK;IFNA10
mRNA stabilization (GO:0048255),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,THRAP3;CIRBP;PABPC1
transcription initiation from RNA polymerase I promoter (GO:0006361),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,TAF1B;POLR1E;POLR2L
transcription from RNA polymerase I promoter (GO:0006360),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,TAF1B;POLR1E;POLR2L
protein autoubiquitination (GO:0051865),4/49,0.22855481299593203,1,0,0,1.6326530612244896,2.4097619846443257,PRKN;RNF146;UBE2D2;RNF220
lipid homeostasis (GO:0055088),4/49,0.22855481299593203,1,0,0,1.6326530612244896,2.4097619846443257,ABCA1;ACOX1;APOA4;PNPLA5
positive regulation of signal transduction (GO:0009967),13/206,0.23233820095135505,1,0,0,1.262135922330097,1.8421646290570604,CD74;LMO3;DLL1;AGPAT2;ROBO1;ERN1;RELN;INS-IGF2;TERT;ULK3;RSPO2;EP300;CD226
negative regulation of epithelial cell proliferation (GO:0050680),5/66,0.23381942521025603,1,0,0,1.5151515151515151,2.201827497975576,SOX2;APOH;HPN;SNAI2;ROBO1
JNK cascade (GO:0007254),5/66,0.23381942521025603,1,0,0,1.5151515151515151,2.201827497975576,ERN1;ADORA2B;IRAK2;MAP3K21;UBA52
positive regulation of cellular protein localization (GO:1903829),5/66,0.23381942521025603,1,0,0,1.5151515151515151,2.201827497975576,PRKN;CCDC88A;HSP90AB1;CROCC;GTSE1
positive regulation of peptidyl-serine phosphorylation (GO:0033138),6/83,0.23481354624178025,1,0,0,1.4457831325301203,2.0948869879664898,LATS1;IL6;IFNK;OSM;CREBL2;IFNA10
protein maturation (GO:0051604),6/83,0.23481354624178025,1,0,0,1.4457831325301203,2.0948869879664898,GCSH;PSENEN;CLN3;TSPAN15;BOLA2;PCSK6
cytosolic transport (GO:0016482),8/118,0.23800829236656018,1,0,0,1.3559322033898304,1.9463725614119634,AP4M1;RNF126;EHD3;WDR81;HEATR5A;ANKFY1;BET1L;VAMP3
neurogenesis (GO:0022008),4/50,0.2394412597417243,1,0,0,1.5999999999999999,2.287115446802478,ABTB2;BCL11A;ROGDI;CHAC1
negative regulation of T cell activation (GO:0050868),3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,SPN;LGALS3;SDC4
endoplasmic reticulum organization (GO:0007029),3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,RTN3;ATL2;SEC31B
regulation of protein localization to plasma membrane (GO:1903076),5/67,0.2431934021901658,1,0,0,1.4925373134328357,2.1102959080752326,MRAP;PRKCH;STAC;STX7;PTPN9
RNA export from nucleus (GO:0006405),8/119,0.24495576693425716,1,0,0,1.3445378151260503,1.8913312643532947,DDX19B;NXF2;SRSF1;IGFLR1;RPSA;AGFG1;POM121L12;NUP37
negative regulation of smoothened signaling pathway (GO:0045879),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,RFX4;ULK3
negative regulation of lymphocyte activation (GO:0051250),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,LGALS3;MICA
regulation of gluconeogenesis (GO:0006111),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,NR1D1;GCK
error-free translesion synthesis (GO:0070987),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,PCNA;UBA52
negative regulation of cell junction assembly (GO:1901889),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,ACVRL1;IKBKB
endoplasmic reticulum mannose trimming (GO:1904380),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,EDEM2;UBA52
positive regulation of STAT cascade (GO:1904894),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,IL6;CRLF2
positive regulation of activated T cell proliferation (GO:0042104),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,IL23A;AGER
"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,RPSA;UTP20
sulfur compound transport (GO:0072348),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,SLC35F3;SLC26A7
endothelial cell development (GO:0001885),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,SOX18;MET
acylglycerol biosynthetic process (GO:0046463),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,GPAT4;AGMO
positive regulation of mononuclear cell migration (GO:0071677),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,LGALS3;CCR2
regulation of transcription factor import into nucleus (GO:0042990),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,NFKBIA;BCL3
intracellular estrogen receptor signaling pathway (GO:0030520),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,RBM14;TADA3
cellular polysaccharide biosynthetic process (GO:0033692),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,EXT2;B3GNT6
positive regulation of immunoglobulin production (GO:0002639),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,SASH3;IL6
innate immune response in mucosa (GO:0002227),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,DEFA4;APOA4
regulation of catenin import into nucleus (GO:0035412),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,WWTR1;SNAI2
arachidonic acid metabolic process (GO:0019369),4/51,0.2504443908625444,1,0,0,1.5686274509803921,2.171793530456325,CYP2B6;CYP2S1;AKR1C3;CYP2C19
regulation of actin filament polymerization (GO:0030833),5/68,0.25266492029805,1,0,0,1.4705882352941175,2.023075137913094,LATS1;PLEKHG2;LMOD1;TWF2;CCL26
anatomical structure homeostasis (GO:0060249),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,PCNA;TERT;APEX1
negative regulation of epithelial cell migration (GO:0010633),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,ACVRL1;PTPRR;APOH
"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,UTP20;RPSA;RPS24
negative regulation of Wnt signaling pathway (GO:0030178),11/174,0.25452932625649577,1,0,0,1.264367816091954,1.7300840696963105,SOX2;LATS1;PRKN;WWTR1;LATS2;NXN;SNAI2;LRP4;APCDD1;UBA52;PSMB8
endosomal transport (GO:0016197),14/229,0.2570157781934642,1,0,0,1.222707423580786,1.661192072586522,ABCA1;ADRB2;BET1L;AP4M1;RNF126;EHD3;WDR81;HEATR5A;KIF13A;ANKFY1;GPRASP1;UBA52;AP5S1;VAMP3
stimulatory C-type lectin receptor signaling pathway (GO:0002223),8/121,0.25904531858348734,1,0,0,1.322314049586777,1.7861186874223587,NFKBIA;IKBKB;MUC2;UBE2D2;ICAM3;EP300;UBA52;PSMB8
toll-like receptor signaling pathway (GO:0002224),6/86,0.25999953625691774,1,0,0,1.3953488372093021,1.8796401371099152,IKBKB;IRAK2;UBE2D2;CD36;CD14;UBA52
regulation of primary metabolic process (GO:0080090),9/139,0.26034792963385517,1,0,0,1.2949640287769784,1.7426801675999373,ABCA1;ACOX1;ID2;ANGPTL8;NR1D1;CD36;NPAS2;PSMB8;PPARD
chemokine-mediated signaling pathway (GO:0070098),4/52,0.26155152638965784,1,0,0,1.5384615384615385,2.0632676511450203,CXCL9;CXCL5;CCR2;CCL26
regulation of endocytosis (GO:0030100),5/69,0.26222604197239524,1,0,0,1.4492753623188406,1.9399252051607478,LGALS3;RAB4B;FLOT1;DLL1;ARFGAP1
regulation of innate immune response (GO:0045088),5/69,0.26222604197239524,1,0,0,1.4492753623188406,1.9399252051607478,HSP90AB1;IFNK;TRAFD1;CD36;IFNA10
negative regulation of innate immune response (GO:0045824),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,TRAFD1;A2M
natural killer cell activation involved in immune response (GO:0002323),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,IFNK;IFNA10
negative regulation of macromolecule biosynthetic process (GO:0010558),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,IL6;NR1D1
negative regulation of actin filament bundle assembly (GO:0032232),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,PRKN;MET
embryonic digestive tract development (GO:0048566),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,RARRES2;ID2
response to progesterone (GO:0032570),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,CATSPER4;CATSPERG
error-prone translesion synthesis (GO:0042276),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,PCNA;UBA52
regulation of anoikis (GO:2000209),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,ANKRD13C;SNAI2
positive regulation of T cell migration (GO:2000406),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,SPN;CCR2
telomere maintenance via telomerase (GO:0007004),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,HSP90AB1;TERT
cellular response to lipoteichoic acid (GO:0071223),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CD14
negative regulation of cholesterol storage (GO:0010887),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ABCA1
polyamine biosynthetic process (GO:0006596),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SAT1
regulation of immunoglobulin mediated immune response (GO:0002889),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CD226
regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PRKN
positive regulation of adaptive immune response (GO:0002821),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SASH3
positive regulation of cellular extravasation (GO:0002693),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CCR2
immunological synapse formation (GO:0001771),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PRF1
negative regulation of mRNA catabolic process (GO:1902373),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PABPC1
epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SNAI2
regulation of endothelial cell development (GO:1901550),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,IKBKB
histone-serine phosphorylation (GO:0035404),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RPS6KA4
protein localization to nuclear envelope (GO:0090435),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,INTS13
negative regulation of transforming growth factor beta production (GO:0071635),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,HSP90AB1
regulation of lymphocyte apoptotic process (GO:0070228),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,LGALS3
galactosylceramide metabolic process (GO:0006681),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CLN3
positive regulation of hormone metabolic process (GO:0032352),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,HPN
SCF complex assembly (GO:0010265),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CAND2
intracellular pH elevation (GO:0051454),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CLN3
regulation of extent of cell growth (GO:0061387),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NRCAM
regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PRKN
protein retention in ER lumen (GO:0006621),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ANKRD13C
positive regulation of T-helper 17 type immune response (GO:2000318),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,IL23A
cellular response to iron ion (GO:0071281),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TF
lipoxin biosynthetic process (GO:2001301),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,HPGD
monoterpenoid metabolic process (GO:0016098),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CYP2C19
T-helper 17 cell lineage commitment (GO:0072540),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,IL6
regulation of skeletal muscle satellite cell proliferation (GO:0014842),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ANGPT1
cellular hyperosmotic response (GO:0071474),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,EPO
lipoprotein metabolic process (GO:0042157),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,APOA4
aldehyde catabolic process (GO:0046185),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,AGXT2
mRNA 3'-splice site recognition (GO:0000389),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ISY1
regulation of dopamine metabolic process (GO:0042053),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PRKN
chromatin silencing at telomere (GO:0006348),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,DYDC1
negative regulation of receptor biosynthetic process (GO:0010871),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NR1D1
"heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,EXT2
response to lipoteichoic acid (GO:0070391),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CD14
negative regulation of bone resorption (GO:0045779),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,IL6
bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PKP2
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ATF3
negative regulation of muscle cell apoptotic process (GO:0010656),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,APOH
inner ear receptor cell development (GO:0060119),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,USH1C
histone H4-K12 acetylation (GO:0043983),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,JADE3
nucleobase metabolic process (GO:0009112),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,UCK1
regulation of protein targeting (GO:1903533),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PRKN
rRNA transport (GO:0051029),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RPSA
negative regulation of neural precursor cell proliferation (GO:2000178),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ID2
dendrite extension (GO:0097484),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SH3GL2
azole transport (GO:0045117),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SLC35F3
spermine metabolic process (GO:0008215),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SAT1
regulation of ribonucleoprotein complex localization (GO:2000197),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,AKAP8L
nucleus localization (GO:0051647),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PAFAH1B1
membrane raft assembly (GO:0001765),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,FLOT1
rescue of stalled ribosome (GO:0072344),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ZNF598
positive regulation of memory T cell differentiation (GO:0043382),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,IL23A
glandular epithelial cell development (GO:0002068),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,DLL1
intermediate filament bundle assembly (GO:0045110),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PKP2
citrate metabolic process (GO:0006101),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ACO2
regulation of cellular response to oxidative stress (GO:1900407),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PRKN
positive regulation of flagellated sperm motility (GO:1902093),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TAC4
regulation of interleukin-5 secretion (GO:2000662),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CRLF2
regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SCN10A
negative regulation of complement activation (GO:0045916),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,A2M
blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ACVRL1
spinal cord dorsal/ventral patterning (GO:0021513),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RFX4
negative regulation of cAMP-mediated signaling (GO:0043951),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PDE3B
regulation of NK T cell activation (GO:0051133),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,IL23A
photoreceptor cell differentiation (GO:0046530),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,MAPRE2
lens fiber cell development (GO:0070307),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,WNT5B
signal complex assembly (GO:0007172),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PXN
negative regulation of leukocyte degranulation (GO:0043301),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CCR2
positive regulation of blood pressure (GO:0045777),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ID2
carbohydrate transport (GO:0008643),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SLC50A1
regulation of chemokine-mediated signaling pathway (GO:0070099),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ROBO1
positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CD74
acetyl-CoA biosynthetic process (GO:0006085),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ACSS1
type B pancreatic cell development (GO:0003323),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,DLL1
adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway (GO:0007196),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GRM5
macrophage derived foam cell differentiation (GO:0010742),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,EP300
mRNA 5'-splice site recognition (GO:0000395),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SRSF1
cerebral cortex cell migration (GO:0021795),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RELN
corticosteroid receptor signaling pathway (GO:0031958),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RBM14
positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PRKN
regulation of cellular carbohydrate catabolic process (GO:0043471),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PPP1R3B
hormone transport (GO:0009914),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SLC16A2
positive regulation of helicase activity (GO:0051096),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,MSH6
ribosomal small subunit export from nucleus (GO:0000056),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,XPO1
regulation of keratinocyte apoptotic process (GO:1902172),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GSN
positive regulation of histone phosphorylation (GO:0033129),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RPS6KA4
positive regulation of toll-like receptor 3 signaling pathway (GO:0034141),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,FLOT1
dosage compensation by inactivation of X chromosome (GO:0009048),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RLIM
plus-end-directed organelle transport along microtubule (GO:0072386),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,KIF13A
positive regulation of microglial cell activation (GO:1903980),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,AGER
regulation of cell cycle checkpoint (GO:1901976),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,FEM1B
negative regulation of systemic arterial blood pressure (GO:0003085),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ADRB2
aggrephagy (GO:0035973),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,WDR81
positive regulation of activation of Janus kinase activity (GO:0010536),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,IL23A
regulation of T-helper 17 cell lineage commitment (GO:2000328),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,IL23A
regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,FOXO1
regulation of anion channel activity (GO:0010359),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GRM5
positive regulation of autophagosome maturation (GO:1901098),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ADRB2
morphogenesis of an endothelium (GO:0003159),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ACVRL1
glomerulus vasculature development (GO:0072012),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ANGPT1
regulation of natural killer cell proliferation (GO:0032817),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,IL23A
regulation of extracellular exosome assembly (GO:1903551),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SDC4
astrocyte differentiation (GO:0048708),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,DLL1
equilibrioception (GO:0050957),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,USH1C
sterol import (GO:0035376),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CD36
peptidyl-serine autophosphorylation (GO:0036289),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ERN1
regulation of mRNA export from nucleus (GO:0010793),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,AKAP8L
peptidyl-proline hydroxylation (GO:0019511),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,OGFOD1
amine metabolic process (GO:0009308),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SULT1A2
inner ear receptor cell differentiation (GO:0060113),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,USH1C
establishment of protein localization to telomere (GO:0070200),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TERT
response to manganese ion (GO:0010042),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PRKN
glucocorticoid receptor signaling pathway (GO:0042921),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RBM14
endoplasmic reticulum membrane organization (GO:0090158),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ATL2
cholesterol import (GO:0070508),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CD36
foam cell differentiation (GO:0090077),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,EP300
neuron remodeling (GO:0016322),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SCARF1
positive regulation of cell differentiation (GO:0045597),12/194,0.26519672492956997,1,0,0,1.2371134020618557,1.6420000455868393,ACVRL1;WWTR1;IL6;PRKCH;HSP90AB1;FES;LMO3;RARRES2;RPS6KA1;CREBL2;CD36;PPARD
protein acylation (GO:0043543),3/36,0.2678594070249647,1,0,0,1.6666666666666665,2.1954883946257717,ZDHHC5;EP300;FOXO1
histone exchange (GO:0043486),3/36,0.2678594070249647,1,0,0,1.6666666666666665,2.1954883946257717,CENPI;RSF1;ANP32B
muscle cell differentiation (GO:0042692),3/36,0.2678594070249647,1,0,0,1.6666666666666665,2.1954883946257717,FBXO40;TMEM204;RORA
calcium ion transmembrane import into cytosol (GO:0097553),3/36,0.2678594070249647,1,0,0,1.6666666666666665,2.1954883946257717,FAM155A;ITPR2;GRIN2B
nervous system development (GO:0007399),26/455,0.26816392595554384,1,0,0,1.1428571428571428,1.504179224512278,PRKN;ROGDI;BARX1;CYP46A1;NPAS2;ROBO1;RELN;DPF1;EP300;NRCAM;CHAC1;SH3GL2;ATOH1;SH3GL1;CHST8;PCDHGA8;BCL11A;CNTN6;TMOD2;GFRA1;NAV2;PCDHB11;PCDHA10;ABTB2;DSCAML1;SCRG1
negative regulation of developmental process (GO:0051093),5/70,0.2718688550208947,1,0,0,1.4285714285714284,1.860622113738027,PRKN;VAT1;ANP32B;DLL1;ROBO1
mRNA export from nucleus (GO:0006406),7/105,0.2718705093844258,1,0,0,1.3333333333333333,1.7365725259764115,ENY2;DDX19B;NXF2;SRSF1;IGFLR1;AGFG1;NUP37
positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),4/53,0.272750159994601,1,0,0,1.5094339622641508,1.9610551964847422,IL6;EPO;IL23A;OSM
positive regulation of protein complex assembly (GO:0031334),6/88,0.2771694338705115,1,0,0,1.3636363636363635,1.7497176615936614,MED25;TPPP3;TAL1;ERCC5;CD36;AJUBA
chemical synaptic transmission (GO:0007268),17/289,0.2794068430649466,1,0,0,1.176470588235294,1.5001015770102055,GABRB3;GRIA2;DTNA;OR11H4;GRIK3;HTR3D;PCDHB11;GRIN2B;GRM5;NOVA1;MPZ;KCNMB4;UTS2;ZACN;BSN;DLGAP2;PAFAH1B1
positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091),13/215,0.2800310091269687,1,0,0,1.2093023255813953,1.5392664330992478,PRKCH;AGER;RPS6KA4;IKBKB;NFKBIA;IL6;RELN;IRAK2;EP300;RBCK1;CD36;UBA52;NKX2-2
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),9/142,0.28045862739678284,1,0,0,1.2676056338028168,1.6115438798995247,MPZ;CD226;PCDHB11;SCARF1;DSCAML1;NECTIN3;FGFRL1;ROBO1;CRB3
innate immune response activating cell surface receptor signaling pathway (GO:0002220),8/124,0.28061953631387226,1,0,0,1.2903225806451613,1.639684503717075,NFKBIA;IKBKB;MUC2;UBE2D2;ICAM3;EP300;UBA52;PSMB8
regulation of cell communication (GO:0010646),5/71,0.2815854896327663,1,0,0,1.408450704225352,1.7849565976318464,SASH3;GRIA2;RELN;GRIK3;CASQ2
phosphatidylcholine metabolic process (GO:0046470),5/71,0.2815854896327663,1,0,0,1.408450704225352,1.7849565976318464,CHKB;GPAT4;LPCAT3;LCAT;APOA4
histone acetylation (GO:0016573),5/71,0.2815854896327663,1,0,0,1.408450704225352,1.7849565976318464,TADA3;CHD5;EP300;JADE3;TAF9B
response to insulin (GO:0032868),5/71,0.2815854896327663,1,0,0,1.408450704225352,1.7849565976318464,INS-IGF2;PDE3B;PCK1;FOXO1;GCK
regulation of DNA repair (GO:0006282),3/37,0.2816374857336128,1,0,0,1.6216216216216217,2.054812778279635,PCNA;PARG;NPAS2
positive regulation of smooth muscle cell proliferation (GO:0048661),3/37,0.2816374857336128,1,0,0,1.6216216216216217,2.054812778279635,ERN1;IL6;ID2
"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",3/37,0.2816374857336128,1,0,0,1.6216216216216217,2.054812778279635,PCNA;ERCC5;UBA52
cobalamin metabolic process (GO:0009235),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,CUBN;MMAA
GTP metabolic process (GO:0046039),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,MOCOS;GPHN
RNA-dependent DNA biosynthetic process (GO:0006278),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,HSP90AB1;TERT
positive regulation of leukocyte cell-cell adhesion (GO:1903039),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,SIRPG;CCR2
establishment of spindle orientation (GO:0051294),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,MOS;PAFAH1B1
tetrapyrrole metabolic process (GO:0033013),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,CUBN;MMAA
negative regulation of ion transmembrane transporter activity (GO:0032413),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,EPO;CASQ2
positive regulation of T cell mediated immunity (GO:0002711),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,IL23A;STX7
zinc II ion transport (GO:0006829),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,SLC30A6;SLC39A14
negative regulation of cytokine biosynthetic process (GO:0042036),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,IL6;BCL3
negative regulation of G-protein coupled receptor protein signaling pathway (GO:0045744),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,GPRASP1;MET
vesicle docking (GO:0048278),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,STX7;CEP83
regulation of nuclear division (GO:0051783),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,CCDC8;MKI67
negative regulation of viral process (GO:0048525),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,CRP;MBL2
negative regulation of cyclin-dependent protein kinase activity (GO:1904030),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,LATS1;LATS2
positive regulation of lipid metabolic process (GO:0045834),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,CREBL2;APOA4
phosphatidylserine acyl-chain remodeling (GO:0036150),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,OSBPL5;LPCAT3
"synaptic transmission, glutamatergic (GO:0035249)",2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,GRIA2;GRIK3
sensory perception (GO:0007600),4/54,0.2840279876642483,1,0,0,1.4814814814814814,1.8647148112043361,SCN10A;OBP2A;KCNA2;USH1C
RNA modification (GO:0009451),4/54,0.2840279876642483,1,0,0,1.4814814814814814,1.8647148112043361,CTU2;METTL1;TSR3;TARBP1
positive regulation of immune response (GO:0050778),4/54,0.2840279876642483,1,0,0,1.4814814814814814,1.8647148112043361,SASH3;IL23A;IFNK;CD226
intracellular protein transport (GO:0006886),20/347,0.2877879299908991,1,0,0,1.152737752161383,1.435771094278239,CRB1;CD74;ANKLE1;COG7;RAB4B;STRADB;STX7;AKR1C3;COPZ2;AP4M1;XPO1;KIF13A;BCL3;HEATR3;ARFIP1;EVI5L;SEC31B;AP1M2;TBC1D16;POM121L12
protein dephosphorylation (GO:0006470),8/125,0.2879156477186434,1,0,0,1.28,1.5937122964641617,PTPRR;PPP1R12A;UBLCP1;PPP2R2B;PPP2R2D;PTPN9;MTMR6;TIMM50
glycoprotein biosynthetic process (GO:0009101),5/72,0.2913681345785638,1,0,0,1.3888888888888888,1.712732977852415,CHST8;COG7;B3GNT6;POMT1;DDOST
regulation of epithelial cell proliferation (GO:0050678),5/72,0.2913681345785638,1,0,0,1.3888888888888888,1.712732977852415,ACVRL1;SOX2;HPN;NR1D1;NME1
regulation of cell cycle process (GO:0010564),6/90,0.29459151170537495,1,0,0,1.3333333333333333,1.6295541177562636,RMI2;CCDC8;KIF13A;TXLNG;MKI67;LINC00598
protein tetramerization (GO:0051262),6/90,0.29459151170537495,1,0,0,1.3333333333333333,1.6295541177562636,CD74;LRP4;HSD17B10;GRIN2B;AASS;TGM3
regulation of Ras protein signal transduction (GO:0046578),6/90,0.29459151170537495,1,0,0,1.3333333333333333,1.6295541177562636,GIT2;DENND4B;EPO;ARAP2;ARFGAP1;AGFG1
regulation of ossification (GO:0030278),3/38,0.29547545275268733,1,0,0,1.5789473684210524,1.9250044986274375,TXLNG;LRP4;SNAI2
chemical homeostasis (GO:0048878),3/38,0.29547545275268733,1,0,0,1.5789473684210524,1.9250044986274375,ACOX1;APOA4;PNPLA5
regulation of cytokine production (GO:0001817),7/108,0.29558593657898286,1,0,0,1.296296296296296,1.5799203089302307,RPS6KA4;IL6;FLOT1;SNAI2;UBA52;AGPAT2;CCR2
organonitrogen compound biosynthetic process (GO:1901566),11/181,0.2964318454547052,1,0,0,1.2154696132596683,1.4779356304738427,CHKB;ELOVL4;B3GNT6;GPAT4;GSTA3;MOCOS;GSTA1;LCAT;SGMS2;GPHN;SULT1A2
positive regulation of nucleic acid-templated transcription (GO:1903508),28/502,0.3015691332064208,1,0,0,1.1155378486055776,1.3372576798343856,ACVRL1;ENY2;SETD3;AIRE;EPO;RORA;CREBL2;RSF1;NPAS2;FOXO1;IKBKB;SOX2;CAND2;SOX18;EP300;CD74;NR1D1;PIAS2;IL6;NR5A2;TAL1;THRAP3;ID2;ZNF318;TADA3;BCL3;PPARD;TP73
skeletal muscle myosin thick filament assembly (GO:0030241),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,MYH11
cellular response to caffeine (GO:0071313),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CASQ2
protein localization to basolateral plasma membrane (GO:1903361),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,AP4M1
histone H3-K4 demethylation (GO:0034720),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,KDM5D
inner ear receptor stereocilium organization (GO:0060122),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,USH1C
cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PKP2
intracellular sterol transport (GO:0032366),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ABCA1
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,MPV17L
positive regulation of dendritic spine morphogenesis (GO:0061003),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,RELN
tRNA pseudouridine synthesis (GO:0031119),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,RPUSD3
venous blood vessel development (GO:0060841),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ACVRL1
coenzyme A biosynthetic process (GO:0015937),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PANK2
tyrosine metabolic process (GO:0006570),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,IYD
negative regulation of keratinocyte proliferation (GO:0010839),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SNAI2
AV node cell action potential (GO:0086016),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SCN10A
regulation of chromatin assembly or disassembly (GO:0001672),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,TAL1
negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CD14
tachykinin receptor signaling pathway (GO:0007217),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,TAC4
regulation of dendritic spine maintenance (GO:1902950),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,GRIN2B
"fatty acid elongation, unsaturated fatty acid (GO:0019368)",1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ELOVL4
negative regulation of interleukin-8 secretion (GO:2000483),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,MAPKBP1
regulation of DNA endoreduplication (GO:0032875),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,STAG2
regulation of cardiac muscle cell membrane potential (GO:0086036),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,EHD3
cellular ion homeostasis (GO:0006873),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SLC4A1
ribonucleoside bisphosphate biosynthetic process (GO:0034030),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PANK2
dorsal aorta development (GO:0035907),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ACVRL1
elastic fiber assembly (GO:0048251),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,MYH11
regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,FGF18
regulation of tube diameter (GO:0035296),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,UTS2
nucleoside diphosphate metabolic process (GO:0009132),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,AK8
negative regulation of type 2 immune response (GO:0002829),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CCR2
cytoplasmic sequestering of NF-kappaB (GO:0007253),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NFKBIA
nucleic acid transport (GO:0050657),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NXF2
positive regulation of apoptotic cell clearance (GO:2000427),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,C4B
retrograde axonal transport (GO:0008090),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PAFAH1B1
positive regulation of autophagy of mitochondrion (GO:1903599),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PRKN
cellular response to leptin stimulus (GO:0044320),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,GCK
valine metabolic process (GO:0006573),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,BCAT2
protein import into mitochondrial inner membrane (GO:0045039),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,AGK
regulation of sterol transport (GO:0032371),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,APOA4
terpenoid metabolic process (GO:0006721),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CYP2C19
regulation of chemokine biosynthetic process (GO:0045073),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,IL6
regulation of T-helper 17 type immune response (GO:2000316),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,IL23A
"fatty acid elongation, saturated fatty acid (GO:0019367)",1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ELOVL4
"fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ELOVL4
regulation of memory T cell differentiation (GO:0043380),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,IL23A
positive regulation of killing of cells of other organism (GO:0051712),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PRF1
adenine nucleotide transport (GO:0051503),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SLC25A17
pituitary gland development (GO:0021983),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SOX2
glycosylceramide metabolic process (GO:0006677),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CLN3
positive regulation of macrophage migration (GO:1905523),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,RARRES2
positive regulation of NK T cell activation (GO:0051135),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,IL23A
lysosomal lumen acidification (GO:0007042),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CLN3
protein localization to cytoplasmic stress granule (GO:1903608),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,DDX1
regulation of vitamin D biosynthetic process (GO:0060556),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SNAI2
zinc II ion transmembrane import (GO:0071578),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SLC39A14
positive regulation of protein kinase A signaling (GO:0010739),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ADRB2
positive regulation of triglyceride catabolic process (GO:0010898),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,APOA4
positive regulation of hemopoiesis (GO:1903708),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,FES
regulation of dendritic cell differentiation (GO:2001198),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,AGER
regulation of pinocytosis (GO:0048548),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ANKFY1
positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PRKN
regulation of glucocorticoid receptor signaling pathway (GO:2000322),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,LMO3
ion homeostasis (GO:0050801),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SLC4A1
purine ribonucleotide transport (GO:0015868),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SLC25A17
auditory receptor cell differentiation (GO:0042491),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,USH1C
regulation of toll-like receptor 3 signaling pathway (GO:0034139),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,FLOT1
V(D)J recombination (GO:0033151),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,DCAF1
activation of signaling protein activity involved in unfolded protein response (GO:0006987),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ERN1
regulation of establishment of protein localization (GO:0070201),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PTP4A3
cellular response to histamine (GO:0071420),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,GABRB3
negative regulation of epidermal cell differentiation (GO:0045605),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,DLL1
"wound healing, spreading of epidermal cells (GO:0035313)",1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ACVRL1
dorsal aorta morphogenesis (GO:0035912),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ACVRL1
ethanol catabolic process (GO:0006068),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SULT1A2
positive regulation of insulin receptor signaling pathway (GO:0046628),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,INS-IGF2
positive regulation of interleukin-5 production (GO:0032754),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CRLF2
positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,GEN1
G-quadruplex DNA unwinding (GO:0044806),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PIF1
"fatty acid elongation, monounsaturated fatty acid (GO:0034625)",1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ELOVL4
purine nucleoside bisphosphate biosynthetic process (GO:0034033),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PANK2
regulation of activation of Janus kinase activity (GO:0010533),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,IL23A
lens fiber cell differentiation (GO:0070306),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,WNT5B
ethanol metabolic process (GO:0006067),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SULT1A2
response to caffeine (GO:0031000),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CASQ2
regulation of microtubule binding (GO:1904526),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,GTSE1
protein maturation by iron-sulfur cluster transfer (GO:0097428),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,BOLA2
positive regulation of macrophage chemotaxis (GO:0010759),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,RARRES2
regulation of microglial cell activation (GO:1903978),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,AGER
spermidine metabolic process (GO:0008216),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SAT1
excitatory chemical synaptic transmission (GO:0098976),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,GRIN2B
glyoxylate metabolic process (GO:0046487),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,AGXT2
myoblast fusion (GO:0007520),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ADGRB3
regulation of protein heterodimerization activity (GO:0043497),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CD36
T-helper 1 type immune response (GO:0042088),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,EBI3
neuron fate specification (GO:0048665),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,DLL1
ER overload response (GO:0006983),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,WFS1
long-chain fatty acid import (GO:0044539),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CD36
hyperosmotic response (GO:0006972),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,EPO
cAMP catabolic process (GO:0006198),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PDE3B
regulation of Cdc42 protein signal transduction (GO:0032489),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ABCA1
regulation of calcium ion transport into cytosol (GO:0010522),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,EPO;CASQ2
glutathione derivative biosynthetic process (GO:1901687),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,GSTA3;GSTA1
regulation of catecholamine secretion (GO:0050433),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,PRKN;KCNA2
"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,ERCC5;BIVM-ERCC5
lymphocyte activation involved in immune response (GO:0002285),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,IFNK;IFNA10
negative regulation of actin filament polymerization (GO:0030837),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,GSN;TWF2
histone lysine methylation (GO:0034968),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,SETD3;DYDC1
positive regulation of erythrocyte differentiation (GO:0045648),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,PRMT1;TAL1
triglyceride catabolic process (GO:0019433),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,APOA4;PNPLA5
rRNA modification (GO:0000154),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,DIMT1;TSR3
C21-steroid hormone metabolic process (GO:0008207),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,GUCY2C;AKR1C3
inner ear morphogenesis (GO:0042472),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,HPN;USH1C
glutathione derivative metabolic process (GO:1901685),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,GSTA3;GSTA1
regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,NR1D1;C2CD2L
glucose transport (GO:0015758),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,RAB4B;PPARD
positive regulation of transcription from RNA polymerase II promoter (GO:0045944),46/848,0.30304716631735346,1,0,0,1.0849056603773584,1.295232872027862,PRKN;ACVRL1;SETD3;AIRE;AKAP8L;RORA;CCNC;LDB2;DLL1;NPAS2;FOXO1;DDN;IKBKB;SOX2;RPS6KA4;DBP;TERT;SOX18;RPS6KA1;SHOX;EP300;ZNF567;TAF9B;WWTR1;RBM14;PPP1R12A;OSM;NR1D1;SENP1;NFKBIA;MED25;IL6;NR5A2;LMX1A;TAL1;THRAP3;RFX4;ZSCAN21;TBPL1;ATF6;MET;UBA52;ATF3;TAF2;PPARD;TP73
positive regulation of gene expression (GO:0010628),42/771,0.30340870344263515,1,0,0,1.0894941634241244,1.2994119350678175,PRKN;CRP;ACVRL1;ENY2;SETD3;AIRE;EPO;HPN;RORA;CREBL2;RSF1;NPAS2;FOXO1;IKBKB;CAND2;SOX2;TAF1B;SOX18;EP300;CD36;POLR2L;CD74;GSN;YTHDF3;DIMT1;CIRBP;SLC50A1;NR1D1;PIAS2;ERN1;IL6;NR5A2;TAL1;THRAP3;ID2;ZNF318;TADA3;BCL3;POLR1E;UBAP2;PPARD;TP73
protein deubiquitination (GO:0016579),15/257,0.3058111081294603,1,0,0,1.1673151750972761,1.383020616336801,PRKN;ENY2;USP20;USP33;ABRAXAS2;ADRB2;USP28;PSMB8;RNF146;NFKBIA;TFPT;TADA3;EP300;TAF9B;UBA52
chromosome organization (GO:0051276),4/56,0.30677317565166196,1,0,0,1.4285714285714284,1.6880666371405524,MSH6;LATS1;CDCA8;UBA52
ribosome assembly (GO:0042255),4/56,0.30677317565166196,1,0,0,1.4285714285714284,1.6880666371405524,SAMD15;MRTO4;RPSA;RSL24D1
regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),4/56,0.30677317565166196,1,0,0,1.4285714285714284,1.6880666371405524,IKBKB;PRKN;RBCK1;UBA52
phosphate-containing compound metabolic process (GO:0006796),11/183,0.3087415408029792,1,0,0,1.2021857923497266,1.4128698017340853,PANK2;ITPKA;MOCOS;LCAT;OCRL;COQ8A;DUSP15;AGPAT2;SLC17A2;GCK;IP6K2
regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),3/39,0.3093526636827237,1,0,0,1.5384615384615385,1.8050359176351607,LGALS3;FEM1B;TNFRSF10B
positive regulation of reactive oxygen species metabolic process (GO:2000379),3/39,0.3093526636827237,1,0,0,1.5384615384615385,1.8050359176351607,CRP;AKR1C3;CD36
"regulation of gene expression, epigenetic (GO:0040029)",5/74,0.31110059336369467,1,0,0,1.3513513513513513,1.577890496988918,TAF1B;EP300;POLR1E;SLC50A1;POLR2L
positive regulation of defense response (GO:0031349),5/74,0.31110059336369467,1,0,0,1.3513513513513513,1.577890496988918,NFKBIA;IL23A;IFNK;CCR2;CCL26
glucose homeostasis (GO:0042593),5/74,0.31110059336369467,1,0,0,1.3513513513513513,1.577890496988918,INS-IGF2;WFS1;PCK1;FOXO1;GCK
positive regulation of cellular metabolic process (GO:0031325),6/92,0.31222205200130426,1,0,0,1.3043478260869563,1.5183138771942595,NFKBIA;ANGPT1;HPN;AKR1C3;APOA4;VAMP3
mitotic cell cycle phase transition (GO:0044772),13/221,0.3134222374811857,1,0,0,1.176470588235294,1.3649458776349923,PPP1R12A;CEP164;USH1C;LATS1;LATS2;CNTRL;PPP2R2D;MCM3;MCM4;UBA52;AJUBA;TAF2;PAFAH1B1
IRE1-mediated unfolded protein response (GO:0036498),4/57,0.31821716196314576,1,0,0,1.4035087719298245,1.6070473403738648,ERN1;WFS1;SRPRA;ARFGAP1
cholesterol efflux (GO:0033344),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,ABCA1;APOA4
"nucleotide-excision repair, DNA gap filling (GO:0006297)",2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,PCNA;UBA52
ammonium transport (GO:0015696),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,RHBG;RHCE
melanosome organization (GO:0032438),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,PMEL;KIF13A
zinc II ion transmembrane transport (GO:0071577),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,SLC30A6;SLC39A14
protein K48-linked deubiquitination (GO:0071108),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,USP20;USP33
vitamin transport (GO:0051180),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,CUBN;SLC35F3
membrane assembly (GO:0071709),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,FLOT1;LRP4
cellular response to ammonium ion (GO:0071242),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,GABRB3;PRKN
negative regulation of signal transduction in absence of ligand (GO:1901099),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,TERT;SNAI2
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,TERT;SNAI2
histone H3-K4 methylation (GO:0051568),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,SETD3;DYDC1
divalent inorganic cation homeostasis (GO:0072507),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,PRKN;WFS1
regulation of chondrocyte differentiation (GO:0032330),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,ACVRL1;SNAI2
retinoid metabolic process (GO:0001523),5/75,0.32103520904984706,1,0,0,1.3333333333333333,1.5149393018047932,SDC4;RARRES2;AKR1C3;APOA4;UGT1A3
regulation of actin cytoskeleton organization (GO:0032956),5/75,0.32103520904984706,1,0,0,1.3333333333333333,1.5149393018047932,CCDC88A;ARHGEF19;TWF2;RHOU;RHOBTB2
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),6/93,0.32110195783620454,1,0,0,1.2903225806451613,1.465802039518082,EPO;UBE2D2;EP300;UBA52;ATF3;PSMB8
negative regulation of canonical Wnt signaling pathway (GO:0090090),9/148,0.32185346752169186,1,0,0,1.2162162162162162,1.3787743461346562,SOX2;LATS1;PRKN;WWTR1;LATS2;SNAI2;LRP4;UBA52;PSMB8
negative regulation of transport (GO:0051051),3/40,0.3232493972692518,1,0,0,1.4999999999999998,1.693996688892286,PRKN;RSC1A1;LGALS3
negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),3/40,0.3232493972692518,1,0,0,1.4999999999999998,1.693996688892286,RNF126;UBA52;SH3GL2
tRNA aminoacylation (GO:0043039),3/40,0.3232493972692518,1,0,0,1.4999999999999998,1.693996688892286,RARS2;PPA2;TARS2
response to peptide hormone (GO:0043434),3/40,0.3232493972692518,1,0,0,1.4999999999999998,1.693996688892286,INS-IGF2;REG1B;PCK1
neuron migration (GO:0001764),3/40,0.3232493972692518,1,0,0,1.4999999999999998,1.693996688892286,RELN;NRCAM;PAFAH1B1
regulation of intracellular transport (GO:0032386),3/40,0.3232493972692518,1,0,0,1.4999999999999998,1.693996688892286,PRKN;FES;UNC13D
positive regulation of cytokine biosynthetic process (GO:0042108),3/40,0.3232493972692518,1,0,0,1.4999999999999998,1.693996688892286,SPN;EBI3;CCR2
regulation of viral transcription (GO:0046782),3/40,0.3232493972692518,1,0,0,1.4999999999999998,1.693996688892286,RSF1;NELFA;POLR2L
protein modification by small protein removal (GO:0070646),15/261,0.32673794968754316,1,0,0,1.1494252873563218,1.2857434557028515,PRKN;USP20;USP33;ABRAXAS2;ADRB2;USP28;PSMB8;SENP1;RNF146;NFKBIA;TFPT;TADA3;EP300;TAF9B;UBA52
response to light stimulus (GO:0009416),4/58,0.3296936338803053,1,0,0,1.379310344827586,1.5304709488498607,MSH6;CIRBP;ERCC5;PRIMPOL
tRNA modification (GO:0006400),4/58,0.3296936338803053,1,0,0,1.379310344827586,1.5304709488498607,CTU2;METTL1;RPUSD3;TARBP1
peptidyl-cysteine modification (GO:0018198),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,TMX3
neuron projection extension involved in neuron projection guidance (GO:1902284),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SEMA3F
barbed-end actin filament capping (GO:0051016),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,TWF2
cell migration involved in heart development (GO:0060973),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SNAI2
cellular response to nitric oxide (GO:0071732),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,FOXO1
"regulation of synaptic transmission, dopaminergic (GO:0032225)",1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,FLOT1
lipoprotein transport (GO:0042953),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CD36
regulation of establishment of protein localization to mitochondrion (GO:1903747),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PRKN
positive regulation of tissue remodeling (GO:0034105),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,IL23A
aminoglycoside antibiotic metabolic process (GO:0030647),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,AKR1C3
ribosomal large subunit export from nucleus (GO:0000055),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,XPO1
neurotransmitter receptor diffusion trapping (GO:0099628),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,GPHN
nucleoside diphosphate phosphorylation (GO:0006165),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,AK8
protein lipoylation (GO:0009249),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,GCSH
negative regulation of leukocyte mediated cytotoxicity (GO:0001911),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,MICA
negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,NR1D1
endodermal cell fate commitment (GO:0001711),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SOX2
"peptidyl-arginine methylation, to asymmetrical-dimethyl arginine (GO:0019919)",1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PRMT1
intestinal cholesterol absorption (GO:0030299),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CD36
positive regulation of chromatin binding (GO:0035563),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,MED25
daunorubicin metabolic process (GO:0044597),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,AKR1C3
cellular response to reactive nitrogen species (GO:1902170),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,FOXO1
negative regulation of potassium ion transmembrane transporter activity (GO:1901017),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CASQ2
regulation of protein deacetylation (GO:0090311),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,EP300
regulation of T cell mediated immunity (GO:0002709),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,AGER
protein K6-linked ubiquitination (GO:0085020),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PRKN
transepithelial transport (GO:0070633),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,RHBG
benzene-containing compound metabolic process (GO:0042537),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,KYAT3
regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CD14
axon extension involved in axon guidance (GO:0048846),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SEMA3F
glycerolipid biosynthetic process (GO:0045017),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,AGK
protein desumoylation (GO:0016926),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SENP1
positive regulation of cAMP-mediated signaling (GO:0043950),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CXCL9
desensitization of G-protein coupled receptor protein signaling pathway (GO:0002029),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,ADRB2
positive regulation of spindle checkpoint (GO:0090232),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,GEN1
bundle of His cell to Purkinje myocyte communication (GO:0086069),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PKP2
insulin metabolic process (GO:1901142),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,ERN1
glycosyl compound metabolic process (GO:1901657),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,NME4
positive regulation of protein localization to cell surface (GO:2000010),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,HSP90AB1
kynurenine metabolic process (GO:0070189),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,KYAT3
negative regulation of hippo signaling (GO:0035331),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,AJUBA
ketone biosynthetic process (GO:0042181),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,AKR1C3
negative regulation of mRNA polyadenylation (GO:1900364),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,RNF40
early endosome to Golgi transport (GO:0034498),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,EHD3
B cell mediated immunity (GO:0019724),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CD74
positive regulation of immunoglobulin mediated immune response (GO:0002891),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CD226
positive regulation of monocyte differentiation (GO:0045657),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CD74
fatty acid alpha-oxidation (GO:0001561),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SLC25A17
phospholipid homeostasis (GO:0055091),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,ABCA1
alpha-amino acid biosynthetic process (GO:1901607),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,BCAT2
cGMP-mediated signaling (GO:0019934),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CD36
regulation of lipid transport (GO:0032368),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PRKN
regulation of cytoplasmic mRNA processing body assembly (GO:0010603),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CNOT2
cellular response to purine-containing compound (GO:0071415),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CASQ2
basement membrane organization (GO:0071711),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,HPN
doxorubicin metabolic process (GO:0044598),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,AKR1C3
negative regulation of exocytosis (GO:0045920),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PRKN
pyrimidine nucleobase metabolic process (GO:0006206),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,UCK1
response to hydroperoxide (GO:0033194),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,APOA4
granulocyte differentiation (GO:0030851),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,TAL1
negative regulation of cAMP-dependent protein kinase activity (GO:2000480),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PRKAR2A
asymmetric protein localization (GO:0008105),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PARD3B
regulation of response to oxidative stress (GO:1902882),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PRKN
negative regulation of bone remodeling (GO:0046851),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,IL6
negative regulation of vascular permeability (GO:0043116),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,ANGPT1
regulation of smooth muscle cell apoptotic process (GO:0034391),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,APOH
calcium ion import into cytosol (GO:1902656),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,FAM155A
negative regulation of cilium assembly (GO:1902018),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,EVI5L
nucleotide phosphorylation (GO:0046939),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,AK8
positive regulation of TORC1 signaling (GO:1904263),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,RRAGB
regulation of long term synaptic depression (GO:1900452),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,AGER
mitochondrial tRNA modification (GO:0070900),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,HSD17B10
positive regulation of viral entry into host cell (GO:0046598),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CD74
peptidyl-lysine acetylation (GO:0018394),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,EP300
calcium ion import across plasma membrane (GO:0098703),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,FAM155A
peptidyl-lysine monomethylation (GO:0018026),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SETD3
postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,GPHN
lipoprotein localization (GO:0044872),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CD36
negative regulation of telomerase activity (GO:0051974),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PIF1
regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,LMO3
regulation of T-helper 2 cell cytokine production (GO:2000551),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,IL6
pantothenate metabolic process (GO:0015939),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PANK2
tRNA aminoacylation for mitochondrial protein translation (GO:0070127),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,TARS2
regulation of apoptotic cell clearance (GO:2000425),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,C4B
bicarbonate transport (GO:0015701),3/41,0.3371468638537048,1,0,0,1.4634146341463412,1.5910780182096236,CA7;SLC26A7;SLC4A1
DNA duplex unwinding (GO:0032508),3/41,0.3371468638537048,1,0,0,1.4634146341463412,1.5910780182096236,PIF1;DDX1;UBA52
regulation of stress-activated MAPK cascade (GO:0032872),3/41,0.3371468638537048,1,0,0,1.4634146341463412,1.5910780182096236,IGBP1;AGER;FOXO1
telomere organization (GO:0032200),3/41,0.3371468638537048,1,0,0,1.4634146341463412,1.5910780182096236,PCNA;TERT;APEX1
monocyte chemotaxis (GO:0002548),3/41,0.3371468638537048,1,0,0,1.4634146341463412,1.5910780182096236,LGALS3;IL6;CCL26
negative regulation of proteolysis (GO:0045861),3/41,0.3371468638537048,1,0,0,1.4634146341463412,1.5910780182096236,CLN3;TM4SF20;CHAC1
gluconeogenesis (GO:0006094),3/41,0.3371468638537048,1,0,0,1.4634146341463412,1.5910780182096236,PC;PCK1;SLC25A11
transcription elongation from RNA polymerase II promoter (GO:0006368),6/95,0.33896434675202747,1,0,0,1.263157894736842,1.3665604407859686,PBRM1;NELFA;SSRP1;TAF9B;TAF2;POLR2L
interleukin-1-mediated signaling pathway (GO:0070498),6/95,0.33896434675202747,1,0,0,1.263157894736842,1.3665604407859686,IKBKB;RPS6KA4;NFKBIA;IRAK2;UBA52;PSMB8
positive regulation of microtubule polymerization (GO:0031116),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,FES;MET
positive regulation of neutrophil chemotaxis (GO:0090023),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,CD74;CXCL5
membrane protein intracellular domain proteolysis (GO:0031293),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,PSENEN;DLL1
positive regulation of immune effector process (GO:0002699),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,IL23A;CCR2
negative regulation of cytoskeleton organization (GO:0051494),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,PRKN;TWF2
response to dsRNA (GO:0043331),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,IFNK;IFNA10
receptor clustering (GO:0043113),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,DNAJA3;LRP4
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,TNFRSF10B;CHAC1
negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,LATS1;LATS2
positive regulation of microtubule polymerization or depolymerization (GO:0031112),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,FES;MET
eosinophil chemotaxis (GO:0048245),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,LGALS3;CCL26
DNA geometric change (GO:0032392),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,PIF1;DDX1
axoneme assembly (GO:0035082),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,RSPH9;MAPRE2
regulation of chemotaxis (GO:0050920),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,RARRES2;CCL26
negative regulation of oxidative stress-induced cell death (GO:1903202),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,PRKN;GPR37L1
cellular senescence (GO:0090398),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,ID2;ULK3
regulation of AMPA receptor activity (GO:2000311),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,RELN;ADRB2
eosinophil migration (GO:0072677),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,LGALS3;CCL26
cilium-dependent cell motility (GO:0060285),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,RSPH9;CFAP44
mucosal immune response (GO:0002385),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,DEFA4;APOA4
mRNA splice site selection (GO:0006376),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,ISY1;SRSF1
"protein alpha-1,2-demannosylation (GO:0036508)",2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,EDEM2;UBA52
transition metal ion homeostasis (GO:0055076),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,PRKN;TF
proteoglycan biosynthetic process (GO:0030166),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,CHST8;EXT2
negative regulation of T cell proliferation (GO:0042130),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,SPN;SDC4
organic cation transport (GO:0015695),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,RHBG;RHCE
water-soluble vitamin metabolic process (GO:0006767),5/77,0.34100404859306127,1,0,0,1.2987012987012985,1.397221985795033,CUBN;PANK2;PC;MMAA;AOX1
epithelial cell differentiation (GO:0030855),6/96,0.3479363200566363,1,0,0,1.25,1.3196697553688395,LATS1;LGALS3;PCNA;DMBT1;GSTA1;PCK1
regulation of cell death (GO:0010941),6/96,0.3479363200566363,1,0,0,1.25,1.3196697553688395,PRKN;PACRG;NOA1;AKR1C3;CD36;NPAS2
regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),5/78,0.3510237868632946,1,0,0,1.282051282051282,1.3421811397066412,EPO;UBE2D2;EP300;UBA52;PSMB8
regulation of protein modification process (GO:0031399),3/42,0.3510272087326468,1,0,0,1.4285714285714284,1.4955593439482697,CCDC88A;GRM5;PARG
glycolipid biosynthetic process (GO:0009247),3/42,0.3510272087326468,1,0,0,1.4285714285714284,1.4955593439482697,PIGC;UGCG;PIGW
translesion synthesis (GO:0019985),3/42,0.3510272087326468,1,0,0,1.4285714285714284,1.4955593439482697,PCNA;UBA52;PRIMPOL
epithelium development (GO:0060429),7/115,0.35239484145081534,1,0,0,1.2173913043478262,1.269742811049461,LGALS3;PCNA;DMBT1;SOX18;GSTA1;SNAI2;DLL1
positive regulation of protein binding (GO:0032092),4/60,0.3527005497730227,1,0,0,1.3333333333333333,1.3895145106479536,PRKN;TERT;USP33;FLOT1
mRNA metabolic process (GO:0016071),6/97,0.3569285827398046,1,0,0,1.2371134020618557,1.2744984316239885,ERN1;SCAF11;AKAP8L;SRSF1;RNASE4;DXO
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),6/97,0.3569285827398046,1,0,0,1.2371134020618557,1.2744984316239885,CD74;KIF2A;SAR1B;SH3GL2;AP1M2;SPTBN2
antigen processing and presentation of exogenous peptide antigen (GO:0002478),6/97,0.3569285827398046,1,0,0,1.2371134020618557,1.2744984316239885,CD74;KIF2A;SAR1B;SH3GL2;AP1M2;SPTBN2
regulation of telomere maintenance (GO:0032204),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,PIF1;HDAC8
"protein import into nucleus, translocation (GO:0000060)",2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,BCL3;AKR1C3
glial cell differentiation (GO:0010001),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,SOX2;RELN
respiratory chain complex IV assembly (GO:0008535),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,COA6;COX20
cyclic nucleotide metabolic process (GO:0009187),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,GUCY2C;PDE8B
inorganic cation import across plasma membrane (GO:0098659),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,FAM155A;SLC9A8
positive regulation of interleukin-12 production (GO:0032735),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,IL23A;AGER
in utero embryonic development (GO:0001701),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,PTPRR;RARRES2
"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,CD74;SNAI2
"RNA splicing, via transesterification reactions (GO:0000375)",2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,SCAF11;TRA2B
monocarboxylic acid catabolic process (GO:0072329),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,AGXT2;PPARD
regulation of glucose metabolic process (GO:0010906),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,PRKN;RORA
ncRNA 3'-end processing (GO:0043628),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,ELAC2;INTS2
positive regulation of neutrophil migration (GO:1902624),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,CD74;CXCL5
protein depolymerization (GO:0051261),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,KIF2A;TWF2
positive regulation of calcium ion transmembrane transport (GO:1904427),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,CXCL9;F2RL3
regulation of protein import into nucleus (GO:0042306),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,WWTR1;CABP1
sphingolipid metabolic process (GO:0006665),7/116,0.3606196265526343,1,0,0,1.206896551724138,1.2309518612816097,UGCG;CLN3;NEU4;ELOVL4;NEU1;SGMS2;ESYT1
positive regulation of intracellular signal transduction (GO:1902533),26/479,0.360992146274285,1,0,0,1.0855949895615866,1.1061117321640468,PRKN;CXCL9;CHD5;ADRB2;AGER;IKBKB;SOX2;RELN;CD14;CD74;ANGPT1;AKR1C3;OSM;TNFRSF10B;GPR37L1;MOS;PTP4A3;IL6;INS-IGF2;RRAGB;FGF18;RBCK1;UBA52;MAP3K14;MET;CRLF2
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),5/79,0.36105764852361333,1,0,0,1.2658227848101267,1.2895160027815111,TNFSF15;TNFRSF10B;ANP32B;ROBO1;SENP1
regulation of tyrosine phosphorylation of STAT protein (GO:0042509),4/61,0.36421006738242967,1,0,0,1.3114754098360655,1.3246222552325246,IL6;EPO;IL23A;OSM
regulation of DNA replication (GO:0006275),4/61,0.36421006738242967,1,0,0,1.3114754098360655,1.3246222552325246,ACVRL1;CCDC88A;PCNA;EPO
positive regulation of cellular amide metabolic process (GO:0034250),4/61,0.36421006738242967,1,0,0,1.3114754098360655,1.3246222552325246,IL6;YTHDF3;BCL3;CIRBP
negative regulation of ERBB signaling pathway (GO:1901185),3/43,0.36487351009848823,1,0,0,1.3953488372093021,1.4067970229812217,RNF126;UBA52;SH3GL2
protein transmembrane import into intracellular organelle (GO:0044743),3/43,0.36487351009848823,1,0,0,1.3953488372093021,1.4067970229812217,AGK;PEX26;TIMM50
negative regulation of DNA metabolic process (GO:0051053),3/43,0.36487351009848823,1,0,0,1.3953488372093021,1.4067970229812217,ACVRL1;APOBEC1;MSH6
positive regulation of protein localization to plasma membrane (GO:1903078),3/43,0.36487351009848823,1,0,0,1.3953488372093021,1.4067970229812217,PRKCH;STAC;PTPN9
histone H3 acetylation (GO:0043966),3/43,0.36487351009848823,1,0,0,1.3953488372093021,1.4067970229812217,TADA3;JADE3;TAF9B
regulation of interferon-gamma production (GO:0032649),3/43,0.36487351009848823,1,0,0,1.3953488372093021,1.4067970229812217,IL23A;CD14;CCR2
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),6/98,0.3659360545830404,1,0,0,1.2244897959183672,1.2309755205294757,CD74;KIF2A;SAR1B;SH3GL2;AP1M2;SPTBN2
positive regulation of neuron differentiation (GO:0045666),6/98,0.3659360545830404,1,0,0,1.2244897959183672,1.2309755205294757,RELN;FES;TWF2;NRCAM;SCARF1;ATOH1
positive regulation of cell growth (GO:0030307),6/98,0.3659360545830404,1,0,0,1.2244897959183672,1.2309755205294757,BRAT1;RPS6KA1;HPN;TWF2;TAF9B;HDGFL2
response to molecule of bacterial origin (GO:0002237),6/98,0.3659360545830404,1,0,0,1.2244897959183672,1.2309755205294757,C4B;IL6;CXCL9;TNFRSF10B;CD14;CXCL5
activation of MAPK activity (GO:0000187),7/117,0.36885988926259045,1,0,0,1.1965811965811965,1.1933963891623318,ERN1;MOS;INS-IGF2;IRAK2;ADORA2B;MAP3K21;UBA52
type B pancreatic cell differentiation (GO:0003309),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,DLL1
regulation of immunoglobulin secretion (GO:0051023),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,IL6
removal of superoxide radicals (GO:0019430),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,APOA4
positive regulation of production of molecular mediator of immune response (GO:0002702),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SASH3
megakaryocyte differentiation (GO:0030219),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,TAL1
regulation of macrophage cytokine production (GO:0010935),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CD74
negative regulation of response to reactive oxygen species (GO:1901032),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,GPR37L1
ATF6-mediated unfolded protein response (GO:0036500),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ATF6
actin filament reorganization (GO:0090527),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,GSN
poly-N-acetyllactosamine biosynthetic process (GO:0030311),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,B3GNT6
lactation (GO:0007595),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,GPAT4
epithelial cell apoptotic process (GO:1904019),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,GSN
neuronal ion channel clustering (GO:0045161),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NRCAM
neuron maturation (GO:0042551),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SCARF1
postsynaptic membrane assembly (GO:0097104),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,LRP4
negative regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902894),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PPARD
short-chain fatty acid metabolic process (GO:0046459),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,MMAA
positive regulation of coagulation (GO:0050820),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,APOH
vasodilation (GO:0042311),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ADRB2
regulation of microtubule-based movement (GO:0060632),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,IGBP1
embryonic digestive tract morphogenesis (GO:0048557),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ID2
positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CD226
cellular response to dopamine (GO:1903351),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PRKN
positive regulation of synapse maturation (GO:0090129),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,RELN
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,GSN
positive regulation of long-term synaptic potentiation (GO:1900273),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,RELN
nuclear migration (GO:0007097),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PAFAH1B1
negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,MICA
positive regulation of cholesterol esterification (GO:0010873),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,APOA4
Cdc42 protein signal transduction (GO:0032488),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,RHOU
negative regulation of mRNA 3'-end processing (GO:0031441),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,RNF40
positive regulation of immunoglobulin secretion (GO:0051024),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,IL6
somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,MSH6
peptidyl-arginine omega-N-methylation (GO:0035247),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PRMT1
maintenance of protein localization in endoplasmic reticulum (GO:0035437),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ANKRD13C
ATP synthesis coupled electron transport (GO:0042773),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,COA6
regulation of endoplasmic reticulum unfolded protein response (GO:1900101),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ERN1
response to dopamine (GO:1903350),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PRKN
negative regulation of gluconeogenesis (GO:0045721),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,GCK
chylomicron remodeling (GO:0034371),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,APOA4
virion attachment to host cell (GO:0019062),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,HSP90AB1
nucleoside phosphate biosynthetic process (GO:1901293),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,AK8
negative regulation of fibrinolysis (GO:0051918),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,APOH
positive regulation of T cell chemotaxis (GO:0010820),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CCR2
positive regulation of astrocyte differentiation (GO:0048711),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,AGER
positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CD226
sympathetic ganglion development (GO:0061549),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SEMA3F
positive regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901409),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CCNC
receptor recycling (GO:0001881),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,EHD3
Golgi vesicle budding (GO:0048194),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SEC31B
podosome assembly (GO:0071800),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,BIN2
nucleoside triphosphate biosynthetic process (GO:0009142),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,AK8
production of siRNA involved in RNA interference (GO:0030422),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,TERT
peptidyl-arginine methylation (GO:0018216),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PRMT1
interleukin-23-mediated signaling pathway (GO:0038155),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,IL23A
positive regulation of ribosome biogenesis (GO:0090070),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,DIMT1
membrane disruption in other organism (GO:0051673),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,DEFA4
intestinal lipid absorption (GO:0098856),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CD36
negative regulation of protein sumoylation (GO:0033234),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,FSCB
regulation of sequestering of calcium ion (GO:0051282),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CASQ2
omega-hydroxylase P450 pathway (GO:0097267),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CYP2C19
positive regulation of hemostasis (GO:1900048),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,APOH
positive regulation of rRNA processing (GO:2000234),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,DIMT1
cellular response to superoxide (GO:0071451),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,APOA4
regulation of methylation-dependent chromatin silencing (GO:0090308),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,APOBEC1
flavonoid glucuronidation (GO:0052696),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,UGT1A3
regulation of cell-cell adhesion mediated by cadherin (GO:2000047),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,FLOT1
regulation of leukocyte activation (GO:0002694),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CD74
glucose import (GO:0046323),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,RAB4B
ether lipid metabolic process (GO:0046485),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,AGMO
regulation of hair cycle (GO:0042634),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,TERT
negative regulation of chromatin silencing (GO:0031936),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,APOBEC1
regulation of helicase activity (GO:0051095),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,MSH6
regulation of flagellated sperm motility (GO:1901317),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,TAC4
T cell mediated immunity (GO:0002456),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,AIRE
negative regulation of transcription by competitive promoter binding (GO:0010944),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,BHLHE41
negative regulation of potassium ion transmembrane transport (GO:1901380),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CASQ2
regulation of oxidative stress-induced cell death (GO:1903201),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PRKN
detection of mechanical stimulus involved in sensory perception (GO:0050974),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,HPN
tRNA wobble uridine modification (GO:0002098),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CTU2
nuclear RNA surveillance (GO:0071027),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,DXO
serine family amino acid catabolic process (GO:0009071),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,GCSH
"negative regulation of synaptic transmission, glutamatergic (GO:0051967)",1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,GRIK3
establishment of epithelial cell apical/basal polarity (GO:0045198),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SYNE4
histone phosphorylation (GO:0016572),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,RPS6KA4
cyclic nucleotide catabolic process (GO:0009214),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PDE3B
RNA transport (GO:0050658),5/80,0.37109875658286956,1,0,0,1.25,1.239108826933398,NXF2;SRSF1;IGFLR1;FLOT1;POM121L12
ERBB signaling pathway (GO:0038127),5/80,0.37109875658286956,1,0,0,1.25,1.239108826933398,PTPRR;FES;PXN;UBA52;FAM83B
NIK/NF-kappaB signaling (GO:0038061),5/80,0.37109875658286956,1,0,0,1.25,1.239108826933398,TNFSF15;TNFRSF10B;UBA52;MAP3K14;PSMB8
nuclear-transcribed mRNA catabolic process (GO:0000956),10/174,0.3718725055193731,1,0,0,1.1494252873563218,1.1370163339675912,THRAP3;PNLDC1;CNOT2;MRTO4;RPSA;DXO;PABPC1;RPL15;UBA52;RPS24
"regulation of transcription, DNA-templated (GO:0006355)",83/1598,0.3727110803714831,1,0,0,1.0387984981226532,1.025243988283068,ACVRL1;ZNF132;SETD3;EPO;FOXI3;FOXI2;BHLHE41;RORA;RSF1;LDB2;MED18;IKBKB;RPS6KA4;SOX2;DBP;ZNF607;SOX18;RPS6KA1;EP300;ZNF600;ZNF200;ZNF284;PRMT1;FOXP4;PIAS2;UBTFL1;PTP4A3;NR5A2;TAL1;THRAP3;RFX4;ZSCAN21;ZNF318;DEPDC1;IFNK;FOXD4L3;ATF6;AJUBA;ATF3;ZNF311;PPARD;ZNF793;ENY2;PCNA;AIRE;FOXG1;CREBL2;ZNF3;BARX1;NPAS2;FOXO1;CIAO1;ZNF7;CAND2;ZNF829;BTAF1;ZNF429;HIVEP2;ZNF148;PATZ1;ZNF224;ZNF223;POLR2L;TRAPPC2;WWTR1;CD74;ZNF341;HSPA8;ASCC1;ANKRD30A;BCL11A;SSRP1;NR1D1;TARBP1;IL6;ID2;CNOT2;ZNF74;ID1;TADA3;BCL3;RLIM;TP73
diterpenoid metabolic process (GO:0016101),4/62,0.37571023981047774,1,0,0,1.2903225806451613,1.263144608372761,SDC4;RARRES2;AKR1C3;APOA4
stress-activated MAPK cascade (GO:0051403),4/62,0.37571023981047774,1,0,0,1.2903225806451613,1.263144608372761,IKBKB;ADORA2B;IRAK2;UBA52
positive regulation of glucose import (GO:0046326),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,RARRES2;CREBL2
response to growth factor (GO:0070848),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,SOX2;TWF2
regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902893),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,TERT;PPARD
regulation of p38MAPK cascade (GO:1900744),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,PRMT1;AGER
positive regulation of granulocyte chemotaxis (GO:0071624),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,CD74;CXCL5
response to ketone (GO:1901654),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,CATSPER4;CATSPERG
negative chemotaxis (GO:0050919),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,SEMA3F;ROBO1
negative regulation of catalytic activity (GO:0043086),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,CLN3;PPP1R12A
regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,PCNA;ID2
regulation of viral entry into host cell (GO:0046596),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,CD74;GSN
T cell activation involved in immune response (GO:0002286),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,IFNK;IFNA10
GPI anchor metabolic process (GO:0006505),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,PIGC;PIGW
regulation of T cell receptor signaling pathway (GO:0050856),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,LGALS3;CD226
cation transmembrane transport (GO:0098655),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,RHBG;RHCE
RNA biosynthetic process (GO:0032774),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,TERT;RSF1
positive regulation of protein serine/threonine kinase activity (GO:0071902),7/118,0.37711178989119853,1,0,0,1.1864406779661016,1.1570330972966532,TNFSF15;FGF18;TNFRSF10B;CCNC;ADRB2;PIK3R6;ROBO1
regulation of translation (GO:0006417),12/213,0.37765962919247165,1,0,0,1.1267605633802817,1.0971965531094479,IL6;GRM5;YTHDF3;OGFOD1;DDX1;CNOT2;RPS6KA1;BCL3;CIRBP;ZNF598;POLR2L;NUP37
muscle contraction (GO:0006936),8/137,0.3782278714972952,1,0,0,1.167883211678832,1.1354842982136466,DTNA;TMOD3;TMOD2;PXN;LMOD1;CASQ2;UTS2;MYH11
positive regulation of viral life cycle (GO:1903902),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,CD74;NR5A2;PABPC1
hexose biosynthetic process (GO:0019319),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,PC;PCK1;SLC25A11
negative regulation of immune response (GO:0050777),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,LGALS3;TRAFD1;CCR2
sensory perception of sound (GO:0007605),5/81,0.3811403952771392,1,0,0,1.2345679012345678,1.1908487409762,WFS1;HPN;USH1C;SNAI2;SERPINB6
regulation of signal transduction (GO:0009966),13/233,0.38273790054688067,1,0,0,1.1158798283261802,1.0716964067740429,SASH3;GIT2;USP20;USP33;TIE1;PXN;AKR1C3;RORA;DLL1;IRAK2;TMEM204;CD36;MET
activation of protein kinase activity (GO:0032147),13/233,0.38273790054688067,1,0,0,1.1158798283261802,1.0716964067740429,ANGPT1;TNFSF15;STRADB;TNFRSF10B;ADRB2;MOS;CCDC88A;INS-IGF2;IRAK2;ADORA2B;PRKAR2A;UBA52;MAP3K14
cellular response to transforming growth factor beta stimulus (GO:0071560),6/100,0.38397671632870417,1,0,0,1.2,1.1486080353521109,ACVRL1;HPGD;PXN;ID1;DUSP15;UBA52
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),6/100,0.38397671632870417,1,0,0,1.2,1.1486080353521109,DDX19B;NXF2;SRSF1;IGFLR1;AGFG1;NUP37
negative regulation of apoptotic process (GO:0043066),26/485,0.38531204842867156,1,0,0,1.0721649484536082,1.022525595761703,PRKN;HPN;DLL1;FOXO1;IKBKB;CLN3;APOH;RPS6KA1;TAF9B;IGBP1;CD74;PRKCH;ANGPT1;WFS1;TIE1;TNFRSF10B;NFKBIA;IL6;INS-IGF2;BCL3;IL2RB;SNAI2;ERCC5;UBA52;MET;TP73
regulation of signal transduction by p53 class mediator (GO:1901796),8/138,0.38588815366024015,1,0,0,1.1594202898550725,1.1040089378109808,RMI2;EP300;CHD5;SSRP1;TAF9B;UBA52;TAF2;TP73
carbohydrate homeostasis (GO:0033500),4/63,0.38719146599357773,1,0,0,1.2698412698412698,1.204871065559935,INS-IGF2;WFS1;PCK1;GCK
negative regulation of neuron apoptotic process (GO:0043524),4/63,0.38719146599357773,1,0,0,1.2698412698412698,1.204871065559935,PRKN;CLN3;WFS1;TP73
positive regulation of cell projection organization (GO:0031346),4/63,0.38719146599357773,1,0,0,1.2698412698412698,1.204871065559935,RELN;FES;TWF2;SCARF1
modulation of chemical synaptic transmission (GO:0050804),5/82,0.39117601725719064,1,0,0,1.2195121951219512,1.1446312783908745,GRIA2;GRM5;RELN;GRIK3;KCNMB4
hexose metabolic process (GO:0019318),3/45,0.3924009183942127,1,0,0,1.3333333333333333,1.2472949477860094,BRAT1;PCK1;PPARD
"regulation of synaptic transmission, glutamatergic (GO:0051966)",3/45,0.3924009183942127,1,0,0,1.3333333333333333,1.2472949477860094,GRM5;RELN;GRIK3
mitochondrial gene expression (GO:0140053),3/45,0.3924009183942127,1,0,0,1.3333333333333333,1.2472949477860094,MRPS17;RARS2;NOA1
telomere maintenance via telomere lengthening (GO:0010833),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,HSP90AB1;TERT
modulation by host of viral transcription (GO:0043921),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,HPN;EP300
microtubule polymerization (GO:0046785),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,TPPP3;MAP7D3
regulation of protein transport (GO:0051223),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,HSPA8;ARFIP1
phosphatidylserine metabolic process (GO:0006658),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,OSBPL5;LPCAT3
cargo loading into vesicle (GO:0035459),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,KIF13A;SEC31B
regulation of protein localization to cell surface (GO:2000008),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,HSP90AB1;LEPROTL1
regulation of gene expression (GO:0010468),54/1037,0.3974672695303416,1,0,0,1.0414657666345226,0.9609007755146399,ACVRL1;ZNF132;AKAP8L;RORA;RPS6KA4;SOX2;ZNF607;FASTK;EP300;CD36;ZNF600;ZNF200;ZNF284;PRMT1;UBTFL1;PTP4A3;DDX19B;NR5A2;ZSCAN21;IFNK;AJUBA;ZNF311;PRKN;ZNF793;CRP;AIRE;HPN;ZNF3;ZNF7;ZNF829;TERT;ZNF429;TRA2B;HIVEP2;ZNF148;PATZ1;ZNF223;TRAPPC2;WWTR1;ZNF341;GSN;ASCC1;ANKRD30A;BCL11A;SSRP1;IL6;PC;INS-IGF2;ID2;ZNF74;TADA3;RLIM;UBAP2;TP73
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),4/64,0.39864450306553323,1,0,0,1.25,1.1496065362528942,CD226;DSCAML1;NECTIN3;ROBO1
positive regulation of JAK-STAT cascade (GO:0046427),4/64,0.39864450306553323,1,0,0,1.25,1.1496065362528942,IL6;EPO;IL23A;OSM
regulation of synapse maturation (GO:0090128),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,RELN
membrane raft organization (GO:0031579),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,FLOT1
ganglion development (GO:0061548),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SEMA3F
cellular response to thyroid hormone stimulus (GO:0097067),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,GAS2L1
dorsal/ventral axis specification (GO:0009950),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,LRP4
positive regulation of calcium ion import (GO:0090280),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,LGALS3
cellular response to growth hormone stimulus (GO:0071378),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PXN
3'-UTR-mediated mRNA destabilization (GO:0061158),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ZC3H12D
regulation of sequestering of zinc ion (GO:0061088),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SLC30A6
regulation of cellular respiration (GO:0043457),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,NOA1
neuron projection regeneration (GO:0031102),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,APOA4
positive regulation of steroid metabolic process (GO:0045940),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,APOA4
negative regulation of oxidative stress-induced neuron death (GO:1903204),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PRKN
macrophage chemotaxis (GO:0048246),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,LGALS3
positive regulation of cytoplasmic transport (GO:1903651),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PRKN
regulation of mammary gland epithelial cell proliferation (GO:0033599),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ROBO1
regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ARFIP1
oxalate transport (GO:0019532),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SLC26A7
presynaptic membrane assembly (GO:0097105),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,LRP4
positive regulation of receptor recycling (GO:0001921),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,VAMP3
glycine metabolic process (GO:0006544),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,GCSH
pyroptosis (GO:0070269),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ARRDC1-AS1
response to laminar fluid shear stress (GO:0034616),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ABCA1
regulation of triglyceride catabolic process (GO:0010896),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,APOA4
hair cell differentiation (GO:0035315),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,USH1C
regulation of NLRP3 inflammasome complex assembly (GO:1900225),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CD36
positive regulation of glucose import in response to insulin stimulus (GO:2001275),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,RARRES2
negative regulation of inclusion body assembly (GO:0090084),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SACS
neuroepithelial cell differentiation (GO:0060563),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,USH1C
astrocyte development (GO:0014002),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,DLL1
positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,LMO3
epithelial cell morphogenesis (GO:0003382),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,MET
peptidyl-lysine dimethylation (GO:0018027),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SETD3
creatine metabolic process (GO:0006600),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CKM
mitotic G1 DNA damage checkpoint (GO:0031571),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,TP73
chylomicron assembly (GO:0034378),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,APOA4
DNA dealkylation involved in DNA repair (GO:0006307),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ASCC1
positive regulation of natural killer cell activation (GO:0032816),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,IL23A
telomere maintenance in response to DNA damage (GO:0043247),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,APEX1
actin filament depolymerization (GO:0030042),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,TWF2
receptor guanylyl cyclase signaling pathway (GO:0007168),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,GUCY2C
macrophage migration (GO:1905517),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,LGALS3
regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CD226
G1 DNA damage checkpoint (GO:0044783),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,TP73
endosomal vesicle fusion (GO:0034058),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ANKFY1
nucleoside metabolic process (GO:0009116),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,NME4
central nervous system projection neuron axonogenesis (GO:0021952),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PAFAH1B1
nuclear mRNA surveillance (GO:0071028),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,DXO
DNA dealkylation (GO:0035510),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ASCC1
positive regulation of T cell receptor signaling pathway (GO:0050862),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CD226
detection of bacterium (GO:0016045),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,DMBT1
protein-cofactor linkage (GO:0018065),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,GCSH
positive regulation of protein exit from endoplasmic reticulum (GO:0070863),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,EDEM2
cytochrome complex assembly (GO:0017004),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,COA6
regulation of DNA damage checkpoint (GO:2000001),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,FEM1B
negative regulation of protein maturation (GO:1903318),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CHAC1
neuron projection fasciculation (GO:0106030),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,NRCAM
polarized epithelial cell differentiation (GO:0030859),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SYNE4
positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,C2CD2L
negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CNOT2
coenzyme A metabolic process (GO:0015936),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PANK2
tRNA wobble base modification (GO:0002097),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CTU2
cilium movement involved in cell motility (GO:0060294),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,RSPH9
UV protection (GO:0009650),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ERCC5
mitotic G1/S transition checkpoint (GO:0044819),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,TP73
chaperone-mediated protein transport (GO:0072321),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,HSPA8
cellular response to leucine starvation (GO:1990253),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,RRAGB
poly-N-acetyllactosamine metabolic process (GO:0030309),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,B3GNT6
regulation of immunoglobulin production (GO:0002637),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SASH3
"complement activation, lectin pathway (GO:0001867)",1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,MBL2
negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,WFS1
endothelial tube morphogenesis (GO:0061154),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ACVRL1
response to histamine (GO:0034776),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,GABRB3
quinone metabolic process (GO:1901661),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,AKR1C3
regulation of lysosomal lumen pH (GO:0035751),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CLN3
regulation of phospholipid metabolic process (GO:1903725),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,WDR81
regulation of plasminogen activation (GO:0010755),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,HPN
histone H2B ubiquitination (GO:0033523),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,RNF40
regulation of T cell apoptotic process (GO:0070232),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,LGALS3
smooth muscle cell differentiation (GO:0051145),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,TMEM204
intracellular cholesterol transport (GO:0032367),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ABCA1
regulation of axon regeneration (GO:0048679),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SCARF1
negative regulation of glucose transport (GO:0010829),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,RSC1A1
positive regulation of type 2 immune response (GO:0002830),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,IL6
regulation of T cell chemotaxis (GO:0010819),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CCR2
detection of chemical stimulus involved in sensory perception (GO:0050907),6/102,0.4020193840167806,1,0,0,1.176470588235294,1.0720646736216428,OR7G2;OR4S1;OR1K1;OR4D6;OR4F21;OR4B1
positive regulation of protein localization to cell periphery (GO:1904377),3/46,0.40605277189227273,1,0,0,1.3043478260869563,1.175572366691541,PRKCH;STAC;PTPN9
negative regulation of protein modification by small protein conjugation or removal (GO:1903321),3/46,0.40605277189227273,1,0,0,1.3043478260869563,1.175572366691541,NXN;HDAC8;FSCB
tRNA aminoacylation for protein translation (GO:0006418),3/46,0.40605277189227273,1,0,0,1.3043478260869563,1.175572366691541,RARS2;PPA2;TARS2
regulation of generation of precursor metabolites and energy (GO:0043467),3/46,0.40605277189227273,1,0,0,1.3043478260869563,1.175572366691541,NOA1;GCK;NUP37
regulation of fibroblast proliferation (GO:0048145),3/46,0.40605277189227273,1,0,0,1.3043478260869563,1.175572366691541,CD74;MORC3;MED25
positive regulation of protein phosphorylation (GO:0001934),22/412,0.4063351744176455,1,0,0,1.0679611650485437,0.9617811630385504,ACVRL1;CD74;ANGPT1;RARRES2;BRAT1;OSM;TNFRSF10B;CREBL2;CCNC;GPR37L1;ADRB2;AGER;SOX2;RPS6KA4;MOS;LATS1;IL6;INS-IGF2;RELN;FLOT1;LCP2;MET
protein localization to membrane (GO:0072657),9/160,0.4073910770526227,1,0,0,1.125,1.0102293873083648,AP4M1;IKBKB;MRAP;TSPAN15;EHD3;PKP2;FLOT1;PIGW;CRB3
O-glycan processing (GO:0016266),4/65,0.41006047139933866,1,0,0,1.2307692307692308,1.0971700171589474,MUC2;GALNT15;B3GNT6;GCNT4
cellular response to type I interferon (GO:0071357),4/65,0.41006047139933866,1,0,0,1.2307692307692308,1.0971700171589474,IRF9;PSMB8;IFNA10;IP6K2
regulation of myeloid cell differentiation (GO:0045637),4/65,0.41006047139933866,1,0,0,1.2307692307692308,1.0971700171589474,LGALS3;PRMT1;FES;EP300
DNA synthesis involved in DNA repair (GO:0000731),4/65,0.41006047139933866,1,0,0,1.2307692307692308,1.0971700171589474,RMI2;PCNA;UBA52;PRIMPOL
type I interferon signaling pathway (GO:0060337),4/65,0.41006047139933866,1,0,0,1.2307692307692308,1.0971700171589474,IRF9;PSMB8;IFNA10;IP6K2
fatty acid catabolic process (GO:0009062),4/65,0.41006047139933866,1,0,0,1.2307692307692308,1.0971700171589474,SLC25A17;ABHD16A;MMAA;PPARD
neuron projection extension (GO:1990138),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,SEMA3F;SH3GL2
negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,CNOT2;PIAS2
cellular response to hydrogen peroxide (GO:0070301),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,IL6;ANKZF1
negative regulation of homeostatic process (GO:0032845),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,IL6;EPO
RNA phosphodiester bond hydrolysis (GO:0090501),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,ERN1;RNASE4
negative regulation of response to DNA damage stimulus (GO:2001021),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,CD74;SNAI2
regulation of receptor internalization (GO:0002090),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,ANGPT1;FLOT1
aerobic respiration (GO:0009060),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,COX6A1;COX20
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway (GO:0051482),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,GPR18;F2RL3
positive regulation of protein tyrosine kinase activity (GO:0061098),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,GRM5;RELN
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,WWTR1;PCSK6
negative regulation of JNK cascade (GO:0046329),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,PRKN;TP73
regulation of lipid biosynthetic process (GO:0046890),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,CREBL2;APOA4
positive regulation of lipid biosynthetic process (GO:0046889),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,CREBL2;APOA4
regulation of actin polymerization or depolymerization (GO:0008064),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,LATS1;PLEKHG2
positive regulation of macromolecule biosynthetic process (GO:0010557),8/142,0.41656279001234714,1,0,0,1.1267605633802817,0.9867245886261043,IL6;PCNA;YTHDF3;EPO;PRMT1;BCL3;CIRBP;GCK
tumor necrosis factor-mediated signaling pathway (GO:0033209),7/123,0.4184152232009605,1,0,0,1.1382113821138211,0.9917019313802579,NFKBIA;IKBKB;TNFSF15;TNFRSF10B;UBA52;MAP3K14;PSMB8
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),3/47,0.4196120451603213,1,0,0,1.276595744680851,1.1086272722292005,NFKBIA;MAPKBP1;RORA
polyol metabolic process (GO:0019751),3/47,0.4196120451603213,1,0,0,1.276595744680851,1.1086272722292005,ITPKA;OCRL;IP6K2
postreplication repair (GO:0006301),3/47,0.4196120451603213,1,0,0,1.276595744680851,1.1086272722292005,PCNA;UBA52;PRIMPOL
inositol phosphate metabolic process (GO:0043647),3/47,0.4196120451603213,1,0,0,1.276595744680851,1.1086272722292005,ITPKA;OCRL;IP6K2
mRNA transport (GO:0051028),6/104,0.4200266801120024,1,0,0,1.1538461538461537,1.0008888988224178,DDX19B;NXF2;SRSF1;IGFLR1;AGFG1;NUP37
cellular response to light stimulus (GO:0071482),4/66,0.421430857889875,1,0,0,1.2121212121212122,1.0473933978386722,PCNA;EP300;USP28;TP73
intracellular steroid hormone receptor signaling pathway (GO:0030518),4/66,0.421430857889875,1,0,0,1.2121212121212122,1.0473933978386722,RBM14;THRAP3;TADA3;PIAS2
dephosphorylation (GO:0016311),7/124,0.42665940706055616,1,0,0,1.129032258064516,0.9616749321100159,PTPRR;PPP1R12A;UBLCP1;PTPN9;DUSP15;MTMR6;TIMM50
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),9/163,0.4289504847985568,1,0,0,1.1042944785276072,0.9346900712747971,IKBKB;PRKN;CD74;IL23A;TNFRSF10B;RBCK1;UBA52;AGER;MAP3K14
"nucleotide-excision repair, preincision complex assembly (GO:0006294)",2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,ERCC5;UBA52
very long-chain fatty acid metabolic process (GO:0000038),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,ELOVL4;ACOX1
cardiac muscle cell action potential (GO:0086001),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,SCN10A;PKP2
cortical cytoskeleton organization (GO:0030865),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,IKBKB;RHOU
protein alkylation (GO:0008213),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,HSPA8;PRMT1
positive regulation of histone modification (GO:0031058),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,RPS6KA4;AKAP8L
negative regulation of Notch signaling pathway (GO:0045746),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,CHAC1;UBA52
regulation of neutrophil chemotaxis (GO:0090022),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,CD74;CXCL5
positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,ATF6;ATF3
negative regulation of lymphocyte proliferation (GO:0050672),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,SPN;SDC4
negative regulation of epithelial cell apoptotic process (GO:1904036),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,ANGPT1;WFS1
regulation of activated T cell proliferation (GO:0046006),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,IL23A;AGER
semaphorin-plexin signaling pathway (GO:0071526),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,SEMA3F;MET
positive regulation of posttranscriptional gene silencing (GO:0060148),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,AJUBA
positive regulation of endothelial cell apoptotic process (GO:2000353),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,AKR1C3
sulfate transmembrane transport (GO:1902358),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,SLC26A7
regulation of stem cell population maintenance (GO:2000036),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CNOT2
regulation of hippo signaling (GO:0035330),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,AJUBA
interleukin-27-mediated signaling pathway (GO:0070106),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,EBI3
replicative senescence (GO:0090399),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,TERT
negative regulation of blood vessel diameter (GO:0097756),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CRP
regulation of histone deacetylation (GO:0031063),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,AKAP8L
cellular response to prostaglandin stimulus (GO:0071379),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,AKR1C3
postsynapse assembly (GO:0099068),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,LRP4
regulation of lipid kinase activity (GO:0043550),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,WDR81
negative regulation of protein localization to nucleus (GO:1900181),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CABP1
negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CASQ2
regulation of inclusion body assembly (GO:0090083),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,SACS
positive regulation by host of viral process (GO:0044794),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PC
positive regulation of superoxide anion generation (GO:0032930),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CRP
interleukin-2-mediated signaling pathway (GO:0038110),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,IL2RB
regulation of hydrogen peroxide-induced cell death (GO:1903205),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,GPR37L1
xenobiotic glucuronidation (GO:0052697),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,UGT1A3
negative regulation of JUN kinase activity (GO:0043508),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,TP73
positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PABPC1
T-helper cell differentiation (GO:0042093),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,RORA
T cell differentiation in thymus (GO:0033077),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CCR6
calcineurin-NFAT signaling cascade (GO:0033173),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ADGRB2
cellular response to sterol (GO:0036315),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,RORA
positive regulation of protein deacetylation (GO:0090312),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,AKAP8L
brain morphogenesis (GO:0048854),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PAFAH1B1
biotin metabolic process (GO:0006768),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PC
activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:0097296),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,TNFRSF10B
regulation of ventricular cardiac muscle cell action potential (GO:0098911),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PKP2
positive regulation of histone deacetylation (GO:0031065),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,AKAP8L
positive regulation of myoblast fusion (GO:1901741),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,FLOT1
phosphatidylinositol dephosphorylation (GO:0046856),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,MTMR6
regulation of hemopoiesis (GO:1903706),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,LGALS3
negative regulation of peptide secretion (GO:0002792),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CD74
negative regulation of myotube differentiation (GO:0010832),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,BHLHE41
regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CCNC
negative regulation of cellular senescence (GO:2000773),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,TERT
cytidine to uridine editing (GO:0016554),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,APOBEC1
regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PABPC1
negative regulation of protein localization to cell surface (GO:2000009),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,LEPROTL1
cellular response to interleukin-2 (GO:0071352),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,IL2RB
cochlea morphogenesis (GO:0090103),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,HPN
response to sterol (GO:0036314),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,RORA
negative regulation of nucleocytoplasmic transport (GO:0046823),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CABP1
icosanoid biosynthetic process (GO:0046456),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,HPGD
progesterone metabolic process (GO:0042448),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,AKR1C3
positive regulation of fatty acid biosynthetic process (GO:0045723),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,APOA4
protein kinase C signaling (GO:0070528),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,FLOT1
regulation of cholesterol esterification (GO:0010872),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,APOA4
positive regulation of chondrocyte differentiation (GO:0032332),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ACVRL1
positive regulation of heterotypic cell-cell adhesion (GO:0034116),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,FLOT1
negative regulation of potassium ion transport (GO:0043267),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CASQ2
response to nitric oxide (GO:0071731),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,FOXO1
photoreceptor cell development (GO:0042461),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,MAPRE2
negative regulation of cardiac muscle hypertrophy (GO:0010614),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,FOXO1
modulation by host of viral genome replication (GO:0044827),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PRKN
negative regulation of chemotaxis (GO:0050922),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ROBO1
cellular response to increased oxygen levels (GO:0036295),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,FOXO1
retinal metabolic process (GO:0042574),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,AKR1C3
cyclooxygenase pathway (GO:0019371),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,AKR1C3
negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CASQ2
L-serine metabolic process (GO:0006563),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PSAT1
embryonic hemopoiesis (GO:0035162),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,TAL1
glutathione biosynthetic process (GO:0006750),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CHAC1
regulation of autophagosome maturation (GO:1901096),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ADRB2
presynaptic membrane organization (GO:0097090),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,LRP4
midbrain dopaminergic neuron differentiation (GO:1904948),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,LMX1A
interleukin-35-mediated signaling pathway (GO:0070757),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,EBI3
regulation of mRNA polyadenylation (GO:1900363),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,RNF40
positive regulation of interferon-gamma biosynthetic process (GO:0045078),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,EBI3
hepatocyte growth factor receptor signaling pathway (GO:0048012),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,HPN
positive regulation of synaptic transmission (GO:0050806),4/67,0.4327475179328833,1,0,0,1.1940298507462686,1.0001203826990046,RELN;FLOT1;AGER;GRIN2B
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),4/67,0.4327475179328833,1,0,0,1.1940298507462686,1.0001203826990046,LATS1;LATS2;CCNG1;CCNC
cellular response to UV (GO:0034644),4/67,0.4327475179328833,1,0,0,1.1940298507462686,1.0001203826990046,PCNA;EP300;USP28;TP73
endosome to lysosome transport (GO:0008333),3/48,0.43306631871249,1,0,0,1.25,1.0460805021359667,KIF13A;ADRB2;GPRASP1
pattern recognition receptor signaling pathway (GO:0002221),3/48,0.43306631871249,1,0,0,1.25,1.0460805021359667,IRAK2;CD36;CD14
"DNA-templated transcription, termination (GO:0006353)",6/106,0.43796290568349927,1,0,0,1.1320754716981132,0.9346653536744506,TAF1B;SRSF1;IGFLR1;POLR1E;MED18;POLR2L
positive regulation of cellular component organization (GO:0051130),6/106,0.43796290568349927,1,0,0,1.1320754716981132,0.9346653536744506,RELN;TAL1;FLOT1;LRP4;AJUBA;DLL1
RNA splicing (GO:0008380),6/106,0.43796290568349927,1,0,0,1.1320754716981132,0.9346653536744506,MAPKBP1;DDX19B;SNRPD2;SCAF11;NOVA1;TRA2B
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),11/204,0.4426837323435653,1,0,0,1.0784313725490196,0.878813387268268,IKBKB;PRKN;NFKBIA;MAPKBP1;CD74;BCL3;TNFRSF10B;RORA;RBCK1;UBA52;MAP3K14
regulation of mitotic cell cycle (GO:0007346),9/165,0.443294181978683,1,0,0,1.0909090909090908,0.8874781763568012,INTS13;TAL1;STRADB;CCDC8;HECA;MKI67;MAP3K14;LINC00598;TP73
positive regulation of T cell activation (GO:0050870),4/68,0.44400267624141365,1,0,0,1.176470588235294,0.9552055164674429,IL6;IL23A;SIRPG;CCR2
protein polyubiquitination (GO:0000209),15/283,0.4459213536724002,1,0,0,1.0600706713780919,0.8561265154438287,PRKN;FBXW4;UBE2D2;FBXO27;PSMB8;RNF146;FBXO40;RNF126;RLIM;TPP2;TRIM69;NHLRC1;RBCK1;UBA52;RNF122
protein heterooligomerization (GO:0051291),3/49,0.44640402063272916,1,0,0,1.2244897959183672,0.987588809585937,CD74;LRP4;GRIN2B
RNA methylation (GO:0001510),3/49,0.44640402063272916,1,0,0,1.2244897959183672,0.987588809585937,DIMT1;METTL1;TARBP1
organic hydroxy compound biosynthetic process (GO:1901617),3/49,0.44640402063272916,1,0,0,1.2244897959183672,0.987588809585937,PSAT1;AKR1C3;CYP46A1
glutathione metabolic process (GO:0006749),3/49,0.44640402063272916,1,0,0,1.2244897959183672,0.987588809585937,GSTA3;GSTA1;CHAC1
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),3/49,0.44640402063272916,1,0,0,1.2244897959183672,0.987588809585937,GNLY;REG1B;DEFA4
positive regulation of response to DNA damage stimulus (GO:2001022),3/49,0.44640402063272916,1,0,0,1.2244897959183672,0.987588809585937,ANKLE1;PCNA;NPAS2
regulation of release of sequestered calcium ion into cytosol (GO:0051279),3/49,0.44640402063272916,1,0,0,1.2244897959183672,0.987588809585937,CXCL9;CASQ2;F2RL3
negative regulation of cation channel activity (GO:2001258),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,EPO;CASQ2
replication fork processing (GO:0031297),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,PCNA;PRIMPOL
bile acid and bile salt transport (GO:0015721),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,SLCO1C1;SLC10A3
negative regulation of secretion by cell (GO:1903531),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,OSM;VAMP3
negative regulation of DNA biosynthetic process (GO:2000279),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,ACVRL1;PIF1
activation of JUN kinase activity (GO:0007257),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,ERN1;MAP3K21
regulation of cell adhesion mediated by integrin (GO:0033628),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,PDE3B;SNAI2
regulation of intracellular estrogen receptor signaling pathway (GO:0033146),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,LATS1;CNOT2
protein localization to lysosome (GO:0061462),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,AP4M1;NAGPA
aminoglycan metabolic process (GO:0006022),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,SDC4;XYLT1
ATP-dependent chromatin remodeling (GO:0043044),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,PBRM1;ANP32B
positive regulation of B cell proliferation (GO:0030890),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,SASH3;CD74
CENP-A containing nucleosome assembly (GO:0034080),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,CENPI;RSF1
CENP-A containing chromatin organization (GO:0061641),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,CENPI;RSF1
viral life cycle (GO:0019058),6/107,0.44689369780524896,1,0,0,1.1214953271028036,0.903291056261686,GPR15;HSP90AB1;XPO1;CXCR6;UBA52;NUP37
cellular response to starvation (GO:0009267),6/107,0.44689369780524896,1,0,0,1.1214953271028036,0.903291056261686,HSPA8;RRAGB;USP33;AKR1C3;GAS2L1;FOXO1
T cell activation (GO:0042110),5/88,0.4509193850280069,1,0,0,1.1363636363636362,0.9050757984351353,IFNK;DDOST;MICA;GPR18;IFNA10
nucleotide-excision repair (GO:0006289),6/108,0.45579415117862115,1,0,0,1.111111111111111,0.8730155491595808,ISY1;PCNA;EP300;ERCC5;UBA52;POLR2L
monocarboxylic acid metabolic process (GO:0032787),6/108,0.45579415117862115,1,0,0,1.111111111111111,0.8730155491595808,PANK2;PC;AGXT2;UGT1A3;PCK1;ACSBG2
mitochondrion organization (GO:0007005),9/167,0.4575934040421251,1,0,0,1.0778443113772456,0.8426309316618426,PRKN;PIF1;MGME1;WDR81;TERT;DNAJA3;HSD17B10;FANCG;TIMM50
regulation of ion transport (GO:0043269),3/50,0.4596144044474325,1,0,0,1.2,0.9328408706750739,PRKN;SCN10A;KCNA2
fatty acid oxidation (GO:0019395),3/50,0.4596144044474325,1,0,0,1.2,0.9328408706750739,SLC25A17;ACOX1;PPARD
regulation of blood vessel endothelial cell migration (GO:0043535),3/50,0.4596144044474325,1,0,0,1.2,0.9328408706750739,ACVRL1;ANGPT1;FGF18
"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,EDEM2
rRNA 3'-end processing (GO:0031125),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,RPSA
regulation of myoblast fusion (GO:1901739),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,FLOT1
axonal fasciculation (GO:0007413),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,NRCAM
negative regulation of chondrocyte differentiation (GO:0032331),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,SNAI2
peptidyl-arginine modification (GO:0018195),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PRMT1
negative regulation of protein oligomerization (GO:0032460),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,EP300
ribose phosphate metabolic process (GO:0019693),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,DERA
fatty acid elongation (GO:0030497),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,ELOVL4
skeletal myofibril assembly (GO:0014866),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,MYH11
establishment of apical/basal cell polarity (GO:0035089),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,SYNE4
positive regulation of establishment of protein localization (GO:1904951),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PTP4A3
pentose-phosphate shunt (GO:0006098),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,DERA
negative regulation of oxidoreductase activity (GO:0051354),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PRKN
pyrimidine nucleoside salvage (GO:0043097),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,UCK1
modification-dependent macromolecule catabolic process (GO:0043632),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,UBA52
sulfation (GO:0051923),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,SULT1A2
cellular modified amino acid catabolic process (GO:0042219),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,CHAC1
regulation of cholesterol storage (GO:0010885),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,ABCA1
epithelial structure maintenance (GO:0010669),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,MUC2
cellular response to arsenic-containing substance (GO:0071243),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,ATF3
histone arginine methylation (GO:0034969),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PRMT1
serine family amino acid biosynthetic process (GO:0009070),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PSAT1
regulation of rRNA processing (GO:2000232),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,DIMT1
lysine catabolic process (GO:0006554),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,AASS
nucleoside catabolic process (GO:0009164),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,DERA
cell wall macromolecule catabolic process (GO:0016998),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,LALBA
nonribosomal peptide biosynthetic process (GO:0019184),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,CHAC1
positive regulation of keratinocyte differentiation (GO:0045618),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PRKCH
protein import into peroxisome matrix (GO:0016558),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PEX26
"alternative mRNA splicing, via spliceosome (GO:0000380)",1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,SRSF1
exit from mitosis (GO:0010458),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PPP2R2D
polyamine metabolic process (GO:0006595),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,SAT1
regulation of cell communication by electrical coupling (GO:0010649),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,CASQ2
somatic hypermutation of immunoglobulin genes (GO:0016446),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,MSH6
plasminogen activation (GO:0031639),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,APOH
regulation of interleukin-8 biosynthetic process (GO:0045414),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,BCL3
regulation of protein localization to cell periphery (GO:1904375),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,STX7
regulation of establishment of endothelial barrier (GO:1903140),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,IKBKB
cargo loading into COPII-coated vesicle (GO:0090110),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,SEC31B
lysine metabolic process (GO:0006553),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,AASS
negative regulation of epithelial cell differentiation (GO:0030857),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,DLL1
ribosomal subunit export from nucleus (GO:0000054),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,XPO1
cardiac muscle fiber development (GO:0048739),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,MYH11
aromatic compound biosynthetic process (GO:0019438),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PSAT1
protein hydroxylation (GO:0018126),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,OGFOD1
regulation of blood vessel size (GO:0050880),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,UTS2
establishment of protein localization to mitochondrial membrane (GO:0090151),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,AGK
PERK-mediated unfolded protein response (GO:0036499),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,ATF3
cellular response to fatty acid (GO:0071398),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,AKR1C3
regulation of hormone secretion (GO:0046883),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,OSM
pyrimidine-containing compound salvage (GO:0008655),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,UCK1
plasma membrane tubulation (GO:0097320),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,BIN2
negative regulation of myoblast differentiation (GO:0045662),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,DLL1
negative regulation of androgen receptor signaling pathway (GO:0060766),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PIAS2
regulation of sister chromatid cohesion (GO:0007063),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,HDAC8
positive regulation of T cell cytokine production (GO:0002726),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,IL6
calcineurin-mediated signaling (GO:0097720),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,ADGRB2
regulation of catabolic process (GO:0009894),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,RARRES2
positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,IL23A
cellular protein metabolic process (GO:0044267),25/484,0.46277612297750825,1,0,0,1.0330578512396693,0.7959833445482524,MRPS17;PRKN;UBE2D2;TNC;SNU13;NAGPA;DLL1;CALB1;DMBT1;RPL15;TGM3;PSENEN;GSN;WFS1;RPSA;APOA4;MRPS5;CKAP4;TF;IL6;ADORA2B;CALU;UBA52;RSL24D1;RPS24
negative regulation of toll-like receptor signaling pathway (GO:0034122),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,CD14;NR1D1
positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,CXCL9;F2RL3
regulation of protein tyrosine kinase activity (GO:0061097),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,GRM5;RELN
renal water homeostasis (GO:0003091),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,WFS1;PRKAR2A
zinc ion homeostasis (GO:0055069),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,PRKN;SLC39A14
positive regulation of viral genome replication (GO:0045070),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,NR5A2;PABPC1
positive regulation of insulin secretion (GO:0032024),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,GCK;C2CD2L
liver development (GO:0001889),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,PCK1;MET
regulation of cell motility (GO:2000145),6/109,0.4646603211324838,1,0,0,1.1009174311926606,0.8437966596577015,DOCK10;KIF2A;FES;ABI3;LDB2;RHOBTB2
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),6/109,0.4646603211324838,1,0,0,1.1009174311926606,0.8437966596577015,GSN;TNFSF15;TNFRSF10B;ANP32B;ROBO1;SENP1
regulation of Notch signaling pathway (GO:0008593),4/70,0.4662992293725246,1,0,0,1.1428571428571428,0.8719174032140833,EP300;CHAC1;UBA52;DLL1
stress-activated protein kinase signaling cascade (GO:0031098),4/70,0.4662992293725246,1,0,0,1.1428571428571428,0.8719174032140833,IKBKB;STRADB;UBA52;MAP3K14
peptidyl-tyrosine modification (GO:0018212),3/51,0.47268752481329424,1,0,0,1.176470588235294,0.881553803378603,RELN;FES;LINC00598
positive regulation of actin filament polymerization (GO:0030838),3/51,0.47268752481329424,1,0,0,1.176470588235294,0.881553803378603,GSN;LMOD1;CCL26
telomere maintenance (GO:0000723),3/51,0.47268752481329424,1,0,0,1.176470588235294,0.881553803378603,PCNA;TERT;APEX1
coenzyme metabolic process (GO:0006732),3/51,0.47268752481329424,1,0,0,1.176470588235294,0.881553803378603,PANK2;GPAT4;MOCOS
cellular response to peptide hormone stimulus (GO:0071375),6/110,0.4734883847029237,1,0,0,1.0909090909090908,0.8155940698683591,PRKAR2A;PDE3B;GNB3;PCK1;FOXO1;GCK
generation of neurons (GO:0048699),7/130,0.47572414988888423,1,0,0,1.0769230769230769,0.8000645797585316,RELN;WNT5B;ID2;ID1;NRCAM;DLL1;PAFAH1B1
actomyosin structure organization (GO:0031032),4/71,0.47732691074516864,1,0,0,1.1267605633802817,0.8332999159019496,TMOD3;TMOD2;LMOD1;MYOZ3
positive regulation of lymphocyte proliferation (GO:0050671),4/71,0.47732691074516864,1,0,0,1.1267605633802817,0.8332999159019496,SASH3;CD74;IL6;IL23A
dendrite morphogenesis (GO:0048813),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,DOCK10;LRP4
positive regulation of calcium ion transport into cytosol (GO:0010524),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,CXCL9;F2RL3
response to zinc ion (GO:0010043),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,SLC30A6;ZACN
cellular response to glucagon stimulus (GO:0071377),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,PRKAR2A;GNB3
central nervous system neuron differentiation (GO:0021953),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,LMX1A;CHD5
oxoacid metabolic process (GO:0043436),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,PPA2;SULT1A2
sister chromatid segregation (GO:0000819),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,LATS1;CDCA8
chromatin remodeling at centromere (GO:0031055),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,CENPI;RSF1
GPI anchor biosynthetic process (GO:0006506),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,PIGC;PIGW
positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,IL23A;CD14
activation of adenylate cyclase activity (GO:0007190),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,ADORA2B;ADRB2
positive regulation of transcription factor import into nucleus (GO:0042993),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,IL23A;AGER
regulation of erythrocyte differentiation (GO:0045646),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,PRMT1;TAL1
positive regulation of myeloid leukocyte differentiation (GO:0002763),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,CD74;IL23A
positive regulation of cellular protein metabolic process (GO:0032270),5/91,0.48023571472567267,1,0,0,1.0989010989010988,0.8060200255732013,NFKBIA;IL6;YTHDF3;BCL3;CIRBP
B cell differentiation (GO:0030183),3/52,0.4856142127878605,1,0,0,1.1538461538461537,0.8334701205650645,DCAF1;IFNK;IFNA10
positive regulation of mitotic cell cycle (GO:0045931),3/52,0.4856142127878605,1,0,0,1.1538461538461537,0.8334701205650645,GEN1;TAL1;LINC00598
DNA-templated transcriptional preinitiation complex assembly (GO:0070897),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,TAF1B
modulation by virus of host process (GO:0019054),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,PRKN
DNA strand elongation (GO:0022616),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,TERT
response to iron ion (GO:0010039),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,TF
regulation of granulocyte chemotaxis (GO:0071622),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,RARRES2
negative regulation of hemostasis (GO:1900047),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,APOH
regulation of plasma membrane bounded cell projection organization (GO:0120035),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,CCDC88A
nucleotide-sugar metabolic process (GO:0009225),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,PARG
cellular response to exogenous dsRNA (GO:0071360),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,FLOT1
positive regulation of sodium ion transport (GO:0010765),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,PKP2
intestinal absorption (GO:0050892),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,CD36
regulation of superoxide anion generation (GO:0032928),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,CRP
embryonic appendage morphogenesis (GO:0035113),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,FBXW4
regulation of NMDA receptor activity (GO:2000310),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,RELN
very long-chain fatty acid biosynthetic process (GO:0042761),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,ELOVL4
chromatin assembly or disassembly (GO:0006333),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,HDAC8
regulation of glucose import in response to insulin stimulus (GO:2001273),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,RARRES2
maintenance of gastrointestinal epithelium (GO:0030277),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,MUC2
striated muscle myosin thick filament assembly (GO:0071688),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,MYH11
mRNA cleavage involved in mRNA processing (GO:0098787),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,ERN1
regulation of DNA-templated transcription in response to stress (GO:0043620),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,RPS6KA1
regulation of biomineral tissue development (GO:0070167),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,TXLNG
positive regulation of glycogen biosynthetic process (GO:0045725),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,GCK
regulation of macromolecule biosynthetic process (GO:0010556),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,ANKRD13C
"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,TP73
positive regulation of actin nucleation (GO:0051127),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,GSN
regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,IL23A
positive regulation of protein complex disassembly (GO:0043243),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,ADRB2
alpha-linolenic acid metabolic process (GO:0036109),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,ACOX1
regulation of cAMP metabolic process (GO:0030814),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,CXCL9
cellular response to interleukin-15 (GO:0071350),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,IL2RB
phospholipase C-activating dopamine receptor signaling pathway (GO:0060158),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,GNA14
toll-like receptor 9 signaling pathway (GO:0034162),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,IRAK2
ER-associated misfolded protein catabolic process (GO:0071712),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,POMT1
negative regulation of reactive oxygen species biosynthetic process (GO:1903427),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,MPV17L
regulation of endothelial cell chemotaxis (GO:2001026),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,MET
regulation of necrotic cell death (GO:0010939),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,UBA52
motile cilium assembly (GO:0044458),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,RSPH9
prostanoid biosynthetic process (GO:0046457),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,CD74
positive regulation of lamellipodium assembly (GO:0010592),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,TWF2
negative regulation of hormone secretion (GO:0046888),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,OSM
regulation of neurotransmitter transport (GO:0051588),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,KCNMB4
positive regulation of ERAD pathway (GO:1904294),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,EDEM2
RNA interference (GO:0016246),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,TERT
mammary gland epithelium development (GO:0061180),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,LATS1
regulation of fibrinolysis (GO:0051917),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,APOH
nucleotide metabolic process (GO:0009117),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,PDE8B
semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,SEMA3F
regulation of retinoic acid receptor signaling pathway (GO:0048385),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,AKR1C3
positive regulation of interleukin-17 production (GO:0032740),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,IL23A
interleukin-15-mediated signaling pathway (GO:0035723),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,IL2RB
negative regulation of cartilage development (GO:0061037),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,SNAI2
negative regulation of chemokine production (GO:0032682),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,IL6
response to fatty acid (GO:0070542),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,CD36
positive regulation of smoothened signaling pathway (GO:0045880),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,ULK3
regulation of synaptic vesicle transport (GO:1902803),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,PRKN
ribonucleoprotein complex disassembly (GO:0032988),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,LIME1
"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,DDX1
lipid biosynthetic process (GO:0008610),4/72,0.48826565745953704,1,0,0,1.111111111111111,0.7965507124555724,GUCY2C;DHRS11;ELOVL4;GPAT4
response to metal ion (GO:0010038),4/72,0.48826565745953704,1,0,0,1.111111111111111,0.7965507124555724,SLC30A6;ZACN;SNCB;GPHN
negative regulation of cell cycle (GO:0045786),4/72,0.48826565745953704,1,0,0,1.111111111111111,0.7965507124555724,LATS1;LATS2;HPGD;HECA
cellular response to hypoxia (GO:0071456),7/132,0.49185149962456454,1,0,0,1.0606060606060606,0.7525831919041477,TERT;EPO;UBE2D2;EP300;RORA;UBA52;PSMB8
translation (GO:0006412),12/232,0.49417266403176446,1,0,0,1.0344827586206895,0.7291761729635255,MRPS17;RARS2;PPA2;NOA1;MRTO4;TARS2;SNU13;RPSA;RPL15;RSL24D1;RPS24;MRPS5
positive regulation of adenylate cyclase activity (GO:0045762),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,ADORA2B;ADRB2
activation of MAPKK activity (GO:0000186),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,MOS;MAP3K14
positive regulation of cell-cell adhesion (GO:0022409),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,SIRPG;FLOT1
positive regulation of calcium ion transport (GO:0051928),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,LGALS3;WFS1
embryonic organ morphogenesis (GO:0048562),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,ID2;DSCAML1
regulation of DNA recombination (GO:0000018),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,MSH6;PPP4C
positive regulation of nucleocytoplasmic transport (GO:0046824),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,ANP32B;GTSE1
positive regulation of Notch signaling pathway (GO:0045747),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,EP300;DLL1
negative regulation of multi-organism process (GO:0043901),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,MAPKBP1;MBL2
positive regulation of locomotion (GO:0040017),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,RARRES2;CCL26
regulation of interleukin-12 production (GO:0032655),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,IL23A;AGER
embryonic organ development (GO:0048568),3/53,0.498386049960954,1,0,0,1.1320754716981132,0.788355058353472,SOX18;TAL1;RARRES2
lymphocyte differentiation (GO:0030098),4/73,0.49910951364629225,1,0,0,1.095890410958904,0.7615668395449564,DCAF1;IFNK;GPR18;IFNA10
cotranslational protein targeting to membrane (GO:0006613),5/93,0.4994819883860412,1,0,0,1.075268817204301,0.7464341299256831,SRPRA;RPSA;RPL15;UBA52;RPS24
proteolysis involved in cellular protein catabolic process (GO:0051603),5/93,0.4994819883860412,1,0,0,1.075268817204301,0.7464341299256831,PRKN;ATE1;NR1D1;UBA52;PSMB8
regulation of canonical Wnt signaling pathway (GO:0060828),11/213,0.5001763192159705,1,0,0,1.0328638497652582,0.7155625020839014,SOX2;PRKN;RNF146;LATS1;WWTR1;LATS2;SNAI2;LRP4;UBA52;PSMB8;RNF220
skin development (GO:0043588),5/94,0.509002443009079,1,0,0,1.0638297872340425,0.7184068753385349,SPRR4;AKR1C3;MET;DLL1;TGM3
mitotic nuclear division (GO:0140014),4/74,0.5098528753630284,1,0,0,1.0810810810810811,0.7282519724998587,KIF2A;PPP2R2D;CDCA8;ABRAXAS2
intracellular transport of virus (GO:0075733),3/54,0.5109953414593842,1,0,0,1.111111111111111,0.7459942281531415,XPO1;UBA52;NUP37
negative regulation of cellular component organization (GO:0051129),3/54,0.5109953414593842,1,0,0,1.111111111111111,0.7459942281531415,LGALS3;HSPA8;SACS
transport of virus (GO:0046794),3/54,0.5109953414593842,1,0,0,1.111111111111111,0.7459942281531415,XPO1;UBA52;NUP37
negative regulation of supramolecular fiber organization (GO:1902904),3/54,0.5109953414593842,1,0,0,1.111111111111111,0.7459942281531415,PRKN;HSPA8;TWF2
nucleoside salvage (GO:0043174),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,UCK1
regulation of Golgi organization (GO:1903358),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,EHD3
"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,PABPC1
acetyl-CoA metabolic process (GO:0006084),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,ACSS1
positive regulation of osteoclast differentiation (GO:0045672),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,IL23A
establishment of mitotic spindle orientation (GO:0000132),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,PAFAH1B1
stem cell development (GO:0048864),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,SNAI2
gliogenesis (GO:0042063),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,RELN
regulation of nucleocytoplasmic transport (GO:0046822),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,XPO1
establishment or maintenance of actin cytoskeleton polarity (GO:0030950),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,RHOBTB2
negative regulation of Rho protein signal transduction (GO:0035024),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,MET
detection of chemical stimulus involved in sensory perception of smell (GO:0050911),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,OR7G2
regulation of monocyte differentiation (GO:0045655),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,CD74
acyl-CoA biosynthetic process (GO:0071616),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,ACSS1
cell communication by electrical coupling involved in cardiac conduction (GO:0086064),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,PKP2
negative regulation of focal adhesion assembly (GO:0051895),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,ACVRL1
thymus development (GO:0048538),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,AIRE
copper ion transport (GO:0006825),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,SLC31A2
positive regulation of mitochondrial fission (GO:0090141),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,PRKN
hydrogen peroxide catabolic process (GO:0042744),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,APOA4
regulation of neural precursor cell proliferation (GO:2000177),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,ID2
positive regulation of glycogen metabolic process (GO:0070875),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,GCK
cell migration involved in sprouting angiogenesis (GO:0002042),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,ROBO1
amyloid-beta metabolic process (GO:0050435),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,PSENEN
smooth muscle contraction (GO:0006939),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,MYH11
response to ethanol (GO:0045471),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,GRIN2B
monosaccharide transport (GO:0015749),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,SLC50A1
regulation of fatty acid metabolic process (GO:0019217),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,PANK2
metallo-sulfur cluster assembly (GO:0031163),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,CIAO1
"DNA damage response, signal transduction resulting in transcription (GO:0042772)",1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,TP73
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,PRKN
oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,ALG13
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,EBI3
positive regulation of vascular smooth muscle cell proliferation (GO:1904707),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,ERN1
glycoside metabolic process (GO:0016137),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,AKR1C3
nucleoside triphosphate metabolic process (GO:0009141),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,AK8
positive regulation of purine nucleotide metabolic process (GO:1900544),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,CXCL9
interleukin-6-mediated signaling pathway (GO:0070102),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,IL6
regulation of interferon-gamma biosynthetic process (GO:0045072),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,EBI3
regulation of response to interferon-gamma (GO:0060330),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,HSP90AB1
regulation of adaptive immune response (GO:0002819),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,SASH3
negative regulation of T cell receptor signaling pathway (GO:0050860),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,LGALS3
establishment of protein localization to chromosome (GO:0070199),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,TERT
negative regulation of cation transmembrane transport (GO:1904063),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,EPO
positive regulation of interleukin-8 secretion (GO:2000484),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,CD14
regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,GEN1
epithelial tube morphogenesis (GO:0060562),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,ACVRL1;MET
negative regulation of cellular metabolic process (GO:0031324),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,PRKN;NR1D1
positive regulation of exocytosis (GO:0045921),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,SDC4;UNC13D
response to peptide (GO:1901652),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,REG1B;AGER
positive regulation of DNA binding (GO:0043388),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,PRKN;NME1
regulation of axon extension (GO:0030516),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,TWF2;NRCAM
negative regulation of endothelial cell migration (GO:0010596),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,ACVRL1;APOH
positive regulation of chemokine production (GO:0032722),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,CD74;IL6
response to glucagon (GO:0033762),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,PRKAR2A;GNB3
cellular macromolecular complex assembly (GO:0034622),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,KIF13A;USH1C
organelle assembly (GO:0070925),19/376,0.5147627245574271,1,0,0,1.0106382978723403,0.6711135668364496,RBM14;GSN;TMOD3;TMOD2;STX7;CEP164;CIRBP;LMOD1;OCRL;EHD3;BIN2;GOLGA8F;GOLGA6D;OGFOD1;RFX4;ULK3;CEP83;BBS9;MYOZ3
positive regulation of protein localization to membrane (GO:1905477),5/95,0.5184489993734346,1,0,0,1.0526315789473684,0.6914880189626921,PRKN;PRKCH;STAC;PTPN9;TP73
regulation of cytoskeleton organization (GO:0051493),5/95,0.5184489993734346,1,0,0,1.0526315789473684,0.6914880189626921,CCDC88A;ARHGEF19;TWF2;RHOU;RHOBTB2
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",4/75,0.520490485053102,1,0,0,1.0666666666666667,0.6965159162578138,IKBKB;CD36;PSMB8;VAMP3
"positive regulation of transcription, DNA-templated (GO:0045893)",56/1120,0.5206428733129057,1,0,0,1,0.6526909361573316,ACVRL1;SETD3;EPO;AKAP8L;RORA;CCNC;RSF1;LDB2;IKBKB;RPS6KA4;SOX2;DBP;SOX18;RPS6KA1;EP300;ZNF567;RBM14;PPP1R12A;PIAS2;SENP1;MED25;NR5A2;LMX1A;TAL1;THRAP3;RFX4;ZSCAN21;ZNF318;TBPL1;ATF6;MET;UBA52;ATF3;PPARD;PRKN;ENY2;AIRE;CREBL2;DLL1;NPAS2;FOXO1;DDN;CAND2;SHOX;TAF9B;WWTR1;CD74;OSM;NR1D1;NFKBIA;IL6;ID2;TADA3;BCL3;TAF2;TP73
regulation of axonogenesis (GO:0050770),3/55,0.5234350892650081,1,0,0,1.0909090909090908,0.706191545588209,LRP4;NRCAM;ROBO1
regulation of RNA splicing (GO:0043484),3/55,0.5234350892650081,1,0,0,1.0909090909090908,0.706191545588209,ERN1;FASTK;TRA2B
DNA recombination (GO:0006310),3/55,0.5234350892650081,1,0,0,1.0909090909090908,0.706191545588209,GEN1;RMI2;RBM14
proteasomal protein catabolic process (GO:0010498),12/237,0.5242381291495107,1,0,0,1.0126582278481011,0.6539840536183389,ABTB2;PRKN;ATE1;RNF126;RLIM;NHLRC1;RBCK1;NR1D1;GTSE1;UBA52;RNF122;PSMB8
positive regulation of protein metabolic process (GO:0051247),5/96,0.5278178232072942,1,0,0,1.0416666666666667,0.6656292568931363,PRKN;NFKBIA;PRMT1;WFS1;FOXO1
protein localization to nucleus (GO:0034504),5/96,0.5278178232072942,1,0,0,1.0416666666666667,0.6656292568931363,INTS13;MORC3;BCL3;HEATR3;POM121L12
positive regulation of MAP kinase activity (GO:0043406),9/177,0.5278368946610092,1,0,0,1.0169491525423728,0.6497979199584173,MOS;INS-IGF2;IRAK2;ADORA2B;FGF18;UBA52;MAP3K14;PIK3R6;ROBO1
positive regulation of RNA metabolic process (GO:0051254),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,ERN1;DIMT1
antibacterial humoral response (GO:0019731),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,DMBT1;DEFA4
regulation of microtubule polymerization (GO:0031113),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,FES;MET
regulation of endothelial cell apoptotic process (GO:2000351),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,ANGPT1;AKR1C3
erythrocyte differentiation (GO:0030218),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,EPO;TAL1
positive regulation of DNA replication (GO:0045740),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,PCNA;EPO
regulation of sodium ion transport (GO:0002028),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,NKAIN4;PKP2
regulation of ion transmembrane transport (GO:0034765),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,SCN10A;CASQ2
regulation of phosphoprotein phosphatase activity (GO:0043666),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,HSP90AB1;PPP1R12A
neural crest cell development (GO:0014032),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,SNAI2;SEMA3F
actin filament bundle organization (GO:0061572),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,USH1C;RHOBTB2
DNA-dependent DNA replication maintenance of fidelity (GO:0045005),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,PCNA;PRIMPOL
regulation of hematopoietic stem cell differentiation (GO:1902036),4/76,0.531017425175643,1,0,0,1.0526315789473684,0.666274150005563,TAL1;UBA52;PSMB8;TP73
nucleic acid-templated transcription (GO:0097659),4/76,0.531017425175643,1,0,0,1.0526315789473684,0.666274150005563,TERT;TAF1B;BCL3;POLR2L
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),4/76,0.531017425175643,1,0,0,1.0526315789473684,0.666274150005563,LGALS3;TERT;TNFRSF10B;SNAI2
regulation of secretion by cell (GO:1903530),3/56,0.5356989644779965,1,0,0,1.0714285714285714,0.6687674026318335,KCNMB4;ARFIP1;VAMP3
positive regulation of peptidyl-lysine acetylation (GO:2000758),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,RPS6KA4
myotube differentiation (GO:0014902),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ADGRB3
pseudouridine synthesis (GO:0001522),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,RPUSD3
catecholamine metabolic process (GO:0006584),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PRKN
retinoic acid metabolic process (GO:0042573),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,UGT1A3
vitamin D metabolic process (GO:0042359),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CUBN
heparan sulfate proteoglycan biosynthetic process (GO:0015012),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,EXT2
selective autophagy (GO:0061912),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,WDR81
digestive tract morphogenesis (GO:0048546),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ID2
histone H4-K8 acetylation (GO:0043982),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,JADE3
phosphatidylethanolamine biosynthetic process (GO:0006646),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CHKB
positive regulation of response to wounding (GO:1903036),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SCARF1
negative regulation of adherens junction organization (GO:1903392),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ACVRL1
endocardial cushion morphogenesis (GO:0003203),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ACVRL1
positive regulation of glycolytic process (GO:0045821),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PFKFB3
response to X-ray (GO:0010165),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,TP73
pyrimidine nucleoside biosynthetic process (GO:0046134),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,UCK1
"protein localization to chromosome, telomeric region (GO:0070198)",1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,TERT
"phototransduction, visible light (GO:0007603)",1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,MAPRE2
transport along microtubule (GO:0010970),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,HSPA8
positive regulation of coenzyme metabolic process (GO:0051197),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PFKFB3
lipoxygenase pathway (GO:0019372),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,HPGD
ventricular cardiac muscle cell action potential (GO:0086005),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PKP2
anterograde synaptic vesicle transport (GO:0048490),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,AP3B2
regulation of establishment of cell polarity (GO:2000114),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,GSN
sodium ion import (GO:0097369),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SLC9A8
unsaturated fatty acid biosynthetic process (GO:0006636),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,HPGD
negative regulation of coagulation (GO:0050819),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,APOH
negative regulation of cell aging (GO:0090344),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,TERT
presynapse assembly (GO:0099054),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,LRP4
mitochondrion localization (GO:0051646),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,BRAT1
mesenchyme morphogenesis (GO:0072132),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ACVRL1
nitric oxide mediated signal transduction (GO:0007263),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CD36
mitotic chromosome condensation (GO:0007076),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,AKAP8L
negative regulation of lipid catabolic process (GO:0050995),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PDE3B
negative regulation of release of cytochrome c from mitochondria (GO:0090201),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PRKN
pyrimidine-containing compound metabolic process (GO:0072527),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,UCK1
cellular biogenic amine biosynthetic process (GO:0042401),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SAT1
neural crest cell differentiation (GO:0014033),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SNAI2
N-terminal protein amino acid acetylation (GO:0006474),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,EP300
mesenchymal cell development (GO:0014031),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SNAI2
negative regulation of muscle cell differentiation (GO:0051148),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,DLL1
positive regulation of viral release from host cell (GO:1902188),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PC
sodium ion import across plasma membrane (GO:0098719),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SLC9A8
regulation of macrophage chemotaxis (GO:0010758),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,RARRES2
negative regulation of viral entry into host cell (GO:0046597),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,GSN
negative regulation of axon extension involved in axon guidance (GO:0048843),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SEMA3F
body fluid secretion (GO:0007589),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,GPAT4
negative regulation of DNA-dependent DNA replication (GO:2000104),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,STAG2
microtubule depolymerization (GO:0007019),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,KIF2A
negative regulation of RNA metabolic process (GO:0051253),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,TERT
positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,FLOT1
positive regulation of exosomal secretion (GO:1903543),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SDC4
regulation of protein complex disassembly (GO:0043244),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,OGFOD1
negative regulation of protein processing (GO:0010955),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CHAC1
regulation of RNA export from nucleus (GO:0046831),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,AKAP8L
regulation of lymphocyte proliferation (GO:0050670),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,LGALS3
toll-like receptor 4 signaling pathway (GO:0034142),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CD14
regulation of fertilization (GO:0080154),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,INTS13
protein targeting to peroxisome (GO:0006625),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PEX26
synaptic vesicle transport along microtubule (GO:0099517),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,AP3B2
sulfate transport (GO:0008272),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SLC26A7
negative regulation of anoikis (GO:2000811),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SNAI2
base conversion or substitution editing (GO:0016553),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,APOBEC1
histone H4-K5 acetylation (GO:0043981),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,JADE3
establishment of protein localization to endoplasmic reticulum (GO:0072599),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SRPRA
nucleobase-containing small molecule catabolic process (GO:0034656),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ENTPD3
cellular response to corticosteroid stimulus (GO:0071384),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,AKR1C3
positive regulation of neuron projection development (GO:0010976),5/97,0.5371052771771576,1,0,0,1.0309278350515463,0.6407846977351693,RELN;FES;TWF2;SCARF1;ROBO1
protein targeting to ER (GO:0045047),5/97,0.5371052771771576,1,0,0,1.0309278350515463,0.6407846977351693,SRPRA;RPSA;RPL15;UBA52;RPS24
protein localization to organelle (GO:0033365),5/97,0.5371052771771576,1,0,0,1.0309278350515463,0.6407846977351693,COG7;DDX1;CROCC;BBS9;CNTLN
regulation of vesicle-mediated transport (GO:0060627),7/138,0.5392352041131376,1,0,0,1.0144927536231885,0.6265542063646131,PRKN;RAB4B;FES;EVI5L;BET1L;ARFGAP1;TBC1D16
ubiquitin-dependent protein catabolic process (GO:0006511),17/341,0.5405105244712303,1,0,0,0.9970674486803518,0.613436944054248,PRKN;FBXW4;ATE1;UBE2D2;USP33;PSMB8;RNF40;ABTB2;RNF146;RNF126;WDR81;RLIM;NHLRC1;RBCK1;GTSE1;UBA52;RNF122
ERAD pathway (GO:0036503),4/77,0.541429111359833,1,0,0,1.0389610389610389,0.6374474106254083,PRKN;WFS1;POMT1;ANKZF1
regulation of hematopoietic progenitor cell differentiation (GO:1901532),4/77,0.541429111359833,1,0,0,1.0389610389610389,0.6374474106254083,TAL1;UBA52;PSMB8;TP73
actin polymerization or depolymerization (GO:0008154),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,GSN;TWF2
regulation of receptor-mediated endocytosis (GO:0048259),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,TF;FLOT1
organic hydroxy compound transport (GO:0015850),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,SLCO1C1;SLC10A3
regulation of smoothened signaling pathway (GO:0008589),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,ULK3;RORA
transferrin transport (GO:0033572),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,TF;ATP6V0D2
lymphocyte proliferation (GO:0046651),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,IFNK;IFNA10
natural killer cell activation (GO:0030101),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,IFNK;IFNA10
organophosphate biosynthetic process (GO:0090407),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,MOCOS;GPHN
heart looping (GO:0001947),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,SOX18;DLL1
ferric iron transport (GO:0015682),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,TF;ATP6V0D2
centromere complex assembly (GO:0034508),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,CENPI;RSF1
epithelial cell migration (GO:0010631),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,PTP4A3;PXN
axonal transport (GO:0098930),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,AP3B2;PAFAH1B1
regulation of cysteine-type endopeptidase activity (GO:2000116),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,SOX2;GRIN2B
phosphatidylinositol biosynthetic process (GO:0006661),5/98,0.5463079186398003,1,0,0,1.0204081632653061,0.616910723108701,PIGC;OCRL;PIGW;MTMR6;PIK3R6
regulation of insulin secretion (GO:0050796),5/98,0.5463079186398003,1,0,0,1.0204081632653061,0.616910723108701,PRKN;MIDN;ITPR2;NR1D1;GCK
histone modification (GO:0016570),5/98,0.5463079186398003,1,0,0,1.0204081632653061,0.616910723108701,RPS6KA4;ENY2;RBM14;PRMT1;EP300
regulation of glycolytic process (GO:0006110),3/57,0.5477812798713707,1,0,0,1.0526315789473684,0.6335570484502631,PFKFB3;GCK;NUP37
positive regulation of cell death (GO:0010942),3/57,0.5477812798713707,1,0,0,1.0526315789473684,0.6335570484502631,AKR1C3;CD36;GRIN2B
epidermal growth factor receptor signaling pathway (GO:0007173),3/57,0.5477812798713707,1,0,0,1.0526315789473684,0.6335570484502631,FES;PXN;FAM83B
cellular respiration (GO:0045333),3/57,0.5477812798713707,1,0,0,1.0526315789473684,0.6335570484502631,COX6A1;COQ10B;COX20
defense response to bacterium (GO:0042742),12/241,0.5478946475793864,1,0,0,0.9958506224066389,0.5991756940670975,SPN;CRP;IL6;DMBT1;IL23A;GNLY;ARRDC1-AS1;RARRES2;DEFA4;LALBA;MICA;MBL2
negative regulation of cell proliferation (GO:0008285),18/363,0.5490379252117642,1,0,0,0.9917355371900827,0.5946324885888693,ACVRL1;PBRM1;MORC3;HPN;SIRPG;OSM;CHD5;DLL1;NME1;SOX2;MED25;IL6;ID2;DNAJA3;IFNK;UTP20;CD33;TP73
regulation of neuron projection development (GO:0010975),6/119,0.5506572107989453,1,0,0,1.0084033613445378,0.6016565903086142,CCDC88A;RELN;FES;TWF2;PTPN9;SCARF1
regulation of phosphorylation (GO:0042325),6/119,0.5506572107989453,1,0,0,1.0084033613445378,0.6016565903086142,IKBKB;CCDC88A;GRM5;LDB2;GCK;NUP37
brain development (GO:0007420),6/119,0.5506572107989453,1,0,0,1.0084033613445378,0.6016565903086142,RELN;ROGDI;GRIN2B;DSCAML1;NKX2-2;PAFAH1B1
sensory perception of mechanical stimulus (GO:0050954),4/78,0.5517212852986342,1,0,0,1.0256410256410255,0.6099613109295229,WFS1;USH1C;SNAI2;SERPINB6
positive regulation of translation (GO:0045727),4/78,0.5517212852986342,1,0,0,1.0256410256410255,0.6099613109295229,IL6;YTHDF3;BCL3;CIRBP
regulation of cellular response to heat (GO:1900034),4/78,0.5517212852986342,1,0,0,1.0256410256410255,0.6099613109295229,HSPA8;HSP90AB1;EP300;NUP37
antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),4/78,0.5517212852986342,1,0,0,1.0256410256410255,0.6099613109295229,IKBKB;CD36;PSMB8;VAMP3
fibroblast growth factor receptor signaling pathway (GO:0008543),4/78,0.5517212852986342,1,0,0,1.0256410256410255,0.6099613109295229,FGF18;UBA52;FGFRL1;POLR2L
response to lipid (GO:0033993),7/140,0.554630993923663,1,0,0,1,0.5894522621768664,CXCL9;TNFRSF10B;NR1D1;CD36;PCK1;CXCL5;PPARD
negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),7/140,0.554630993923663,1,0,0,1,0.5894522621768664,NFKBIA;IRAK2;WFS1;ID2;ID1;RBCK1;COMMD6
positive regulation of receptor activity (GO:2000273),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,RELN;ADRB2
phospholipid biosynthetic process (GO:0008654),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,AGK;SGMS2
protein K63-linked ubiquitination (GO:0070534),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,PRKN;RNF126
positive regulation of axonogenesis (GO:0050772),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,TWF2;ROBO1
regulation of carbohydrate catabolic process (GO:0043470),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,GCK;NUP37
actin filament bundle assembly (GO:0051017),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,USH1C;RHOBTB2
response to steroid hormone (GO:0048545),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,CATSPER4;CATSPERG
actin filament organization (GO:0007015),6/120,0.558921512029944,1,0,0,1,0.5817462235027698,GSN;TMOD3;TMOD2;LMOD1;RHOU;RHOBTB2
neutrophil mediated immunity (GO:0002446),24/487,0.5594149167429713,1,0,0,0.9856262833675564,0.5725146608215005,VAT1;HSPA8;GSN;RAB4B;HSP90AB1;DEFA4;RETN;MMP8;AGPAT2;UNC13D;DDOST;CXCL5;CKAP4;SERPINB6;DERA;LGALS3;IL6;BIN2;NEU1;STOM;CYSTM1;CD14;CD36;CD33
phospholipid transport (GO:0015914),3/58,0.559676962497205,1,0,0,1.0344827586206895,0.6004091528069233,ABCA1;OSBPL5;APOA4
ubiquitin-dependent ERAD pathway (GO:0030433),3/58,0.559676962497205,1,0,0,1.0344827586206895,0.6004091528069233,WFS1;EDEM2;ANKZF1
regulation of epidermal growth factor receptor signaling pathway (GO:0042058),3/58,0.559676962497205,1,0,0,1.0344827586206895,0.6004091528069233,RNF126;UBA52;SH3GL2
cholesterol homeostasis (GO:0042632),3/58,0.559676962497205,1,0,0,1.0344827586206895,0.6004091528069233,ABCA1;LCAT;APOA4
sterol homeostasis (GO:0055092),3/58,0.559676962497205,1,0,0,1.0344827586206895,0.6004091528069233,ABCA1;LCAT;APOA4
post-Golgi vesicle-mediated transport (GO:0006892),3/58,0.559676962497205,1,0,0,1.0344827586206895,0.6004091528069233,AP4M1;OSBPL5;AP3B2
protein localization to microtubule organizing center (GO:1905508),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,CEP83
negative regulation of NF-kappaB import into nucleus (GO:0042347),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,NFKBIA
"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,PABPC1
C21-steroid hormone biosynthetic process (GO:0006700),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,GUCY2C
DNA strand elongation involved in DNA replication (GO:0006271),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,PCNA
glucose transmembrane transport (GO:1904659),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,PPARD
cellular response to dsRNA (GO:0071359),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,FLOT1
negative regulation of immune effector process (GO:0002698),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,LGALS3
establishment of skin barrier (GO:0061436),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,MET
regulation of membrane depolarization (GO:0003254),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,SCN10A
positive regulation of dendrite morphogenesis (GO:0050775),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,RELN
regulation of toll-like receptor 4 signaling pathway (GO:0034143),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,NR1D1
positive regulation of regulated secretory pathway (GO:1903307),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,UNC13D
leukocyte tethering or rolling (GO:0050901),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,SPN
regulation of cell cycle phase transition (GO:1901987),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,GTSE1
cytoplasmic sequestering of transcription factor (GO:0042994),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,NFKBIA
regulation of reactive oxygen species biosynthetic process (GO:1903426),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,CD36
epithelial cell development (GO:0002064),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,WNT5B
regulation of water loss via skin (GO:0033561),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,MET
sympathetic nervous system development (GO:0048485),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,SEMA3F
negative regulation of striated muscle cell differentiation (GO:0051154),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,BHLHE41
negative regulation of steroid biosynthetic process (GO:0010894),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,SNAI2
leukocyte adhesion to vascular endothelial cell (GO:0061756),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,SPN
extracellular matrix assembly (GO:0085029),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,MYH11
hexose transport (GO:0008645),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,SLC50A1
positive regulation of myotube differentiation (GO:0010831),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,FLOT1
peptidyl-lysine methylation (GO:0018022),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,SETD3
dendritic spine morphogenesis (GO:0060997),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,DOCK10
negative regulation of DNA recombination (GO:0045910),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,MSH6
rRNA transcription (GO:0009303),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,TAF1B
positive regulation of triglyceride metabolic process (GO:0090208),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,APOA4
regulation of SMAD protein import into nucleus (GO:0060390),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,WWTR1
positive regulation of cyclic nucleotide metabolic process (GO:0030801),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,CXCL9
positive regulation of nitric-oxide synthase activity (GO:0051000),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,TERT
mRNA transcription from RNA polymerase II promoter (GO:0042789),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,SOX18
cardiac epithelial to mesenchymal transition (GO:0060317),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,SNAI2
odontogenesis of dentin-containing tooth (GO:0042475),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,ROGDI
regulation of stem cell proliferation (GO:0072091),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,TERT
artery development (GO:0060840),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,ACVRL1
regulation of necroptotic process (GO:0060544),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,UBA52
aorta morphogenesis (GO:0035909),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,ACVRL1
activation of protein kinase A activity (GO:0034199),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,PRKAR2A
embryonic heart tube development (GO:0035050),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,SOX18
regulation of membrane repolarization (GO:0060306),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,CASQ2
detection of visible light (GO:0009584),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,MAPRE2
linoleic acid metabolic process (GO:0043651),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,GSTA1
regulation of glucose transport (GO:0010827),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,RSC1A1
positive regulation of response to endoplasmic reticulum stress (GO:1905898),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,ERN1
regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,SNAI2
steroid biosynthetic process (GO:0006694),4/79,0.561890006637219,1,0,0,1.0126582278481011,0.5837459908567373,GUCY2C;DHRS11;AKR1C3;CYP46A1
regulation of MAPK cascade (GO:0043408),10/203,0.5650441783296952,1,0,0,0.9852216748768473,0.5624151321758981,SOX2;MOS;CD74;IL6;INS-IGF2;OSM;TNFRSF10B;GPR37L1;ADRB2;MET
cellular macromolecule biosynthetic process (GO:0034645),18/367,0.5680755876127079,1,0,0,0.9809264305177112,0.5547146736771454,MRPS17;PIF1;RMI2;RBM14;SNU13;RPSA;MRPS5;EXT2;TERT;TAF1B;B3GNT6;BCL3;MCM3;MCM4;RPL15;RSL24D1;RPS24;POLR2L
regulation of protein metabolic process (GO:0051246),3/59,0.5713815260202666,1,0,0,1.0169491525423728,0.5691845296161483,ABTB2;WFS1;ANGPTL8
renal system development (GO:0072001),3/59,0.5713815260202666,1,0,0,1.0169491525423728,0.5691845296161483,PYGO2;WFS1;LRP4
regulation of extrinsic apoptotic signaling pathway (GO:2001236),3/59,0.5713815260202666,1,0,0,1.0169491525423728,0.5691845296161483,LGALS3;FEM1B;TNFRSF10B
keratinocyte differentiation (GO:0030216),3/59,0.5713815260202666,1,0,0,1.0169491525423728,0.5691845296161483,SPRR4;AKR1C3;TGM3
"retrograde vesicle-mediated transport, Golgi to ER (GO:0006890)",4/80,0.5719316453053178,1,0,0,1,0.5587357959576575,COG7;KIF2A;COPZ2;ARFGAP1
spindle assembly (GO:0051225),4/80,0.5719316453053178,1,0,0,1,0.5587357959576575,KIF2A;GOLGA8F;GOLGA6D;ABRAXAS2
nucleic acid metabolic process (GO:0090304),4/80,0.5719316453053178,1,0,0,1,0.5587357959576575,ANKLE1;DDX1;DXO;POLR2L
negative regulation of MAPK cascade (GO:0043409),4/80,0.5719316453053178,1,0,0,1,0.5587357959576575,IGBP1;PTPRR;LMO3;FOXO1
negative regulation of defense response (GO:0031348),4/80,0.5719316453053178,1,0,0,1,0.5587357959576575,MAPKBP1;TRAFD1;RORA;PPARD
cellular protein localization (GO:0034613),16/327,0.5719928511281699,1,0,0,0.9785932721712538,0.5466703713351585,CD74;COG7;RAB4B;ANGPT1;STX7;COPZ2;AP4M1;RRAGB;CROCC;ID1;KIF13A;ARFIP1;EVI5L;SEC31B;TBC1D16;CNTLN
membrane depolarization during action potential (GO:0086010),2/38,0.5730476768580657,1,0,0,1.0526315789473684,0.5860909053082317,SCN10A;CATSPER4
DNA damage checkpoint (GO:0000077),2/38,0.5730476768580657,1,0,0,1.0526315789473684,0.5860909053082317,USP28;MAP3K14
positive regulation of DNA repair (GO:0045739),2/38,0.5730476768580657,1,0,0,1.0526315789473684,0.5860909053082317,PCNA;NPAS2
cytokine-mediated signaling pathway (GO:0019221),31/633,0.5745545827959841,1,0,0,0.9794628751974723,0.5427793202726001,CXCL9;EPO;EBI3;RORA;FOXO1;CXCL5;IKBKB;SOX2;RPS6KA4;IRAK2;CD36;IP6K2;CCR2;HSPA8;TNFSF15;OSM;TNFRSF10B;PSMB8;NFKBIA;IL6;IL23A;IL2RB;BOLA2;IFNK;RHOU;UBA52;MAP3K14;IRF9;CCL26;CRLF2;IFNA10
sulfur compound biosynthetic process (GO:0044272),6/122,0.5752322098774906,1,0,0,0.9836065573770492,0.5439162063367176,EXT2;ANGPT1;GSTA3;GSTA1;CHAC1;MAT2B
vesicle-mediated transport (GO:0016192),20/410,0.5781846907866909,1,0,0,0.975609756097561,0.534499441089679,GIT2;HSPA8;STX7;ARAP2;ADRB2;BET1L;ARFGAP1;RNF126;EHD3;HEATR5A;KIF13A;ANKFY1;CEP83;RHOU;KIF1A;GPRASP1;CYTH1;VAMP3;AGFG1;SPTBN2
glycerophospholipid biosynthetic process (GO:0046474),8/164,0.5794459572335974,1,0,0,0.975609756097561,0.5323735396380541,CHKB;GPAT4;AGK;LCAT;OCRL;AGPAT2;MTMR6;PIK3R6
ribosome biogenesis (GO:0042254),11/226,0.5801164050386578,1,0,0,0.9734513274336283,0.5300700415575347,SAMD15;XPO1;NOA1;MRTO4;HEATR3;SNU13;RPSA;UTP20;RPL15;UBA52;RPS24
sensory perception of light stimulus (GO:0050953),4/81,0.5818428728182232,1,0,0,0.9876543209876543,0.5348689833845679,CRYGB;WFS1;USH1C;ATF6
negative regulation of cell death (GO:0060548),4/81,0.5818428728182232,1,0,0,0.9876543209876543,0.5348689833845679,PRKN;PACRG;WFS1;NPAS2
regulation of protein sumoylation (GO:0033233),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,FSCB
regulation of tissue remodeling (GO:0034103),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,IL23A
negative regulation of axon guidance (GO:1902668),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,SEMA3F
negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,LGALS3
positive regulation of lymphocyte migration (GO:2000403),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,SPN
positive regulation of epidermal cell differentiation (GO:0045606),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,PRKCH
glycosphingolipid biosynthetic process (GO:0006688),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,UGCG
cardiac muscle cell contraction (GO:0086003),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,PKP2
positive regulation of fatty acid metabolic process (GO:0045923),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,APOA4
positive regulation of monocyte chemotaxis (GO:0090026),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,CCR2
"mRNA cis splicing, via spliceosome (GO:0045292)",1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,SRSF1
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,MPV17L
negative regulation of lipid biosynthetic process (GO:0051055),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,AKR1C3
N-glycan processing (GO:0006491),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,EDEM2
negative regulation of reactive oxygen species metabolic process (GO:2000378),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,PRKN
positive regulation of stem cell proliferation (GO:2000648),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,TERT
negative regulation of intracellular transport (GO:0032387),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,MPV17L
negative regulation of stress fiber assembly (GO:0051497),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,MET
negative regulation of cellular carbohydrate metabolic process (GO:0010677),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,GCK
negative regulation of phosphoprotein phosphatase activity (GO:0032515),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,IKBKB
peptidyl-lysine trimethylation (GO:0018023),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,SETD3
regulation of collagen biosynthetic process (GO:0032965),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,IL6
embryo development ending in birth or egg hatching (GO:0009792),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,NR5A2
positive regulation of signal transduction by p53 class mediator (GO:1901798),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,CHD5
positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,CD226
positive regulation of macrophage activation (GO:0043032),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,AGER
long-term memory (GO:0007616),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,CALB1
regulation of transcription from RNA polymerase I promoter (GO:0006356),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,POLR2L
virion assembly (GO:0019068),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,UBA52
nucleotide catabolic process (GO:0009166),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,DERA
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,CASQ2
chaperone-mediated protein complex assembly (GO:0051131),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,HSP90AB1
regulation of lamellipodium organization (GO:1902743),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,TWF2
regulation of B cell receptor signaling pathway (GO:0050855),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,PRKCH
positive regulation of cartilage development (GO:0061036),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,ACVRL1
cellular response to inorganic substance (GO:0071241),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,FOXO1
nucleobase-containing compound biosynthetic process (GO:0034654),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,TERT
positive regulation of cation transmembrane transport (GO:1904064),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,STAC
positive regulation of transcription of Notch receptor target (GO:0007221),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,EP300
cellular response to glucocorticoid stimulus (GO:0071385),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,PCK1
viral entry into host cell (GO:0046718),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,GPR15
positive regulation of natural killer cell mediated immunity (GO:0002717),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,CD226
gene expression (GO:0010467),20/411,0.5826261843407886,1,0,0,0.9732360097323601,0.5257513299507968,MRPS17;APOBEC1;RBM39;SRSF1;SNU13;RPSA;MRPS5;TSPAN15;DDX19B;NXF2;TAF1B;NOVA1;BCL3;IGFLR1;RPL15;RSL24D1;RPS24;POLR2L;AGFG1;NUP37
response to reactive oxygen species (GO:0000302),3/60,0.5828910435264506,1,0,0,1,0.5397549994176116,MPV17L;PXN;AKR1C3
neuron development (GO:0048666),7/144,0.5847203579347515,1,0,0,0.9722222222222222,0.521715412033393,IL6;PRMT1;USH1C;BICDL1;AGER;MAPRE2;SH3GL2
regulation of programmed cell death (GO:0043067),13/268,0.5849361349815388,1,0,0,0.9701492537313433,0.5202450681239338,PRKN;WFS1;STRADB;TNFRSF10B;NME4;NME1;APEX1;DNAJA3;BCL3;ANP32B;UBA52;MAP3K14;TP73
regulation of type I interferon-mediated signaling pathway (GO:0060338),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,HSP90AB1;IFNA10
"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,THRAP3;TRA2B
positive regulation of phagocytosis (GO:0050766),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,C4B;SIRPG
ERBB2 signaling pathway (GO:0038128),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,PTPRR;UBA52
regulation of RNA metabolic process (GO:0051252),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,FASTK;TRA2B
Golgi to plasma membrane transport (GO:0006893),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,OSBPL5;KIF13A
DNA replication-independent nucleosome assembly (GO:0006336),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,CENPI;RSF1
DNA biosynthetic process (GO:0071897),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,RMI2;TERT
regulation of coenzyme metabolic process (GO:0051196),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,GCK;NUP37
platelet degranulation (GO:0002576),6/124,0.5912375561010063,1,0,0,0.9677419354838709,0.5085845672526835,TF;TMX3;APOH;RARRES2;CD36;A2M
negative regulation of macromolecule metabolic process (GO:0010605),6/124,0.5912375561010063,1,0,0,0.9677419354838709,0.5085845672526835,ACVRL1;PRKN;PC;TERT;ID2;ZNF148
negative regulation of NF-kappaB transcription factor activity (GO:0032088),4/82,0.591620653904691,1,0,0,0.975609756097561,0.5120874505494942,NFKBIA;IRAK2;RBCK1;COMMD6
positive regulation of cell cycle (GO:0045787),4/82,0.591620653904691,1,0,0,0.975609756097561,0.5120874505494942,HSP90AB1;TAL1;CCNC;LINC00598
peptidyl-serine phosphorylation (GO:0018105),7/145,0.5920854218584392,1,0,0,0.9655172413793103,0.5060317966611959,ERN1;IKBKB;LATS1;MORC3;PRKCH;LATS2;PSKH1
glycosaminoglycan metabolic process (GO:0030203),3/61,0.5942021207725078,1,0,0,0.9836065573770492,0.5120023739386589,EXT2;SDC4;XYLT1
neuron projection development (GO:0031175),8/167,0.6000926173801865,1,0,0,0.9580838323353293,0.4892658906618576,DOCK10;IL6;PRMT1;USH1C;BICDL1;APOA4;AGER;SH3GL2
embryonic heart tube morphogenesis (GO:0003143),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,SOX18;DLL1
cognition (GO:0050890),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,GTF2A1L;GRM5
sensory organ development (GO:0007423),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,SOX2;ATF6
androgen receptor signaling pathway (GO:0030521),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,THRAP3;PIAS2
negative regulation of ERK1 and ERK2 cascade (GO:0070373),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,PTPRR;LMO3
phosphatidic acid biosynthetic process (GO:0006654),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,GPAT4;AGPAT2
negative regulation of cytokine-mediated signaling pathway (GO:0001960),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,IL6;ROBO1
determination of heart left/right asymmetry (GO:0061371),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,SOX18;DLL1
negative regulation of neuron death (GO:1901215),4/83,0.6012622374752512,1,0,0,0.963855421686747,0.4903364861494962,PRKN;CLN3;WFS1;TP73
long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,ACSBG2
membrane lipid metabolic process (GO:0006643),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,AGMO
"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,RELN
membrane protein ectodomain proteolysis (GO:0006509),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,PSENEN
regulation of viral process (GO:0050792),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,MBL2
homologous chromosome segregation (GO:0045143),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,TERB2
mitotic recombination (GO:0006312),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,GEN1
protein localization to centrosome (GO:0071539),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,CEP83
receptor localization to synapse (GO:0097120),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,GPHN
response to nutrient levels (GO:0031667),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,INS-IGF2
actin filament polymerization (GO:0030041),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,GSN
anion transmembrane transport (GO:0098656),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,LRRIQ4
posttranscriptional gene silencing by RNA (GO:0035194),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,AJUBA
regulation of keratinocyte proliferation (GO:0010837),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,SNAI2
release of cytochrome c from mitochondria (GO:0001836),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,TIMM50
calcium-mediated signaling using intracellular calcium source (GO:0035584),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,GRM5
positive regulation of lipid catabolic process (GO:0050996),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,APOA4
endoplasmic reticulum calcium ion homeostasis (GO:0032469),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,WFS1
establishment of mitotic spindle localization (GO:0040001),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,PAFAH1B1
regulation of dephosphorylation (GO:0035303),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,IGBP1
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,RNF126
anion homeostasis (GO:0055081),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,ABCA1
regulation of cardiac muscle cell proliferation (GO:0060043),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,TP73
tRNA metabolic process (GO:0006399),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,ADAT1
dolichol-linked oligosaccharide biosynthetic process (GO:0006488),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,ALG13
positive regulation of actin cytoskeleton reorganization (GO:2000251),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,FES
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,PRKN
regulation of epithelial cell differentiation (GO:0030856),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,DLL1
positive regulation of carbohydrate metabolic process (GO:0045913),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,PFKFB3
regulation of peptidase activity (GO:0052547),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,PSMB8
glyceraldehyde-3-phosphate metabolic process (GO:0019682),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,DERA
snRNA metabolic process (GO:0016073),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,INTS2
DNA ligation (GO:0006266),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,PCNA
negative regulation of calcium-mediated signaling (GO:0050849),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,CASQ2
positive regulation of type I interferon production (GO:0032481),3/62,0.6053118695713461,1,0,0,0.9677419354838709,0.48581754858797044,FLOT1;EP300;POLR2L
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),3/62,0.6053118695713461,1,0,0,0.9677419354838709,0.48581754858797044,PRKN;EPO;SNAI2
cellular amide metabolic process (GO:0043603),3/62,0.6053118695713461,1,0,0,0.9677419354838709,0.48581754858797044,CLN3;PANK2;PC
G1/S transition of mitotic cell cycle (GO:0000082),5/105,0.6081022529852088,1,0,0,0.9523809523809523,0.47372593514716843,LATS1;LATS2;PCNA;MCM3;MCM4
positive regulation of supramolecular fiber organization (GO:1902905),4/84,0.61076514771337,1,0,0,0.9523809523809523,0.4695645403132304,FES;LMOD1;MET;CCL26
protein modification process (GO:0036211),4/84,0.61076514771337,1,0,0,0.9523809523809523,0.4695645403132304,UBE2D2;NAGPA;UBA52;TGM3
regulation of cell cycle G2/M phase transition (GO:1902749),4/84,0.61076514771337,1,0,0,0.9523809523809523,0.4695645403132304,CEP164;CNTRL;GTSE1;PAFAH1B1
cellular response to molecule of bacterial origin (GO:0071219),4/84,0.61076514771337,1,0,0,0.9523809523809523,0.4695645403132304,IL6;DEFA4;CD14;NR1D1
"transcription, DNA-templated (GO:0006351)",17/356,0.6127243078606208,1,0,0,0.9550561797752808,0.4678248973996096,GTF2A1L;TCERG1;RSF1;SSRP1;PAX1;TAF1B;BCL3;SHOX;TBPL1;HIVEP2;NELFA;ZNF148;TAF9B;IRF9;ATOH1;TAF2;POLR2L
protein homooligomerization (GO:0051260),9/190,0.6138065265282766,1,0,0,0.9473684210526315,0.4623873194507082,EHD3;MLKL;ATL2;PRF1;FLOT1;STOM;LY6G5C;HSD17B10;FGFRL1
phosphatidic acid metabolic process (GO:0046473),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,GPAT4;AGPAT2
positive regulation of cell division (GO:0051781),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,TAL1;TAS1R2
positive regulation of receptor-mediated endocytosis (GO:0048260),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,TF;ANGPT1
negative regulation of cell projection organization (GO:0031345),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,PTPN9;GRIN2B
kidney development (GO:0001822),3/63,0.6162178817161523,1,0,0,0.9523809523809523,0.4610996894309503,PYGO2;WFS1;LRP4
oligosaccharide metabolic process (GO:0009311),3/63,0.6162178817161523,1,0,0,0.9523809523809523,0.4610996894309503,NEU4;GALNT15;NEU1
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193),3/63,0.6162178817161523,1,0,0,0.9523809523809523,0.4610996894309503,GRM5;RGS1;GPR37L1
regulation of proteolysis (GO:0030162),3/63,0.6162178817161523,1,0,0,0.9523809523809523,0.4610996894309503,ABTB2;CLN3;TM4SF20
negative regulation of dephosphorylation (GO:0035305),3/63,0.6162178817161523,1,0,0,0.9523809523809523,0.4610996894309503,PPP1R12A;WDR81;CCDC8
"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",3/63,0.6162178817161523,1,0,0,0.9523809523809523,0.4610996894309503,PNLDC1;CNOT2;PABPC1
fatty acid metabolic process (GO:0006631),5/106,0.6165249871762161,1,0,0,0.9433962264150944,0.4562796476411569,ELOVL4;HPGD;ACOX1;ACSBG2;PPARD
regulation of mitotic spindle assembly (GO:1901673),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,STAG2
positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,HSP90AB1
protein import into mitochondrial matrix (GO:0030150),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,TIMM50
regulation of protein kinase A signaling (GO:0010738),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,ADRB2
regulation of sprouting angiogenesis (GO:1903670),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,DLL1
histone methylation (GO:0016571),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,PRMT1
negative regulation of protein localization to plasma membrane (GO:1903077),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,MRAP
NADP metabolic process (GO:0006739),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,DERA
production of small RNA involved in gene silencing by RNA (GO:0070918),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,TERT
regulation of myotube differentiation (GO:0010830),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,BHLHE41
regulation of heterotypic cell-cell adhesion (GO:0034114),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,FLOT1
morphogenesis of an epithelium (GO:0002009),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,AIRE
negative regulation of response to biotic stimulus (GO:0002832),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,MAPKBP1
cyclic nucleotide biosynthetic process (GO:0009190),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,GUCY2C
excitatory postsynaptic potential (GO:0060079),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,GRIN2B
purine ribonucleoside bisphosphate metabolic process (GO:0034035),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,SULT1A2
ribosomal small subunit assembly (GO:0000028),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,RPSA
endocardial cushion development (GO:0003197),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,ACVRL1
positive regulation of toll-like receptor signaling pathway (GO:0034123),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,FLOT1
negative regulation of lipid metabolic process (GO:0045833),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,PDE3B
regulation of mitochondrial fission (GO:0090140),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,PRKN
nucleosome disassembly (GO:0006337),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,PBRM1
chromatin disassembly (GO:0031498),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,PBRM1
leukotriene metabolic process (GO:0006691),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,PTGR1
gamma-aminobutyric acid signaling pathway (GO:0007214),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,GABRB3
purine ribonucleotide catabolic process (GO:0009154),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,PDE3B
cellular response to interleukin-7 (GO:0098761),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,CRLF2
histone deubiquitination (GO:0016578),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,ENY2
positive regulation of excitatory postsynaptic potential (GO:2000463),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,RELN
macromolecule biosynthetic process (GO:0009059),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,TERT
negative regulation of protein localization to cell periphery (GO:1904376),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,MRAP
positive regulation of blood coagulation (GO:0030194),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,APOH
calcium ion transport into cytosol (GO:0060402),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,GRIN2B
positive regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902895),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,TERT
aspartate family amino acid catabolic process (GO:0009068),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,AASS
interleukin-7-mediated signaling pathway (GO:0038111),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,CRLF2
negative regulation of calcium ion transport (GO:0051926),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,EPO
hexose transmembrane transport (GO:0035428),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,PPARD
mitochondrial membrane organization (GO:0007006),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,TIMM50
positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,HSP90AB1
positive regulation of axon extension (GO:0045773),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,TWF2
mitochondrial translation (GO:0032543),5/107,0.6248402405451496,1,0,0,0.9345794392523363,0.43949465144730016,RARS2;MRPS17;NOA1;MRPL46;MRPS5
positive regulation of cell cycle process (GO:0090068),5/107,0.6248402405451496,1,0,0,0.9345794392523363,0.43949465144730016,GEN1;MED25;ID2;TAS1R2;TP73
cellular response to interleukin-1 (GO:0071347),7/150,0.6278858639339182,1,0,0,0.9333333333333333,0.4343704160691258,RPS6KA4;NFKBIA;IKBKB;IRAK2;UBA52;PSMB8;CCL26
positive regulation of protein localization to nucleus (GO:1900182),2/42,0.6279256694973029,1,0,0,0.9523809523809523,0.4431747430401906,TERT;GTSE1
negative regulation of protein secretion (GO:0050709),2/42,0.6279256694973029,1,0,0,0.9523809523809523,0.4431747430401906,PRKN;MIDN
regulation of telomerase activity (GO:0051972),2/42,0.6279256694973029,1,0,0,0.9523809523809523,0.4431747430401906,PIF1;HSP90AB1
ceramide metabolic process (GO:0006672),2/42,0.6279256694973029,1,0,0,0.9523809523809523,0.4431747430401906,CLN3;SGMS2
cellular response to retinoic acid (GO:0071300),2/42,0.6279256694973029,1,0,0,0.9523809523809523,0.4431747430401906,WNT5B;TWF2
regulation of peptidyl-serine phosphorylation (GO:0033135),4/86,0.6293463661035574,1,0,0,0.9302325581395349,0.4307660579611482,LATS1;IL6;OSM;CREBL2
regulation of macromolecule metabolic process (GO:0060255),6/129,0.6298141258718173,1,0,0,0.9302325581395349,0.4300749222582539,SOX2;DDX19B;INS-IGF2;FLOT1;TBC1D16;TP73
RNA processing (GO:0006396),9/193,0.6324859877108375,1,0,0,0.9326424870466321,0.4272409235217067,APOBEC1;MAPKBP1;RBM39;DDX19B;SNRPD2;SCAF11;NOVA1;AKAP8L;SRSF1
positive regulation of protein kinase activity (GO:0045860),8/172,0.6333337048835047,1,0,0,0.9302325581395349,0.4248909914769504,ERN1;GRM5;RELN;IL23A;STRADB;LCP2;ADRB2;MAP3K14
protein ubiquitination (GO:0016567),24/506,0.63535797093826,1,0,0,0.9486166007905137,0.4302609060868843,FBXW4;PRKN;PCNA;KLHL36;UBE2D2;FBXO27;KLHL23;PSMB8;RNF40;ABTB2;RNF146;DCAF15;CAND2;FBXO40;RNF126;RLIM;TPP2;TRIM69;NHLRC1;RBCK1;UBA52;ZNF598;RNF122;RNF220
positive regulation of protein modification by small protein conjugation or removal (GO:1903322),3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,ANGPT1;WFS1;ADRB2
regulation of JAK-STAT cascade (GO:0046425),3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,IL6;IL23A;BCL3
negative regulation of blood vessel morphogenesis (GO:2000181),3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,APOH;PDE3B;CCR2
regulation of cell division (GO:0051302),3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,TAL1;KIF13A;DLL1
negative regulation of apoptotic signaling pathway (GO:2001234),3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,PRKN;LGALS3;MPV17L
positive regulation of cellular component biogenesis (GO:0044089),4/87,0.6384210161989183,1,0,0,0.9195402298850575,0.41265040301361416,SDC4;TAL1;FLOT1;AJUBA
regulation of B cell proliferation (GO:0030888),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,SASH3;CD74
membrane depolarization (GO:0051899),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,SCN10A;CATSPER4
eye development (GO:0001654),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,SOX2;ATF6
RNA catabolic process (GO:0006401),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,ERN1;DXO
response to hydrogen peroxide (GO:0042542),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,IL6;ANKZF1
regulation of ATP metabolic process (GO:1903578),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,GCK;NUP37
Wnt signaling pathway (GO:0016055),5/109,0.6411418318346604,1,0,0,0.9174311926605505,0.4078023669950098,RNF146;WNT5B;SNAI2;LRP4;UBA52
regulation of Wnt signaling pathway (GO:0030111),5/109,0.6411418318346604,1,0,0,0.9174311926605505,0.4078023669950098,PRKN;TERT;NXN;RSPO2;APCDD1
positive regulation of interleukin-2 production (GO:0032743),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,CCR2
Golgi to endosome transport (GO:0006895),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,AP4M1
cell projection assembly (GO:0030031),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,RHOU
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,PRKN
hydrogen peroxide metabolic process (GO:0042743),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,APOA4
proteoglycan metabolic process (GO:0006029),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,CHST8
negative regulation of intracellular protein transport (GO:0090317),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,CABP1
regulation of epidermal cell differentiation (GO:0045604),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,DLL1
positive regulation of dendritic spine development (GO:0060999),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,RELN
"wound healing, spreading of cells (GO:0044319)",1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,ACVRL1
synapsis (GO:0007129),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,TERB2
negative regulation of ion transport (GO:0043271),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,CASQ2
negative regulation of cyclase activity (GO:0031280),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,CCR2
regulation of cholesterol transport (GO:0032374),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,APOA4
phosphatidylethanolamine metabolic process (GO:0046337),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,CHKB
regulation of calcium ion transmembrane transport (GO:1903169),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,CASQ2
mitochondrial respiratory chain complex IV assembly (GO:0033617),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,COX20
axon extension (GO:0048675),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,SEMA3F
dopamine metabolic process (GO:0042417),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,PRKN
adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,ADRB2
regulation of cell development (GO:0060284),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,DLL1
positive regulation of gene silencing by miRNA (GO:2000637),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,AJUBA
glial cell development (GO:0021782),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,DLL1
regulation of response to cytokine stimulus (GO:0060759),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,IRAK2
negative regulation of telomere maintenance via telomerase (GO:0032211),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,PIF1
growth hormone receptor signaling pathway (GO:0060396),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,PXN
regulation of glycogen biosynthetic process (GO:0005979),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,GCK
organelle disassembly (GO:1903008),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,KIF9
regulation of toll-like receptor signaling pathway (GO:0034121),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,CD36
steroid hormone mediated signaling pathway (GO:0043401),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,THRAP3
adrenergic receptor signaling pathway (GO:0071875),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,ADRB2
dorsal/ventral pattern formation (GO:0009953),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,DSCAML1
inositol phosphate-mediated signaling (GO:0048016),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,ADGRB2
heparan sulfate proteoglycan metabolic process (GO:0030201),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,EXT2
negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,EVI5L
negative regulation of adenylate cyclase activity (GO:0007194),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,CCR2
cellular response to steroid hormone stimulus (GO:0071383),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,AKR1C3
entrainment of circadian clock by photoperiod (GO:0043153),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,ID2
dopaminergic neuron differentiation (GO:0071542),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,LMX1A
mitochondrial RNA metabolic process (GO:0000959),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,ELAC2
regulation of stem cell differentiation (GO:2000736),4/88,0.6473496582204271,1,0,0,0.9090909090909091,0.39533518222257213,TAL1;UBA52;PSMB8;TP73
"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",4/88,0.6473496582204271,1,0,0,0.9090909090909091,0.39533518222257213,ARHGEF19;PRICKLE2;UBA52;PSMB8
sphingolipid biosynthetic process (GO:0030148),3/66,0.6476960862533626,1,0,0,0.9090909090909091,0.3948488139467768,UGCG;ELOVL4;SGMS2
viral gene expression (GO:0019080),5/110,0.6491253231277532,1,0,0,0.9090909090909091,0.3928449809345964,RPSA;RPL15;UBA52;RPS24;NUP37
negative regulation of cytokine production (GO:0001818),5/110,0.6491253231277532,1,0,0,0.9090909090909091,0.3928449809345964,RPS6KA4;IL23A;UBA52;AGER;DLL1
cellular response to insulin stimulus (GO:0032869),5/110,0.6491253231277532,1,0,0,0.9090909090909091,0.3928449809345964,PDE3B;PCK1;ATP6V0D2;FOXO1;GCK
protein oligomerization (GO:0051259),10/217,0.6494177009402682,1,0,0,0.9216589861751152,0.3978609790860964,EHD3;TRA2B;ATL2;PRF1;FLOT1;STOM;LY6G5C;FGFRL1;AASS;TGM3
lymphocyte chemotaxis (GO:0048247),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,CXCL9;CCL26
unsaturated fatty acid metabolic process (GO:0033559),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,ACOX1;GSTA1
regulation of smooth muscle cell proliferation (GO:0048660),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,IL6;ID2
positive regulation of transport (GO:0051050),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,FLOT1;DLL1
microtubule cytoskeleton organization involved in mitosis (GO:1902850),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,INTS13;KIF2A
inorganic anion transport (GO:0015698),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,SLC26A7;SLC4A1
myeloid cell differentiation (GO:0030099),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,EPO;TAL1
SRP-dependent cotranslational protein targeting to membrane (GO:0006614),4/89,0.6561310542796738,1,0,0,0.898876404494382,0.3787817816859613,RPSA;RPL15;UBA52;RPS24
regulation of establishment of planar polarity (GO:0090175),4/89,0.6561310542796738,1,0,0,0.898876404494382,0.3787817816859613,ARHGEF19;PRICKLE2;UBA52;PSMB8
regulation of neuron apoptotic process (GO:0043523),4/89,0.6561310542796738,1,0,0,0.898876404494382,0.3787817816859613,PRKN;CLN3;WFS1;TP73
regulation of protein binding (GO:0043393),5/111,0.6569956320397741,1,0,0,0.9009009009009008,0.37844856654136433,PRKN;TERT;USP33;FLOT1;CD36
epidermal cell differentiation (GO:0009913),3/67,0.657771791741192,1,0,0,0.8955223880597014,0.3751318467538853,SPRR4;AKR1C3;TGM3
regulation of gene silencing by miRNA (GO:0060964),3/67,0.657771791741192,1,0,0,0.8955223880597014,0.3751318467538853,AJUBA;POLR2L;NUP37
negative regulation of protein serine/threonine kinase activity (GO:0071901),3/67,0.657771791741192,1,0,0,0.8955223880597014,0.3751318467538853,LATS1;LATS2;PRKAR2A
negative regulation of protein binding (GO:0032091),3/67,0.657771791741192,1,0,0,0.8955223880597014,0.3751318467538853,USP33;ADRB2;GTSE1
regulation of transcription from RNA polymerase II promoter (GO:0006357),71/1478,0.6585417984062573,1,0,0,0.9607577807848444,0.40133473895720345,ACVRL1;TCERG1;SETD3;EPO;FOXI3;AKAP8L;FOXI2;BHLHE41;CHD5;RORA;CCNC;LDB2;PCSK6;MED18;IKBKB;DCAF1;RPS6KA4;SOX2;DBP;SOX18;RPS6KA1;EP300;ZNF567;RBM14;PPP1R12A;FOXP4;SENP1;MED25;NR5A2;LMX1A;TAL1;THRAP3;RFX4;ZSCAN21;TBPL1;FOXD4L3;ATF6;MET;UBA52;ATF3;PPARD;PRKN;ENY2;AIRE;FOXG1;BARX1;HDAC8;DLL1;NPAS2;FOXO1;CIAO1;DDN;SHOX;ZNF148;TAF9B;ZNF224;IGBP1;WWTR1;WFS1;BCL11A;OSM;NR1D1;TARBP1;NFKBIA;IL6;CNOT2;DNAJA3;TADA3;SNAI2;TAF2;TP73
"mRNA splicing, via spliceosome (GO:0000398)",12/261,0.6585582788214799,1,0,0,0.9195402298850575,0.38409403156639316,ISY1;HSPA8;SNRPD2;SCAF11;DDX1;TRA2B;SRSF1;IGFLR1;SNU13;PABPC1;LIME1;POLR2L
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,EP300
mRNA transcription (GO:0009299),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,SOX18
establishment of protein localization to vacuole (GO:0072666),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,TMEM50B
regulation of interleukin-17 production (GO:0032660),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,IL23A
cortical actin cytoskeleton organization (GO:0030866),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,IKBKB
"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,COX6A1
regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,CASQ2
histone lysine demethylation (GO:0070076),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,KDM5D
mesoderm development (GO:0007498),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,TIE1
histone ubiquitination (GO:0016574),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,RNF40
ventricular cardiac muscle tissue development (GO:0003229),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,PKP2
mitochondrial fission (GO:0000266),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,PRKN
phospholipid translocation (GO:0045332),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,ABCA1
positive regulation of translational initiation (GO:0045948),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,YTHDF3
positive regulation of histone acetylation (GO:0035066),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,RPS6KA4
positive regulation of lamellipodium organization (GO:1902745),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,TWF2
protein O-linked glycosylation via threonine (GO:0018243),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,GALNT15
regulation of macrophage activation (GO:0043030),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,CD74
embryonic skeletal system morphogenesis (GO:0048704),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,DSCAML1
establishment of endothelial barrier (GO:0061028),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,SOX18
positive regulation of BMP signaling pathway (GO:0030513),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,ACVRL1
regulation of interleukin-2 production (GO:0032663),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,CCR2
"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,ERCC5
positive regulation of defense response to virus by host (GO:0002230),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,IL23A
limb morphogenesis (GO:0035108),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,FBXW4
protein-DNA complex disassembly (GO:0032986),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,PBRM1
cellular response to alkaloid (GO:0071312),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,CASQ2
negative regulation of cAMP biosynthetic process (GO:0030818),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,CCR2
mitochondrial respiratory chain complex IV biogenesis (GO:0097034),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,COX20
long-term synaptic potentiation (GO:0060291),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,GRIN2B
lipid catabolic process (GO:0016042),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,APOA4
positive regulation of receptor internalization (GO:0002092),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,ANGPT1
embryonic skeletal system development (GO:0048706),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,DSCAML1
photoperiodism (GO:0009648),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,ID2
negative regulation of cell cycle arrest (GO:0071157),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,HSP90AB1
hepaticobiliary system development (GO:0061008),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,MET
response to lipopolysaccharide (GO:0032496),7/155,0.6618579190514627,1,0,0,0.9032258064516128,0.37276523730143096,IL6;CXCL9;DEFA4;TNFRSF10B;CD14;NR1D1;CXCL5
negative regulation of cellular process (GO:0048523),25/534,0.66252771141564,1,0,0,0.9363295880149813,0.3854802373077152,ACVRL1;PRKN;ADAMDEC1;HPGD;EPO;SIRPG;PDE3B;CHD5;DLL1;NPAS2;SPN;UTP20;CD33;IP6K2;PACRG;PBRM1;ANGPT1;OSM;NME1;IL6;ASTL;DNAJA3;IFNK;ANP32B;VAMP3
"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",5/112,0.6647517057733329,1,0,0,0.8928571428571428,0.3645907882365566,RPSA;PABPC1;RPL15;UBA52;RPS24
phosphatidylinositol metabolic process (GO:0046488),5/112,0.6647517057733329,1,0,0,0.8928571428571428,0.3645907882365566,OCRL;PIGW;MTMR6;PIK3R6;IP6K2
positive regulation of blood vessel endothelial cell migration (GO:0043536),2/45,0.665369764985953,1,0,0,0.8888888888888888,0.3621443158089169,ANGPT1;FGF18
positive regulation of cytokine production (GO:0001819),10/220,0.6662715120641264,1,0,0,0.9090909090909091,0.36914365067906874,IL6;IL23A;FLOT1;EP300;RORA;CD14;AGER;AGPAT2;CCR2;POLR2L
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),3/68,0.6676380497864279,1,0,0,0.8823529411764706,0.3564786122927678,IGBP1;RPS6KA1;TNFRSF10B
negative regulation of phosphatase activity (GO:0010923),3/68,0.6676380497864279,1,0,0,0.8823529411764706,0.3564786122927678,PPP1R12A;WDR81;CCDC8
COPII-coated vesicle budding (GO:0090114),3/68,0.6676380497864279,1,0,0,0.8823529411764706,0.3564786122927678,TRAPPC2;SAR1B;SEC31B
termination of RNA polymerase II transcription (GO:0006369),3/68,0.6676380497864279,1,0,0,0.8823529411764706,0.3564786122927678,SRSF1;IGFLR1;MED18
viral transcription (GO:0019083),5/113,0.6723926318192525,1,0,0,0.8849557522123893,0.3512502969378424,RPSA;RPL15;UBA52;RPS24;NUP37
positive regulation of kinase activity (GO:0033674),5/113,0.6723926318192525,1,0,0,0.8849557522123893,0.3512502969378424,CD74;RELN;TIE1;LCP2;MET
cellular response to acid chemical (GO:0071229),4/91,0.6732482464251353,1,0,0,0.8791208791208791,0.34781639730574376,WNT5B;RRAGB;TWF2;AKR1C3
cellular response to lipopolysaccharide (GO:0071222),4/91,0.6732482464251353,1,0,0,0.8791208791208791,0.34781639730574376,IL6;DEFA4;CD14;NR1D1
phospholipase C-activating G-protein coupled receptor signaling pathway (GO:0007200),4/91,0.6732482464251353,1,0,0,0.8791208791208791,0.34781639730574376,GNA14;GRM5;GPR18;F2RL3
protein-DNA complex assembly (GO:0065004),4/91,0.6732482464251353,1,0,0,0.8791208791208791,0.34781639730574376,RSF1;ERCC5;ANP32B;UBA52
regulation of interferon-gamma-mediated signaling pathway (GO:0060334),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,HSP90AB1
regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,TMEM204
regulation of calcium ion import (GO:0090279),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,LGALS3
protein localization to cilium (GO:0061512),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,BBS9
negative regulation of protein polymerization (GO:0032272),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,TWF2
cellular response to nerve growth factor stimulus (GO:1990090),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,SH3GL2
protein homotrimerization (GO:0070207),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,MLKL
positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,PRKN
early endosome to late endosome transport (GO:0045022),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,WDR81
lipid translocation (GO:0034204),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,ABCA1
hematopoietic progenitor cell differentiation (GO:0002244),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,ARMC6
nuclear transport (GO:0051169),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,XPO1
negative regulation of response to endoplasmic reticulum stress (GO:1903573),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,PRKN
regulation of DNA biosynthetic process (GO:2000278),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,ACVRL1
negative regulation of myeloid cell differentiation (GO:0045638),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,PRMT1
positive regulation of interleukin-10 production (GO:0032733),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,IL23A
protein localization to cell surface (GO:0034394),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,ANGPT1
"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,UBA52
STAT cascade (GO:0097696),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,CCR2
protein O-linked glycosylation via serine (GO:0018242),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,GALNT15
viral genome replication (GO:0019079),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,CXCR6
negative regulation of nervous system development (GO:0051961),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,RFX4
maturation of LSU-rRNA (GO:0000470),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,SNU13
regulation of bone resorption (GO:0045124),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,IL6
negative regulation of lyase activity (GO:0051350),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,CCR2
regulation of monocyte chemotaxis (GO:0090025),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,CCR2
positive regulation of phosphatase activity (GO:0010922),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,HSP90AB1
digestive system development (GO:0055123),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,BARX1
nucleocytoplasmic transport (GO:0006913),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,XPO1;SNRPD2
protein methylation (GO:0006479),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,HSPA8;PRMT1
nuclear envelope disassembly (GO:0051081),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,AKAP8L;NUP37
pyruvate metabolic process (GO:0006090),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,PCK1;GCK
RNA secondary structure unwinding (GO:0010501),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,DDX19B;DDX1
positive regulation of ion transport (GO:0043270),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,WFS1;PKP2
mitotic spindle assembly (GO:0090307),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,KIF2A;ABRAXAS2
regulation of cellular component movement (GO:0051270),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,IGBP1;FES
icosanoid metabolic process (GO:0006690),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,HPGD;PTGR1
regulation of endothelial cell migration (GO:0010594),3/69,0.6772948191670352,1,0,0,0.8695652173913043,0.338824888725687,ACVRL1;ANGPT1;APOH
negative regulation of angiogenesis (GO:0016525),3/69,0.6772948191670352,1,0,0,0.8695652173913043,0.338824888725687,APOH;PDE3B;CCR2
positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),3/69,0.6772948191670352,1,0,0,0.8695652173913043,0.338824888725687,CCDC88A;CROCC;TWF2
axon guidance (GO:0007411),7/158,0.6813097466135722,1,0,0,0.8860759493670886,0.3400212212397225,DAB1;RELN;USP33;GFRA1;SEMA3F;SPTBN2;ROBO1
cell cycle G1/S phase transition (GO:0044843),4/92,0.6815826288475257,1,0,0,0.8695652173913043,0.333337208380493,LATS1;LATS2;MCM3;MCM4
ER to Golgi vesicle-mediated transport (GO:0006888),8/180,0.683178744936179,1,0,0,0.8888888888888888,0.33866555380766933,TRAPPC2;COG7;SAR1B;COPZ2;SEC31B;BET1L;ARFGAP1;SPTBN2
rRNA processing (GO:0006364),9/202,0.6854564440136306,1,0,0,0.891089108910891,0.3365379098030343,SAMD15;TSR3;MRTO4;SNU13;RPSA;UTP20;RPL15;UBA52;RPS24
positive regulation of endothelial cell migration (GO:0010595),3/70,0.6867423738774998,1,0,0,0.8571428571428571,0.32211090747805676,ANGPT1;FGF18;MET
phospholipid metabolic process (GO:0006644),3/70,0.6867423738774998,1,0,0,0.8571428571428571,0.32211090747805676,CLN3;LCAT;AGPAT2
snRNA transcription (GO:0009301),3/70,0.6867423738774998,1,0,0,0.8571428571428571,0.32211090747805676,INTS13;INTS2;POLR2L
snRNA transcription from RNA polymerase II promoter (GO:0042795),3/70,0.6867423738774998,1,0,0,0.8571428571428571,0.32211090747805676,INTS13;INTS2;POLR2L
regulation of cytosolic calcium ion concentration (GO:0051480),6/137,0.6868931771447399,1,0,0,0.8759124087591241,0.3289721085839843,CLN3;CALB1;OCM;TAC4;CD36;CCR2
protein O-linked glycosylation (GO:0006493),5/115,0.687326064513291,1,0,0,0.8695652173913043,0.32604041610621337,MUC2;GALNT15;B3GNT6;POMT1;GCNT4
peptide cross-linking (GO:0018149),2/47,0.6886033156551076,1,0,0,0.8510638297872339,0.3175233302317852,SPRR4;TGM3
regulation of organelle assembly (GO:1902115),2/47,0.6886033156551076,1,0,0,0.8510638297872339,0.3175233302317852,KIF9;GSN
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),4/93,0.6897669196744971,1,0,0,0.8602150537634409,0.3194851922842808,SOX2;IGBP1;RPS6KA1;TNFRSF10B
neutrophil degranulation (GO:0043312),22/479,0.6905251956762599,1,0,0,0.918580375782881,0.3401529014978572,VAT1;HSPA8;GSN;RAB4B;HSP90AB1;DEFA4;RETN;MMP8;AGPAT2;UNC13D;DDOST;CKAP4;SERPINB6;DERA;LGALS3;BIN2;NEU1;STOM;CYSTM1;CD14;CD36;CD33
regulation of autophagy (GO:0010506),9/203,0.6910425757023396,1,0,0,0.8866995073891626,0.32768321009203705,PRKN;ERN1;RRAGB;USP33;ULK3;EP300;ATP6V0D2;MET;FOXO1
"negative regulation of transcription, DNA-templated (GO:0045892)",38/813,0.6917106771464308,1,0,0,0.9348093480934808,0.34455904750839544,PRKN;TCERG1;EPO;FOXG1;BHLHE41;RSF1;LDB2;HDAC8;FOXO1;DCAF1;SOX2;BTAF1;SOX18;EP300;ZNF567;ZNF148;TAF9B;PATZ1;ZNF224;IGBP1;HSPA8;WFS1;BCL11A;NR1D1;MED25;ID2;CNOT2;DNAJA3;ID1;ZNF318;BCL3;DEPDC1;RLIM;SNAI2;UBA52;ATF3;PPARD;TP73
regulation of axon extension involved in axon guidance (GO:0048841),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,SEMA3F
regulation of protein oligomerization (GO:0032459),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,EP300
cellular response to catecholamine stimulus (GO:0071870),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,PRKN
chromosome condensation (GO:0030261),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,AKAP8L
positive regulation of ERBB signaling pathway (GO:1901186),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,UBA52
glycolytic process (GO:0006096),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,GCK
regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,LATS1
TOR signaling (GO:0031929),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,CCDC88A
lamellipodium assembly (GO:0030032),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,CCDC88A
positive regulation of mRNA catabolic process (GO:0061014),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,PABPC1
vesicle-mediated transport between endosomal compartments (GO:0098927),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,WDR81
"nucleotide-excision repair, DNA damage recognition (GO:0000715)",1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,UBA52
positive regulation of ATP metabolic process (GO:1903580),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,PFKFB3
phospholipid dephosphorylation (GO:0046839),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,MTMR6
cellular nitrogen compound biosynthetic process (GO:0044271),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,SULT1A2
regulation of smooth muscle contraction (GO:0006940),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,ADRB2
apoptotic nuclear changes (GO:0030262),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,BLCAP
cellular response to interleukin-6 (GO:0071354),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,IL6
regulation of dendritic spine morphogenesis (GO:0061001),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,RELN
rRNA methylation (GO:0031167),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,DIMT1
protein localization to Golgi apparatus (GO:0034067),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,COG7
autophagosome maturation (GO:0097352),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,CLN3
negative regulation of axonogenesis (GO:0050771),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,LRP4
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,CASQ2
negative regulation of transcription factor import into nucleus (GO:0042992),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,NFKBIA
positive regulation of ion transmembrane transporter activity (GO:0032414),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,STAC
positive regulation of monooxygenase activity (GO:0032770),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,TERT
positive regulation of cell junction assembly (GO:1901890),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,FLOT1
regulation of ion homeostasis (GO:2000021),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,SLC30A6
negative regulation of axon extension (GO:0030517),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,SEMA3F
chromatin remodeling (GO:0006338),5/116,0.6946174064374339,1,0,0,0.8620689655172414,0.3141328270082842,UBTFL1;PBRM1;RSF1;ANP32B;SSRP1
nuclear import (GO:0051170),3/71,0.6959812822212856,1,0,0,0.8450704225352113,0.30628099636865247,SNRPD2;HEATR3;POM121L12
regulation of cation channel activity (GO:2001257),3/71,0.6959812822212856,1,0,0,0.8450704225352113,0.30628099636865247,RELN;EPO;STAC
cellular response to fibroblast growth factor stimulus (GO:0044344),4/94,0.6978008887433855,1,0,0,0.8510638297872339,0.3062310439097954,FGF18;UBA52;FGFRL1;POLR2L
negative regulation of transcription from RNA polymerase II promoter (GO:0000122),26/565,0.6979361780758137,1,0,0,0.9203539823008849,0.3309847083668817,PRKN;TCERG1;EPO;BHLHE41;LDB2;HDAC8;DCAF1;SOX2;SOX18;EP300;ZNF567;ZNF148;TAF9B;ZNF224;IGBP1;WFS1;BCL11A;NR1D1;MED25;CNOT2;DNAJA3;SNAI2;UBA52;ATF3;PPARD;TP73
interstrand cross-link repair (GO:0036297),2/48,0.6997136081858564,1,0,0,0.8333333333333333,0.29757013234898655,UBA52;FANCG
cellular macromolecule catabolic process (GO:0044265),2/48,0.6997136081858564,1,0,0,0.8333333333333333,0.29757013234898655,PRKN;NEU4
cellular response to mechanical stimulus (GO:0071260),2/48,0.6997136081858564,1,0,0,0.8333333333333333,0.29757013234898655,TNFRSF10B;MAP3K14
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),13/291,0.7010452991923047,1,0,0,0.8934707903780068,0.3173454331166055,PRKN;FBXW4;WFS1;PSMB8;ABTB2;RNF126;RLIM;NHLRC1;RBCK1;GTSE1;UBA52;RNF122;ANKZF1
ncRNA processing (GO:0034470),10/227,0.7037170209340903,1,0,0,0.8810572687224669,0.3095849890146857,SAMD15;INTS2;MRTO4;ADAT1;SNU13;RPSA;UTP20;RPL15;UBA52;RPS24
negative regulation of cysteine-type endopeptidase activity (GO:2000117),3/72,0.7050123870135998,1,0,0,0.8333333333333333,0.2912832550768055,IGBP1;RPS6KA1;TNFRSF10B
regulation of phosphatase activity (GO:0010921),3/72,0.7050123870135998,1,0,0,0.8333333333333333,0.2912832550768055,PPP1R12A;WDR81;CCDC8
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),3/72,0.7050123870135998,1,0,0,0.8333333333333333,0.2912832550768055,FBXW4;UBA52;PSMB8
neutrophil activation involved in immune response (GO:0002283),22/483,0.7050423061718905,1,0,0,0.9109730848861283,0.3183827876914731,VAT1;HSPA8;GSN;RAB4B;HSP90AB1;DEFA4;RETN;MMP8;AGPAT2;UNC13D;DDOST;CKAP4;SERPINB6;DERA;LGALS3;BIN2;NEU1;STOM;CYSTM1;CD14;CD36;CD33
positive regulation of Wnt signaling pathway (GO:0030177),6/140,0.7067393435253332,1,0,0,0.8571428571428571,0.29750859485229647,RNF146;TERT;RSPO2;UBA52;PSMB8;RNF220
regulation of cellular component organization (GO:0051128),6/140,0.7067393435253332,1,0,0,0.8571428571428571,0.29750859485229647,ABCA1;LATS1;HSPA8;RAB4B;GSN;ARFGAP1
dendritic spine organization (GO:0097061),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,DOCK10
cellular lipid catabolic process (GO:0044242),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,PPARD
negative regulation of protein localization to membrane (GO:1905476),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,MRAP
histone monoubiquitination (GO:0010390),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,RNF40
response to glucocorticoid (GO:0051384),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,IL6
ear morphogenesis (GO:0042471),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,USH1C
Golgi to plasma membrane protein transport (GO:0043001),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,KIF13A
cellular modified amino acid biosynthetic process (GO:0042398),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,CHAC1
negative regulation of sequestering of calcium ion (GO:0051283),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,ITPR2
proteasomal ubiquitin-independent protein catabolic process (GO:0010499),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,PSMB8
regulation of actin filament bundle assembly (GO:0032231),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,PRKN
ATP generation from ADP (GO:0006757),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,GCK
receptor catabolic process (GO:0032801),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,GPRASP1
neuromuscular synaptic transmission (GO:0007274),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,DTNA
positive regulation of endopeptidase activity (GO:0010950),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,GRIN2B
sensory perception of pain (GO:0019233),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,KCNA2
regulation of transmembrane transport (GO:0034762),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,SCN10A
negative regulation of endothelial cell apoptotic process (GO:2000352),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,ANGPT1
limb development (GO:0060173),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,LRP4
positive regulation of vascular endothelial growth factor production (GO:0010575),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,RORA
chaperone mediated protein folding requiring cofactor (GO:0051085),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,HSPA8
mammary gland development (GO:0030879),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,GPAT4
actin nucleation (GO:0045010),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,LMOD1
regulation of cardiac muscle cell action potential (GO:0098901),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,PKP2
negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,HSP90AB1
cGMP biosynthetic process (GO:0006182),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,GUCY2C
regulation of cell cycle G1/S phase transition (GO:1902806),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,ID2
cAMP metabolic process (GO:0046058),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,PDE3B
regulation of cellular senescence (GO:2000772),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,TERT
plasma membrane bounded cell projection organization (GO:0120036),5/118,0.7088473515444491,1,0,0,0.847457627118644,0.29162294635276975,IL6;PRMT1;BICDL1;AGER;SH3GL2
regulation of reactive oxygen species metabolic process (GO:2000377),2/49,0.7104927276749392,1,0,0,0.8163265306122448,0.2790176057147895,PRKN;AKR1C3
regulation of megakaryocyte differentiation (GO:0045652),2/49,0.7104927276749392,1,0,0,0.8163265306122448,0.2790176057147895,PRMT1;EP300
T cell receptor signaling pathway (GO:0050852),7/163,0.7121164303112548,1,0,0,0.8588957055214724,0.29160699221433833,NFKBIA;IKBKB;UBE2D2;LCP2;RBCK1;UBA52;PSMB8
ciliary basal body-plasma membrane docking (GO:0097711),4/96,0.7134178055156833,1,0,0,0.8333333333333333,0.28140670641508325,CEP164;CNTRL;CEP83;PAFAH1B1
B cell activation (GO:0042113),3/73,0.7138367865008747,1,0,0,0.821917808219178,0.2770692600889438,DCAF1;IFNK;IFNA10
chloride transport (GO:0006821),3/73,0.7138367865008747,1,0,0,0.821917808219178,0.2770692600889438,GABRB3;SLC26A7;SLC4A1
regulation of cellular protein metabolic process (GO:0032268),2/50,0.7209459791839935,1,0,0,0.7999999999999999,0.2617528554824198,NFKBIA;GRM5
positive regulation of JUN kinase activity (GO:0043507),2/50,0.7209459791839935,1,0,0,0.7999999999999999,0.2617528554824198,ERN1;MAP3K21
blood circulation (GO:0008015),2/50,0.7209459791839935,1,0,0,0.7999999999999999,0.2617528554824198,ACVRL1;EPO
negative regulation of protein ubiquitination (GO:0031397),2/50,0.7209459791839935,1,0,0,0.7999999999999999,0.2617528554824198,NXN;HDAC8
mitotic spindle organization (GO:0007052),3/74,0.722455815470999,1,0,0,0.8108108108108109,0.2635937966943547,INTS13;KIF2A;ABRAXAS2
mRNA 3'-end processing (GO:0031124),3/74,0.722455815470999,1,0,0,0.8108108108108109,0.2635937966943547,SRSF1;IGFLR1;PABPC1
regulation of G-protein coupled receptor protein signaling pathway (GO:0008277),3/74,0.722455815470999,1,0,0,0.8108108108108109,0.2635937966943547,GIT2;USP20;USP33
macromolecular complex assembly (GO:0065003),5/120,0.7226056756270708,1,0,0,0.8333333333333333,0.2707430048728052,CD74;IL2RB;USH1C;APOA4;VAMP3
DNA replication (GO:0006260),5/120,0.7226056756270708,1,0,0,0.8333333333333333,0.2707430048728052,PIF1;RMI2;RBM14;MCM3;MCM4
glycolytic process through glucose-6-phosphate (GO:0061620),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,GCK
heterotypic cell-cell adhesion (GO:0034113),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,PKP2
negative regulation of wound healing (GO:0061045),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,APOH
regulation of centrosome duplication (GO:0010824),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,GEN1
organophosphate ester transport (GO:0015748),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,OSBPL5
canonical glycolysis (GO:0061621),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,GCK
glucose catabolic process to pyruvate (GO:0061718),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,GCK
regulation of spindle assembly (GO:0090169),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,STAG2
lamellipodium organization (GO:0097581),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,CCDC88A
regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000058),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,LATS1
regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,CASQ2
peptide catabolic process (GO:0043171),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,CHAC1
response to alcohol (GO:0097305),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,GRIN2B
regulation of lamellipodium assembly (GO:0010591),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,TWF2
positive regulation of glucose transport (GO:0010828),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,CREBL2
negative regulation of cellular protein localization (GO:1903828),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,LEPROTL1
modulation of excitatory postsynaptic potential (GO:0098815),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,RELN
cellular response to epidermal growth factor stimulus (GO:0071364),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,SNAI2
cellular response to vascular endothelial growth factor stimulus (GO:0035924),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,ERN1
regulation of potassium ion transmembrane transporter activity (GO:1901016),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,CASQ2
long-chain fatty acid transport (GO:0015909),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,CD36
long-chain fatty-acyl-CoA metabolic process (GO:0035336),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,ACSBG2
respiratory tube development (GO:0030323),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,HECA
peptide hormone secretion (GO:0030072),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,IL6
negative regulation of epithelial to mesenchymal transition (GO:0010719),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,HPN
3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,SULT1A2
regulation of nervous system development (GO:0051960),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,DLL1
peptidyl-tyrosine dephosphorylation (GO:0035335),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,PTPN9
regulation of vascular smooth muscle cell proliferation (GO:1904705),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,ERN1
signal transduction in response to DNA damage (GO:0042770),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,BCL3
apoptotic process (GO:0006915),10/231,0.72388661555566,1,0,0,0.8658008658008657,0.279758014899848,NFKBIA;FEM1B;BRAT1;DPF1;PRF1;EP300;TNFRSF10B;CD14;LALBA;PPARD
positive regulation of macromolecule metabolic process (GO:0010604),12/276,0.7307640483041671,1,0,0,0.8695652173913043,0.2727518701517271,PRKN;CRP;IL6;GSN;ANGPT1;WFS1;ID2;HPN;TADA3;UBAP2;CD36;VAMP3
negative regulation of neuron projection development (GO:0010977),2/51,0.7310789651903944,1,0,0,0.7843137254901961,0.24567356984329963,LRP4;PTPN9
response to organonitrogen compound (GO:0010243),2/51,0.7310789651903944,1,0,0,0.7843137254901961,0.24567356984329963,PRKN;IL6
positive regulation of developmental growth (GO:0048639),2/51,0.7310789651903944,1,0,0,0.7843137254901961,0.24567356984329963,TWF2;DLL1
cellular protein complex assembly (GO:0043623),6/144,0.7318438803263533,1,0,0,0.8333333333333333,0.26015672167545917,CAND2;HSP90AB1;ANGPT1;PXN;CASQ2;ADRB2
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),6/144,0.7318438803263533,1,0,0,0.8333333333333333,0.26015672167545917,ACVRL1;HPGD;PXN;ID1;DUSP15;UBA52
glycosaminoglycan biosynthetic process (GO:0006024),4/99,0.7357196016371502,1,0,0,0.8080808080808081,0.24800501727640314,EXT2;SDC4;ANGPT1;XYLT1
positive regulation of cyclin-dependent protein kinase activity (GO:1904031),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,CCNC
bile acid biosynthetic process (GO:0006699),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,CYP46A1
apoptotic cell clearance (GO:0043277),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,TMX3
response to gamma radiation (GO:0010332),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,TP73
snRNA processing (GO:0016180),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,INTS2
positive regulation of interferon-beta production (GO:0032728),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,FLOT1
regulation of centrosome cycle (GO:0046605),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,GEN1
nucleotide biosynthetic process (GO:0009165),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,GUCY2C
positive regulation of wound healing (GO:0090303),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,APOH
regulation of supramolecular fiber organization (GO:1902903),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,HSPA8
positive regulation of cAMP metabolic process (GO:0030816),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,CXCL9
internal peptidyl-lysine acetylation (GO:0018393),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,EP300
regulation of cardiac muscle cell contraction (GO:0086004),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,PKP2
regulation of microtubule-based process (GO:0032886),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,IGBP1
regulation of histone acetylation (GO:0035065),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,RPS6KA4
fat-soluble vitamin metabolic process (GO:0006775),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,CUBN
phosphatidylethanolamine acyl-chain remodeling (GO:0036152),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,LPCAT3
strand displacement (GO:0000732),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,RMI2
endocrine system development (GO:0035270),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,SOX2
snRNA 3'-end processing (GO:0034472),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,INTS2
negative regulation of telomere maintenance via telomere lengthening (GO:1904357),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,PIF1
hemopoiesis (GO:0030097),3/76,0.739084180089673,1,0,0,0.7894736842105262,0.2386922002972212,ARMC6;TAL1;DLL1
response to interleukin-1 (GO:0070555),3/76,0.739084180089673,1,0,0,0.7894736842105262,0.2386922002972212,IGBP1;IRAK2;CCL26
positive regulation of proteolysis (GO:0045862),2/52,0.740897542993205,1,0,0,0.7692307692307693,0.23068687062400378,ASTL;ANGPTL8
negative regulation of programmed cell death (GO:0043069),18/408,0.7411589547167552,1,0,0,0.8823529411764706,0.26430014373798455,CD74;ANGPT1;WFS1;TIE1;HPN;FOXO1;IKBKB;NFKBIA;CLN3;IL6;INS-IGF2;BCL3;IL2RB;RPS6KA1;ERCC5;TAF9B;UBA52;MET
cellular calcium ion homeostasis (GO:0006874),5/123,0.7423591890762312,1,0,0,0.8130081300813008,0.24221306555432562,CLN3;CALB1;WFS1;OCM;CCR2
RNA metabolic process (GO:0016070),8/191,0.74442837802639,1,0,0,0.837696335078534,0.24723655114369342,APOBEC1;RBM39;DDX19B;PCNA;TERT;NOVA1;DDX1;POLR2L
response to ionizing radiation (GO:0010212),3/77,0.7470972136000291,1,0,0,0.7792207792207791,0.22718958204818146,BRAT1;USP28;TP73
positive regulation of cytoskeleton organization (GO:0051495),3/77,0.7470972136000291,1,0,0,0.7792207792207791,0.22718958204818146,FES;LMOD1;CCL26
regulation of kinase activity (GO:0043549),4/101,0.7498448770134236,1,0,0,0.792079207920792,0.22803083128155077,CD74;TIE1;LDB2;MET
intrinsic apoptotic signaling pathway (GO:0097193),4/101,0.7498448770134236,1,0,0,0.792079207920792,0.22803083128155077,MSH6;TNFRSF10B;CHAC1;TP73
phosphatidylcholine acyl-chain remodeling (GO:0036151),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,LPCAT3
mRNA polyadenylation (GO:0006378),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,PABPC1
phosphatidylinositol phosphorylation (GO:0046854),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,IP6K2
response to hexose (GO:0009746),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,INS-IGF2
negative regulation of synaptic transmission (GO:0050805),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,GRIK3
leukocyte cell-cell adhesion (GO:0007159),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,APOA4
endocytic recycling (GO:0032456),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,EHD3
cardiac muscle cell development (GO:0055013),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,MYH11
regulation of double-strand break repair via homologous recombination (GO:0010569),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,PPP4C
regulation of protein localization to nucleus (GO:1900180),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,GTSE1
phagosome acidification (GO:0090383),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,ATP6V0D2
transition metal ion transport (GO:0000041),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,SLC31A2
release of sequestered calcium ion into cytosol (GO:0051209),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,ITPR2
negative regulation of cell-matrix adhesion (GO:0001953),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,ACVRL1
extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,TNFRSF10B
regulation of neurotransmitter secretion (GO:0046928),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,KCNMB4
muscle fiber development (GO:0048747),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,MYH11
regulation of autophagy of mitochondrion (GO:1903146),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,PRKN
neutrophil chemotaxis (GO:0030593),2/53,0.7504077852742062,1,0,0,0.7547169811320754,0.21670830680118947,LGALS3;CCL26
peptidyl-serine modification (GO:0018209),7/170,0.7517812588214371,1,0,0,0.8235294117647058,0.23496107482455797,IKBKB;LATS1;MORC3;PRKCH;LATS2;GALNT15;PSKH1
regulation of cell cycle (GO:0051726),9/215,0.7531519872933761,1,0,0,0.8372093023255813,0.2373389825815171,INTS13;HPGD;ID2;STRADB;ID1;TXLNG;EP300;MAP3K14;TP73
positive regulation of cellular process (GO:0048522),23/519,0.754685278276112,1,0,0,0.8863198458574181,0.24945867945689376,WWTR1;ANKLE1;HSP90AB1;EPO;PRMT1;REG1B;BRAT1;HPN;SIRPG;AKR1C3;OSM;DLL1;CXCL5;CIAO1;IL6;INS-IGF2;TAL1;RPS6KA1;FLOT1;CD36;TAF9B;HDGFL2;CRLF2
negative regulation of cell communication (GO:0010648),3/78,0.7549122409335416,1,0,0,0.7692307692307693,0.2162721335871487,TIE1;OSM;MET
visual perception (GO:0007601),3/78,0.7549122409335416,1,0,0,0.7692307692307693,0.2162721335871487,CRYGB;WFS1;ATF6
negative regulation of multicellular organismal process (GO:0051241),5/125,0.7549416651407419,1,0,0,0.7999999999999999,0.2248918379459466,RPS6KA4;PTPRR;HPN;LRP4;ROBO1
regulated exocytosis (GO:0045055),6/148,0.7553912967971983,1,0,0,0.8108108108108109,0.22744815412465288,TF;TMX3;APOH;RARRES2;CD36;A2M
protein transport (GO:0015031),14/326,0.7577948854375782,1,0,0,0.8588957055214724,0.23820830767058568,CD74;COG7;RAB4B;STX7;COPZ2;AP4M1;TF;KIF13A;ARFIP1;CD36;EVI5L;ATP6V0D2;SEC31B;TBC1D16
cell morphogenesis involved in differentiation (GO:0000904),2/54,0.7596159436572443,1,0,0,0.7407407407407407,0.2036609709042825,RELN;VAMP3
protein targeting to mitochondrion (GO:0006626),2/54,0.7596159436572443,1,0,0,0.7407407407407407,0.2036609709042825,AGK;TIMM50
cytoplasmic translation (GO:0002181),2/54,0.7596159436572443,1,0,0,0.7407407407407407,0.2036609709042825,MRTO4;RPL15
positive regulation of response to stimulus (GO:0048584),2/54,0.7596159436572443,1,0,0,0.7407407407407407,0.2036609709042825,ANKLE1;C2CD2L
membrane fusion (GO:0061025),2/54,0.7596159436572443,1,0,0,0.7407407407407407,0.2036609709042825,OTOF;VAMP3
cellular response to tumor necrosis factor (GO:0071356),8/194,0.7596168702829397,1,0,0,0.8247422680412371,0.22675553885422534,IKBKB;NFKBIA;TNFSF15;TNFRSF10B;UBA52;MAP3K14;PSMB8;CCL26
mRNA processing (GO:0006397),12/283,0.7608347028834079,1,0,0,0.8480565371024735,0.23180705734297768,ERN1;ISY1;HSPA8;SNRPD2;SCAF11;TRA2B;AKAP8L;SRSF1;IGFLR1;SNU13;PABPC1;POLR2L
regulation of protein phosphorylation (GO:0001932),11/261,0.7609210904301343,1,0,0,0.842911877394636,0.23030511899280615,PRKN;MOB1B;WWTR1;CCDC88A;CD74;GRM5;RARRES2;BRAT1;AKAP8L;FLOT1;AGER
sensory perception of chemical stimulus (GO:0007606),14/327,0.7616599464074388,1,0,0,0.856269113149847,0.2331236222884696,OR2T27;OR2D3;OR13J1;OR1K1;OR10AD1;OR2T5;OR4S1;OR2T4;OBP2A;CD36;OR4D6;OR8D1;OR4B1;OR4F21
regulation of vasculature development (GO:1901342),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,IL6
negative regulation of endocytosis (GO:0045806),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,LGALS3
RNA polyadenylation (GO:0043631),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,PABPC1
regulation of TORC1 signaling (GO:1903432),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,RRAGB
cellular response to ketone (GO:1901655),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,PCK1
negative regulation of proteasomal protein catabolic process (GO:1901799),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,HSP90AB1
cellular amino acid biosynthetic process (GO:0008652),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,BCAT2
positive regulation of sprouting angiogenesis (GO:1903672),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,DLL1
chondrocyte differentiation (GO:0002062),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,WNT5B
positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,PPP2R1B
organelle fission (GO:0048285),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,PRKN
protein K11-linked ubiquitination (GO:0070979),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,PRKN
cardiac muscle cell action potential involved in contraction (GO:0086002),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,PKP2
neural crest cell migration (GO:0001755),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,SEMA3F
cGMP metabolic process (GO:0046068),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,GUCY2C
antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,SAR1B
dopamine receptor signaling pathway (GO:0007212),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,GNA14
regulation of fatty acid biosynthetic process (GO:0042304),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,APOA4
regulation of defense response to virus by virus (GO:0050690),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,AP1M2
regulation of adenylate cyclase activity (GO:0045761),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,CCR2
positive regulation of fibroblast proliferation (GO:0048146),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,CD74
bicellular tight junction assembly (GO:0070830),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,CRB3
nucleosome organization (GO:0034728),3/79,0.7625315297227274,1,0,0,0.7594936708860759,0.2059074082780564,PBRM1;RSF1;ANP32B
cation transport (GO:0006812),3/79,0.7625315297227274,1,0,0,0.7594936708860759,0.2059074082780564,CLN3;RHBG;RHCE
regulation of endothelial cell proliferation (GO:0001936),3/79,0.7625315297227274,1,0,0,0.7594936708860759,0.2059074082780564,ACVRL1;APOH;CCL26
response to calcium ion (GO:0051592),3/79,0.7625315297227274,1,0,0,0.7594936708860759,0.2059074082780564,CASQ2;AKR1C3;KCNMB4
protein import into nucleus (GO:0006606),4/103,0.7633839575456066,1,0,0,0.7766990291262135,0.20970419679401037,BCL3;AKR1C3;HEATR3;POM121L12
long-chain fatty acid metabolic process (GO:0001676),2/55,0.7685284162153218,1,0,0,0.7272727272727272,0.1914747203489268,ACOX1;GSTA1
regulation of gene silencing by RNA (GO:0060966),2/55,0.7685284162153218,1,0,0,0.7272727272727272,0.1914747203489268,POLR2L;NUP37
regulation of posttranscriptional gene silencing (GO:0060147),2/55,0.7685284162153218,1,0,0,0.7272727272727272,0.1914747203489268,POLR2L;NUP37
positive regulation of lymphocyte activation (GO:0051251),4/104,0.7699363530876122,1,0,0,0.7692307692307693,0.20111340452197826,IL6;IL23A;SIRPG;CCR2
positive regulation of stress-activated MAPK cascade (GO:0032874),3/80,0.7699574892635191,1,0,0,0.7499999999999999,0.1960649808053572,PRMT1;DUSP15;AGER
cellular response to hormone stimulus (GO:0032870),3/80,0.7699574892635191,1,0,0,0.7499999999999999,0.1960649808053572,AKR1C3;GAS2L1;GCK
peptide biosynthetic process (GO:0043043),7/174,0.7726216545178958,1,0,0,0.8045977011494252,0.20755869048599532,MRPS17;RPSA;SNU13;RPL15;RSL24D1;RPS24;MRPS5
regulation of protein processing (GO:0070613),5/128,0.7729447333197296,1,0,0,0.78125,0.20120916351791152,C4B;C1QB;ASTL;ANGPTL8;CHAC1
regulation of striated muscle contraction (GO:0006942),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,SCN10A
dicarboxylic acid transport (GO:0006835),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,SLC26A7
cellular response to cadmium ion (GO:0071276),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,AKR1C3
superoxide metabolic process (GO:0006801),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,APOA4
determination of bilateral symmetry (GO:0009855),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,DLL1
regulation of vasoconstriction (GO:0019229),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,KCNMB4
regulation of embryonic development (GO:0045995),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,DLL1
lysosome localization (GO:0032418),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,ARL8B
regulation of keratinocyte differentiation (GO:0045616),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,PRKCH
positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,UBA52
carbohydrate derivative biosynthetic process (GO:1901137),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,B3GNT6
regulation of myoblast differentiation (GO:0045661),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,DLL1
translational elongation (GO:0006414),4/105,0.7763456159434972,1,0,0,0.761904761904762,0.192881886919067,MRPS17;MRPL46;ZNF598;MRPS5
DNA-dependent DNA replication (GO:0006261),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,MGME1;PRIMPOL
granulocyte chemotaxis (GO:0071621),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,LGALS3;CCL26
chordate embryonic development (GO:0043009),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,PTPRR;RARRES2
regulation of BMP signaling pathway (GO:0030510),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,ACVRL1;PCSK6
protein import (GO:0017038),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,HEATR3;POM121L12
cellular iron ion homeostasis (GO:0006879),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,TF;UBA52
ATP metabolic process (GO:0046034),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,HSPA8;PARG
epidermis development (GO:0008544),3/81,0.7771926567464108,1,0,0,0.7407407407407407,0.18671630360614933,UGCG;KRT31;DLL1
protein modification by small protein conjugation (GO:0032446),17/398,0.7815665736556979,1,0,0,0.8542713567839195,0.21053940087433334,PRKN;PCNA;KLHL36;BCL11A;UBE2D2;CDCA8;KLHL23;RNF40;PIAS2;SENP1;DCAF15;CAND2;RLIM;UBA52;ZNF598;RNF220;NUP37
positive regulation of DNA metabolic process (GO:0051054),3/82,0.7842396846897038,1,0,0,0.7317073170731706,0.17783457445402553,PCNA;EPO;NPAS2
protein glycosylation (GO:0006486),5/130,0.784373955308741,1,0,0,0.7692307692307693,0.18682260656936742,COG7;B3GNT6;POMT1;GCNT4;DDOST
chloride transmembrane transport (GO:1902476),2/57,0.7854924470082494,1,0,0,0.7017543859649122,0.16943469252891025,GABRB3;SLC26A7
response to retinoic acid (GO:0032526),2/57,0.7854924470082494,1,0,0,0.7017543859649122,0.16943469252891025,WNT5B;TWF2
regulation of actin cytoskeleton reorganization (GO:2000249),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,FES
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,TP73
regulation of defense response to virus by host (GO:0050691),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,IL23A
negative regulation of endothelial cell proliferation (GO:0001937),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,APOH
positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,CCNC
negative regulation of transferase activity (GO:0051348),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,PIF1
activation of protein kinase B activity (GO:0032148),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,CCDC88A
cyclic purine nucleotide metabolic process (GO:0052652),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,GUCY2C
protein palmitoylation (GO:0018345),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,ZDHHC5
fatty-acyl-CoA biosynthetic process (GO:0046949),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,ACSBG2
'de novo' posttranslational protein folding (GO:0051084),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,HSPA8
phosphatidylinositol 3-kinase signaling (GO:0014065),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,PIK3R6
artery morphogenesis (GO:0048844),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,HPGD
positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,TP73
regulation of blood coagulation (GO:0030193),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,APOH
bile acid metabolic process (GO:0008206),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,CYP46A1
negative regulation of cell morphogenesis involved in differentiation (GO:0010771),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,LRP4
rRNA metabolic process (GO:0016072),8/200,0.7880410319886767,1,0,0,0.7999999999999999,0.1905640955426303,SAMD15;MRTO4;SNU13;RPSA;UTP20;RPL15;UBA52;RPS24
regulation of intracellular signal transduction (GO:1902531),18/422,0.7887228411543117,1,0,0,0.8530805687203792,0.2024703968139338,ARHGAP11B;RMI2;PLEKHG2;ARHGEF19;ARAP2;OCRL;SSRP1;AGER;RHOBTB2;RRAGB;TRIP10;EP300;RHOU;TAF9B;A2M;UBA52;TAF2;TP73
axonogenesis (GO:0007409),9/223,0.7894214255919177,1,0,0,0.8071748878923766,0.1908605175379942,RELN;DAB1;USP33;GFRA1;NRCAM;SEMA3F;DSCAML1;SPTBN2;ROBO1
negative regulation of nucleic acid-templated transcription (GO:1903507),19/444,0.7894376191303879,1,0,0,0.8558558558558558,0.20235381843731465,HSPA8;FOXG1;BHLHE41;RSF1;NR1D1;LDB2;FOXO1;BTAF1;SOX18;ID2;ZNF318;BCL3;ID1;RLIM;DEPDC1;ZNF148;PATZ1;ZNF224;PPARD
negative regulation of signaling (GO:0023057),3/83,0.7911013287526669,1,0,0,0.7228915662650601,0.1693946149369998,TIE1;OSM;MET
positive regulation of protein ubiquitination (GO:0031398),3/83,0.7911013287526669,1,0,0,0.7228915662650601,0.1693946149369998,ANGPT1;WFS1;ADRB2
positive regulation of homeostatic process (GO:0032846),3/83,0.7911013287526669,1,0,0,0.7228915662650601,0.1693946149369998,PRMT1;TAL1;C2CD2L
cellular response to lipid (GO:0071396),7/178,0.7921477736375266,1,0,0,0.7865168539325842,0.1832641856039621,IL6;WNT5B;DEFA4;TWF2;RORA;CD14;NR1D1
receptor metabolic process (GO:0043112),2/58,0.7935572729047958,1,0,0,0.689655172413793,0.15946866485970154,EHD3;CD36
neutrophil migration (GO:1990266),2/58,0.7935572729047958,1,0,0,0.689655172413793,0.15946866485970154,LGALS3;CCL26
sodium ion transport (GO:0006814),2/58,0.7935572729047958,1,0,0,0.689655172413793,0.15946866485970154,SCN10A;SLC17A2
cellular protein modification process (GO:0006464),45/1001,0.7937671286327698,1,0,0,0.899100899100899,0.207660973691688,ACVRL1;SPRR4;PTPRR;UBE2D2;FBXO27;POMT1;TNC;NAGPA;ASB18;MTMR6;TIMM50;IKBKB;RPS6KA4;FBXO40;PPP4R1;IRAK2;FASTK;OGFOD1;RPS6KA1;MAP3K21;TGM3;FBXW4;ATE1;MORC3;PPP1R12A;PRKCH;COG7;FEM1B;WFS1;PSMB8;DDOST;CKAP4;ERN1;LATS1;TF;IL6;LATS2;UBLCP1;NEURL2;B3GNT6;FES;CCDC8;CALU;PTPN9;UBA52
positive regulation of cell proliferation (GO:0008284),18/424,0.794994356500142,1,0,0,0.8490566037735848,0.1947907894202499,WWTR1;CD74;PRKCH;EPO;PRMT1;REG1B;SIRPG;AKR1C3;OSM;DLL1;CXCL5;CIAO1;NME1;IL6;INS-IGF2;TERT;ID2;CRLF2
negative regulation of cell-cell adhesion (GO:0022408),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,SNAI2
negative regulation of blood vessel endothelial cell migration (GO:0043537),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,ACVRL1
regulation of ubiquitin-protein transferase activity (GO:0051438),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,FEM1B
regulation of glucose import (GO:0046324),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,CREBL2
positive regulation of protein dephosphorylation (GO:0035307),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,HSP90AB1
skeletal system morphogenesis (GO:0048705),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,DSCAML1
anterograde axonal transport (GO:0008089),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,AP3B2
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,TNFRSF10B
regulation of protein autophosphorylation (GO:0031952),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,MOB1B
cellular zinc ion homeostasis (GO:0006882),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,SLC39A14
response to cadmium ion (GO:0046686),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,AKR1C3
regulation of cytokine secretion (GO:0050707),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,CRP
gene silencing by miRNA (GO:0035195),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,AJUBA
vesicle-mediated transport to the plasma membrane (GO:0098876),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,OSBPL5
regulation of mitotic nuclear division (GO:0007088),3/84,0.7977804363560652,1,0,0,0.7142857142857142,0.16137275842992269,STAG2;CCDC8;MKI67
positive regulation of cytosolic calcium ion concentration (GO:0007204),5/133,0.8006749703651704,1,0,0,0.7518796992481203,0.1671430030702634,TAC4;CD36;GPR18;CCR2;F2RL3
Golgi vesicle transport (GO:0048193),11/271,0.8011598729380457,1,0,0,0.8118081180811807,0.17997360602306553,TRAPPC2;EHD3;COG7;KIF2A;SAR1B;COPZ2;AP3B2;SEC31B;ARFGAP1;BET1L;SPTBN2
regulation of apoptotic process (GO:0042981),36/815,0.803994504004731,1,0,0,0.8834355828220859,0.19273282068946407,PRKN;ANKRD13C;HPN;FOXO1;IKBKB;SOX2;CLN3;RPS6KA1;TAF9B;IP6K2;PSENEN;CD74;PLEKHG2;ANGPT1;TIE1;STRADB;ARHGEF19;TNFRSF10B;NME4;NME1;NFKBIA;LATS1;IL6;INS-IGF2;LATS2;APEX1;DNAJA3;IL2RB;BCL3;ERCC5;ANP32B;ATF6;MET;UBA52;MAP3K14;TP73
regulation of type I interferon production (GO:0032479),3/85,0.8042799356196909,1,0,0,0.7058823529411764,0.15374674713305503,EP300;UBA52;POLR2L
adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188),5/134,0.8058877075534783,1,0,0,0.7462686567164178,0.16105288569760093,ABCA1;GNA14;RGS1;GPR37L1;ADRB2
negative regulation of calcium ion transmembrane transporter activity (GO:1901020),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,CASQ2
protein deacetylation (GO:0006476),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,RBM14
7-methylguanosine mRNA capping (GO:0006370),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,POLR2L
cellular response to amino acid stimulus (GO:0071230),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,RRAGB
regulation of glutamate receptor signaling pathway (GO:1900449),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,RELN
ceramide biosynthetic process (GO:0046513),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,SGMS2
protein trimerization (GO:0070206),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,MLKL
cyclic-nucleotide-mediated signaling (GO:0019935),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,CD36
7-methylguanosine RNA capping (GO:0009452),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,POLR2L
negative regulation of receptor activity (GO:2000272),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,CASQ2
phagosome maturation (GO:0090382),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,ATP6V0D2
positive regulation of TOR signaling (GO:0032008),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,RRAGB
mitochondrial transmembrane transport (GO:1990542),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,AGK
endodermal cell differentiation (GO:0035987),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,MMP8
purine ribonucleoside triphosphate metabolic process (GO:0009205),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,HSPA8
regulation of cell-cell adhesion (GO:0022407),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,SIRPG
substrate adhesion-dependent cell spreading (GO:0034446),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,VAMP3
G2 DNA damage checkpoint (GO:0031572),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,MAP3K14
positive regulation of T cell differentiation (GO:0045582),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,IL23A
aminoglycan catabolic process (GO:0006026),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,SDC4
vasculogenesis (GO:0001570),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,SOX18
global genome nucleotide-excision repair (GO:0070911),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,UBA52
"regulation of mRNA splicing, via spliceosome (GO:0048024)",2/60,0.8088860547790443,1,0,0,0.6666666666666666,0.14139814589399213,THRAP3;TRA2B
cell chemotaxis (GO:0060326),2/60,0.8088860547790443,1,0,0,0.6666666666666666,0.14139814589399213,BIN2;CCR6
nucleosome assembly (GO:0006334),2/60,0.8088860547790443,1,0,0,0.6666666666666666,0.14139814589399213,RSF1;ANP32B
regulation of stress fiber assembly (GO:0051492),2/60,0.8088860547790443,1,0,0,0.6666666666666666,0.14139814589399213,PXN;MET
membrane lipid biosynthetic process (GO:0046467),2/60,0.8088860547790443,1,0,0,0.6666666666666666,0.14139814589399213,ELOVL4;SGMS2
cellular response to oxygen-containing compound (GO:1901701),11/274,0.8122111565206551,1,0,0,0.802919708029197,0.16700322658038597,IL6;WNT5B;RRAGB;DEFA4;MPV17L;PXN;TWF2;AKR1C3;RORA;CD14;NR1D1
phosphorylation (GO:0016310),16/386,0.8133469485214102,1,0,0,0.8290155440414507,0.1712725467504835,ACVRL1;PANK2;MORC3;PRKCH;IKBKB;RPS6KA4;ERN1;LATS1;PPP4R1;LATS2;IRAK2;FES;FASTK;RPS6KA1;MAP3K21;COQ8A
extracellular matrix organization (GO:0030198),9/229,0.8139497618246632,1,0,0,0.7860262008733624,0.1618087068034026,ADAM19;KIF9;TNC;FLOT1;ICAM3;MMP19;ITGAE;A2M;MMP8
potassium ion transport (GO:0006813),2/61,0.8161634632362453,1,0,0,0.6557377049180327,0.1332069649091696,KCNA2;KCNMB4
regulation of vesicle fusion (GO:0031338),2/61,0.8161634632362453,1,0,0,0.6557377049180327,0.1332069649091696,EVI5L;TBC1D16
regulation of cellular ketone metabolic process (GO:0010565),2/61,0.8161634632362453,1,0,0,0.6557377049180327,0.1332069649091696,PANK2;PSMB8
regulation of tumor necrosis factor production (GO:0032680),2/61,0.8161634632362453,1,0,0,0.6557377049180327,0.1332069649091696,IL23A;CD14
RNA 3'-end processing (GO:0031123),2/61,0.8161634632362453,1,0,0,0.6557377049180327,0.1332069649091696,SRSF1;IGFLR1
striated muscle contraction (GO:0006941),2/61,0.8161634632362453,1,0,0,0.6557377049180327,0.1332069649091696,DTNA;CASQ2
"chemical synaptic transmission, postsynaptic (GO:0099565)",1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,GRIN2B
oligosaccharide biosynthetic process (GO:0009312),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,GALNT15
tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,NUP37
tRNA export from nucleus (GO:0006409),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,NUP37
positive regulation of cell-matrix adhesion (GO:0001954),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,CD36
regulation of postsynaptic membrane potential (GO:0060078),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,GRIN2B
positive regulation of catalytic activity (GO:0043085),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,PSENEN
regulation of phosphatidylinositol 3-kinase activity (GO:0043551),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,WDR81
regulation of intracellular protein transport (GO:0033157),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,XPO1
regulation of neurotransmitter receptor activity (GO:0099601),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,RELN
positive regulation of organelle organization (GO:0010638),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,ADRB2
mitochondrial translational elongation (GO:0070125),3/87,0.8167521653641692,1,0,0,0.689655172413793,0.13959970848873965,MRPS17;MRPL46;MRPS5
regulation of MAP kinase activity (GO:0043405),3/87,0.8167521653641692,1,0,0,0.689655172413793,0.13959970848873965,FGF18;PIK3R6;ROBO1
positive regulation of phosphorylation (GO:0042327),8/208,0.8219637874426173,1,0,0,0.7692307692307693,0.1508145685403337,CD74;PFKFB3;RARRES2;BRAT1;TIE1;FLOT1;AGER;MET
regulation of organelle organization (GO:0033043),4/113,0.8226434279131911,1,0,0,0.7079646017699115,0.13821765033879096,PRKN;EHD3;EVI5L;TBC1D16
positive regulation of developmental process (GO:0051094),4/113,0.8226434279131911,1,0,0,0.7079646017699115,0.13821765033879096,PRKN;HSP90AB1;RPS6KA1;HPN
positive regulation of canonical Wnt signaling pathway (GO:0090263),4/113,0.8226434279131911,1,0,0,0.7079646017699115,0.13821765033879096,RNF146;UBA52;PSMB8;RNF220
negative regulation of translation (GO:0017148),3/88,0.8227310669841436,1,0,0,0.6818181818181818,0.1330403886090264,YTHDF3;CNOT2;AJUBA
regulation of protein targeting to mitochondrion (GO:1903214),3/88,0.8227310669841436,1,0,0,0.6818181818181818,0.1330403886090264,PRKN;UGCG;RHOU
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),2/62,0.8231918367006723,1,0,0,0.6451612903225806,0.12552645874570276,UBA52;PSMB8
positive regulation of catabolic process (GO:0009896),2/62,0.8231918367006723,1,0,0,0.6451612903225806,0.12552645874570276,PRKN;FOXO1
establishment of protein localization to organelle (GO:0072594),2/62,0.8231918367006723,1,0,0,0.6451612903225806,0.12552645874570276,HEATR3;POM121L12
second-messenger-mediated signaling (GO:0019932),2/62,0.8231918367006723,1,0,0,0.6451612903225806,0.12552645874570276,CD36;CCR6
regulation of translational initiation (GO:0006446),2/62,0.8231918367006723,1,0,0,0.6451612903225806,0.12552645874570276,YTHDF3;DDX1
cellular response to cytokine stimulus (GO:0071345),19/456,0.8242479819232588,1,0,0,0.8333333333333333,0.16106987117726593,HSPA8;OSM;RORA;FOXO1;IKBKB;SOX2;IL6;IL23A;IRAK2;IL2RB;IFNK;PTPN9;RHOU;CD36;UBA52;CCL26;CRLF2;IFNA10;CCR2
regulation of double-strand break repair (GO:2000779),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,PPP4C
embryonic limb morphogenesis (GO:0030326),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,FBXW4
apoptotic mitochondrial changes (GO:0008637),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,TIMM50
regulation of interleukin-8 production (GO:0032677),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,CRP
response to amino acid (GO:0043200),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,RRAGB
regulation of JUN kinase activity (GO:0043506),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,TP73
positive regulation of cytokinesis (GO:0032467),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,TAS1R2
ventricular cardiac muscle tissue morphogenesis (GO:0055010),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,PKP2
regulation of insulin receptor signaling pathway (GO:0046626),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,INS-IGF2
regulation of interferon-beta production (GO:0032648),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,FLOT1
macromolecule catabolic process (GO:0009057),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,CLN3
response to cytokine (GO:0034097),5/138,0.8256627743834776,1,0,0,0.7246376811594203,0.13881800889973492,IGBP1;IRAK2;TRAFD1;PTPN9;DDOST
mitochondrial translational termination (GO:0070126),3/89,0.8285426848935676,1,0,0,0.6741573033707865,0.1268001726406977,MRPS17;MRPL46;MRPS5
negative regulation of cellular protein metabolic process (GO:0032269),3/89,0.8285426848935676,1,0,0,0.6741573033707865,0.1268001726406977,CLN3;CNOT2;TM4SF20
synapse assembly (GO:0007416),2/63,0.8299778549215587,1,0,0,0.6349206349206349,0.1183214345173536,NRCAM;PCDHB11
negative regulation of protein modification process (GO:0031400),2/63,0.8299778549215587,1,0,0,0.6349206349206349,0.1183214345173536,PRKN;WWTR1
vesicle coating (GO:0006901),2/63,0.8299778549215587,1,0,0,0.6349206349206349,0.1183214345173536,TRAPPC2;SAR1B
COPII vesicle coating (GO:0048208),2/63,0.8299778549215587,1,0,0,0.6349206349206349,0.1183214345173536,TRAPPC2;SAR1B
iron ion homeostasis (GO:0055072),2/63,0.8299778549215587,1,0,0,0.6349206349206349,0.1183214345173536,TF;UBA52
"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",2/63,0.8299778549215587,1,0,0,0.6349206349206349,0.1183214345173536,TRAPPC2;SAR1B
regulation of viral genome replication (GO:0045069),2/63,0.8299778549215587,1,0,0,0.6349206349206349,0.1183214345173536,NR5A2;PABPC1
positive regulation of programmed cell death (GO:0043068),10/257,0.8325414497299947,1,0,0,0.7782101167315175,0.14262433377551237,PSENEN;LATS1;IL6;PLEKHG2;LATS2;ARHGEF19;ATF6;UBA52;FOXO1;IP6K2
cellular response to oxidative stress (GO:0034599),4/115,0.832896768257819,1,0,0,0.6956521739130435,0.12719691976114322,MPV17L;PXN;AKR1C3;FOXO1
lipid phosphorylation (GO:0046834),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,IP6K2
regulation of cyclin-dependent protein kinase activity (GO:1904029),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,CCNG1
regulation of heart rate by cardiac conduction (GO:0086091),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,PKP2
negative regulation of protein complex assembly (GO:0031333),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,EP300
apical junction assembly (GO:0043297),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,CRB3
regulation of mitotic spindle organization (GO:0060236),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,STAG2
tRNA transport (GO:0051031),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,NUP37
cholesterol biosynthetic process (GO:0006695),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,APOA4
regulation of mitochondrial membrane potential (GO:0051881),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,PPA2
membrane protein proteolysis (GO:0033619),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,PSENEN
positive regulation of telomerase activity (GO:0051973),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,HSP90AB1
regulation of cardiac muscle contraction (GO:0055117),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,SCN10A
flagellated sperm motility (GO:0030317),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,INTS13
positive regulation of osteoblast differentiation (GO:0045669),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,IL6
sulfur compound catabolic process (GO:0044273),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,CHAC1
protein kinase B signaling (GO:0043491),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,FOXO1
regulation of JNK cascade (GO:0046328),3/90,0.8341902087803339,1,0,0,0.6666666666666666,0.120862556363351,PRKN;DUSP15;AGER
receptor-mediated endocytosis (GO:0006898),7/188,0.8353889283325726,1,0,0,0.7446808510638298,0.13393671925321257,CUBN;CLN3;CD163;ADRB2;CD36;SCARF1;DLL1
inorganic anion transmembrane transport (GO:0098661),2/64,0.8365281531009908,1,0,0,0.625,0.11155943955785279,GABRB3;SLC26A7
cellular response to decreased oxygen levels (GO:0036294),2/64,0.8365281531009908,1,0,0,0.625,0.11155943955785279,TERT;RORA
protein complex assembly (GO:0006461),7/189,0.8392908125027082,1,0,0,0.7407407407407407,0.12977630709053944,TRAPPC2;PYGO2;BIN2;TERT;SAR1B;TRA2B;EP300
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",9/236,0.839759149258675,1,0,0,0.7627118644067796,0.13320011847344498,ISY1;HSPA8;SNRPD2;TRA2B;SRSF1;IGFLR1;SNU13;PABPC1;POLR2L
regulation of potassium ion transport (GO:0043266),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,CASQ2
carbohydrate biosynthetic process (GO:0016051),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,GALNT15
regulation of nitric-oxide synthase activity (GO:0050999),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,TERT
positive regulation of signaling (GO:0023056),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,VAMP3
endoderm formation (GO:0001706),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,MMP8
sodium ion transmembrane transport (GO:0035725),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,SCN10A
histone deacetylation (GO:0016575),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,RBM14
regulation of blood circulation (GO:1903522),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,KCNMB4
plasma membrane organization (GO:0007009),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,BIN2
zymogen activation (GO:0031638),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,APOH
regulation of cell morphogenesis involved in differentiation (GO:0010769),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,ADGRB3
acylglycerol metabolic process (GO:0006639),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,APOH
cardiac muscle contraction (GO:0060048),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,CASQ2
cardiac muscle tissue morphogenesis (GO:0055008),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,PKP2
negative regulation of blood coagulation (GO:0030195),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,APOH
inner mitochondrial membrane organization (GO:0007007),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,AGK
secondary alcohol biosynthetic process (GO:1902653),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,APOA4
regulation of inflammatory response (GO:0050727),6/166,0.8426824754400535,1,0,0,0.7228915662650601,0.1237337726371208,NFKBIA;IL23A;RORA;CCR2;PPARD;CCL26
chromatin assembly (GO:0031497),2/65,0.8428493095437481,1,0,0,0.6153846153846154,0.10521051812214251,RSF1;ANP32B
negative regulation of gene expression (GO:0010629),26/618,0.844755433333936,1,0,0,0.8414239482200647,0.14195505370994252,ACVRL1;PRKN;FOXG1;BHLHE41;RSF1;LDB2;FOXO1;BTAF1;TERT;SOX18;ZNF148;PATZ1;ZNF224;HSPA8;NR1D1;ERN1;PC;CNOT2;ID2;ZNF318;BCL3;ID1;RLIM;DEPDC1;DXO;PPARD
purine ribonucleotide metabolic process (GO:0009150),2/66,0.8489478345965421,1,0,0,0.6060606060606061,0.09924699267132996,HSPA8;SULT1A2
cellular transition metal ion homeostasis (GO:0046916),3/93,0.8501804853980194,1,0,0,0.6451612903225806,0.10471394598415903,TF;SLC39A14;UBA52
epithelial to mesenchymal transition (GO:0001837),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,SNAI2
spliceosomal snRNP assembly (GO:0000387),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,SNRPD2
base-excision repair (GO:0006284),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,APEX1
myelination (GO:0042552),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,MPZ
regulation of regulated secretory pathway (GO:1903305),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,UNC13D
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,TP73
regulation of dendrite development (GO:0050773),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,ADGRB3
regulation of osteoclast differentiation (GO:0045670),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,IL23A
positive regulation of stress fiber assembly (GO:0051496),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,PXN
negative regulation of Ras protein signal transduction (GO:0046580),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,MET
regulation of metal ion transport (GO:0010959),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,NKAIN4
positive regulation of multi-organism process (GO:0043902),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,PRF1
cilium organization (GO:0044782),7/192,0.8505551215977437,1,0,0,0.7291666666666666,0.11802733427321463,EHD3;GSN;RFX4;CEP164;CEP83;BBS9;OCRL
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),21/512,0.8536292028447626,1,0,0,0.8203125,0.12982131765351637,ACVRL1;HSPA8;FOXG1;BHLHE41;RSF1;NR1D1;LDB2;FOXO1;BTAF1;SOX18;CNOT2;ID2;ZNF318;BCL3;ID1;RLIM;DEPDC1;ZNF148;PATZ1;ZNF224;PPARD
insulin receptor signaling pathway (GO:0008286),2/67,0.8548301611907013,1,0,0,0.5970149253731343,0.0936432666623936,ATP6V0D2;FOXO1
positive regulation of autophagy (GO:0010508),2/67,0.8548301611907013,1,0,0,0.5970149253731343,0.0936432666623936,PRKN;FOXO1
regulation of cardiac conduction (GO:1903779),2/67,0.8548301611907013,1,0,0,0.5970149253731343,0.0936432666623936,CASQ2;ITPR2
vesicle fusion (GO:0006906),3/94,0.855203978006065,1,0,0,0.6382978723404255,0.09983953259459333,STX7;ANKFY1;VAMP3
enzyme linked receptor protein signaling pathway (GO:0007167),4/120,0.8563810483662649,1,0,0,0.6666666666666666,0.10335990128643677,GUCY2C;FES;LCP2;MPZL1
DNA repair (GO:0006281),11/288,0.8577848610413262,1,0,0,0.763888888888889,0.11718204944948626,MSH6;MGME1;RMI2;RBM14;PCNA;ASCC1;APEX1;DDX1;UBA52;FANCG;TP73
cilium assembly (GO:0060271),11/288,0.8577848610413262,1,0,0,0.763888888888889,0.11718204944948626,EHD3;GSN;RFX4;CNTRL;CEP164;CEP83;BBS9;OCRL;RSPH9;MAPRE2;PAFAH1B1
T cell differentiation (GO:0030217),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,GPR18
positive regulation of neuron death (GO:1901216),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,GRIN2B
mitochondrion disassembly (GO:0061726),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,PRKN
regulation of cellular amide metabolic process (GO:0034248),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,GRM5
positive regulation of innate immune response (GO:0045089),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,IFNK
retina homeostasis (GO:0001895),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,TF
post-translational protein modification (GO:0043687),14/357,0.858441032490142,1,0,0,0.7843137254901961,0.11971551974738132,FBXW4;WFS1;FEM1B;FBXO27;TNC;ASB18;PSMB8;CKAP4;FBXO40;TF;IL6;NEURL2;CCDC8;CALU
regulation of heart contraction (GO:0008016),3/95,0.86007960317269,1,0,0,0.631578947368421,0.09519810454070905,SCN10A;CASQ2;ITPR2
regulation of epithelial to mesenchymal transition (GO:0010717),2/68,0.860502636162266,1,0,0,0.588235294117647,0.08837564694787858,WWTR1;HPN
monocarboxylic acid biosynthetic process (GO:0072330),2/68,0.860502636162266,1,0,0,0.588235294117647,0.08837564694787858,ELOVL4;CYP46A1
regulation of endopeptidase activity (GO:0052548),2/68,0.860502636162266,1,0,0,0.588235294117647,0.08837564694787858,PSMB8;SERPINB6
ion transport (GO:0006811),11/289,0.8606759332603792,1,0,0,0.7612456747404844,0.11421519203659355,GABRB3;SLC9A8;CLCA3P;CASQ2;SLC26A7;HTR3D;SLC4A1;ZACN;ATP6V0D2;UBA52;SLC17A2
regulation of acute inflammatory response (GO:0002673),4/121,0.8607254206096335,1,0,0,0.6611570247933884,0.09916015401943896,C4B;C1QB;IL6;OSM
Golgi organization (GO:0007030),4/121,0.8607254206096335,1,0,0,0.6611570247933884,0.09916015401943896,COG7;GOLGA8F;GOLGA6D;ATL2
ion transmembrane transport (GO:0034220),8/219,0.8615580448957499,1,0,0,0.730593607305936,0.10886783469315728,GABRB3;CLCA3P;CASQ2;HTR3D;LRRIQ4;ZACN;ATP6V0D2;UBA52
viral process (GO:0016032),8/220,0.8647752462940217,1,0,0,0.7272727272727272,0.10566228122626253,XPO1;RPSA;CXCR6;RPL15;UBA52;RPS24;AP1M2;NUP37
translational termination (GO:0006415),3/96,0.8648106182658194,1,0,0,0.625,0.09077795902611915,MRPS17;MRPL46;MRPS5
signal transduction by p53 class mediator (GO:0072331),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,BCL3
regulation of proteasomal protein catabolic process (GO:0061136),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,PRKN
clathrin-dependent endocytosis (GO:0072583),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,DLL1
purine ribonucleoside monophosphate metabolic process (GO:0009167),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,HSPA8
positive regulation of peptide hormone secretion (GO:0090277),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,GCK
regulation of plasma membrane bounded cell projection assembly (GO:0120032),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,TWF2
mitotic DNA damage checkpoint (GO:0044773),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,TP73
alpha-amino acid catabolic process (GO:1901606),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,IVD
cellular response to amino acid starvation (GO:0034198),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,RRAGB
acyl-CoA metabolic process (GO:0006637),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,GPAT4
positive regulation of hydrolase activity (GO:0051345),6/172,0.8654695388328904,1,0,0,0.6976744186046511,0.10080216269543664,DOCK10;MSH6;DNMBP;RGS1;EVI5L;CCL26
DNA metabolic process (GO:0006259),12/314,0.8659051275167354,1,0,0,0.7643312101910827,0.11004835333154779,GEN1;MSH6;PIF1;RMI2;RBM14;PCNA;TERT;APEX1;MCM3;MCM4;UBA52;FANCG
positive regulation of neurogenesis (GO:0050769),2/69,0.8659715129706728,1,0,0,0.5797101449275363,0.08342218313842696,NRCAM;ATOH1
regulation of osteoblast differentiation (GO:0045667),2/69,0.8659715129706728,1,0,0,0.5797101449275363,0.08342218313842696,IL6;SNAI2
negative regulation of cell cycle G2/M phase transition (GO:1902750),2/69,0.8659715129706728,1,0,0,0.5797101449275363,0.08342218313842696,UBA52;PSMB8
cell morphogenesis involved in neuron differentiation (GO:0048667),3/97,0.8694002721574682,1,0,0,0.6185567010309279,0.08656802931150201,LRP4;NRCAM;DSCAML1
response to tumor necrosis factor (GO:0034612),3/97,0.8694002721574682,1,0,0,0.6185567010309279,0.08656802931150201,IKBKB;IGBP1;CCL26
regulation of cell migration (GO:0030334),12/316,0.8711897134333509,1,0,0,0.7594936708860759,0.10473077072423917,ACVRL1;DOCK10;KIF2A;WNT5B;ABI3;SNAI2;LDB2;SEMA3F;GTSE1;ROBO1;CCL26;RHOBTB2
protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),2/70,0.8712429450339811,1,0,0,0.5714285714285714,0.0787625225498065,PRKN;ABTB2
calcium-mediated signaling (GO:0019722),2/70,0.8712429450339811,1,0,0,0.5714285714285714,0.0787625225498065,GRM5;CCR6
regulation of G2/M transition of mitotic cell cycle (GO:0010389),5/149,0.871720550894918,1,0,0,0.6711409395973154,0.09213850710843985,CEP164;CNTRL;UBA52;PSMB8;PAFAH1B1
positive regulation of epithelial to mesenchymal transition (GO:0010718),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,WWTR1
autophagy of mitochondrion (GO:0000422),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,PRKN
ameboidal-type cell migration (GO:0001667),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,SEMA3F
sterol biosynthetic process (GO:0016126),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,APOA4
negative regulation of cytokine secretion (GO:0050710),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,MAPKBP1
peptidyl-proline modification (GO:0018208),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,OGFOD1
regulation of release of cytochrome c from mitochondria (GO:0090199),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,PRKN
negative regulation of catabolic process (GO:0009895),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,PDE3B
JAK-STAT cascade (GO:0007259),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,CCR2
regulation of ERK1 and ERK2 cascade (GO:0070372),9/247,0.8745524666634054,1,0,0,0.7287449392712549,0.09768315070829925,CD74;PTPRR;ANGPT1;LMO3;TIE1;CD36;AGER;MET;CCL26
recombinational repair (GO:0000725),2/71,0.8763229800185758,1,0,0,0.5633802816901409,0.07437777878706983,GEN1;AP5S1
negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436),2/71,0.8763229800185758,1,0,0,0.5633802816901409,0.07437777878706983,UBA52;PSMB8
organelle membrane fusion (GO:0090174),2/71,0.8763229800185758,1,0,0,0.5633802816901409,0.07437777878706983,STX7;VAMP3
"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",4/125,0.8769959948339774,1,0,0,0.64,0.08400182624919345,GNA14;CNR2;OR11H4;ADRB2
small GTPase mediated signal transduction (GO:0007264),3/99,0.8781684208695373,1,0,0,0.6060606060606061,0.07873750329026426,DNMBP;USP28;RIN2
odontogenesis (GO:0042476),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,ROGDI
regulation of phagocytosis (GO:0050764),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,SIRPG
mesenchymal cell differentiation (GO:0048762),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,SNAI2
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,PCDHB11
negative regulation of STAT cascade (GO:1904893),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,BCL3
regulation of cell growth (GO:0001558),7/201,0.8805619416668193,1,0,0,0.6965174129353233,0.08859353598323239,ACVRL1;BRAT1;RPS6KA1;HPN;TAF9B;HDGFL2;IP6K2
positive regulation of ERK1 and ERK2 cascade (GO:0070374),7/201,0.8805619416668193,1,0,0,0.6965174129353233,0.08859353598323239,CD74;ANGPT1;TIE1;CD36;AGER;MET;CCL26
regulation of neuron death (GO:1901214),2/72,0.8812175551168138,1,0,0,0.5555555555555555,0.07025041245674381,PRKN;GRIN2B
Rho protein signal transduction (GO:0007266),2/72,0.8812175551168138,1,0,0,0.5555555555555555,0.07025041245674381,RHOU;RHOBTB2
regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439),2/72,0.8812175551168138,1,0,0,0.5555555555555555,0.07025041245674381,UBA52;PSMB8
regulation of angiogenesis (GO:0045765),6/177,0.8823041654912956,1,0,0,0.6779661016949152,0.08489384650292695,IL6;APOH;FGF18;PDE3B;PIK3R6;CCR2
cellular response to metal ion (GO:0071248),3/100,0.8823533306415342,1,0,0,0.6,0.07509762093621879,PRKN;TF;AKR1C3
positive regulation of multicellular organismal process (GO:0051240),7/202,0.883563654381017,1,0,0,0.6930693069306931,0.08579639534037632,WWTR1;PRKCH;TERT;IL23A;HPN;FLOT1;AGPAT2
regulation of interleukin-6 production (GO:0032675),1/42,0.8842793063304941,1,0,0,0.47619047619047616,0.05856300421956226,IL6
cellular response to calcium ion (GO:0071277),1/42,0.8842793063304941,1,0,0,0.47619047619047616,0.05856300421956226,AKR1C3
determination of left/right symmetry (GO:0007368),1/42,0.8842793063304941,1,0,0,0.47619047619047616,0.05856300421956226,DLL1
positive regulation of protein kinase B signaling (GO:0051897),4/127,0.884496020278119,1,0,0,0.6299212598425197,0.07731481246950389,ANGPT1;FGF18;AKR1C3;MET
protein lipidation (GO:0006497),4/127,0.884496020278119,1,0,0,0.6299212598425197,0.07731481246950389,PIGC;LY6K;ZDHHC5;PIGW
non-canonical Wnt signaling pathway (GO:0035567),4/127,0.884496020278119,1,0,0,0.6299212598425197,0.07731481246950389,ARHGEF19;PRICKLE2;UBA52;PSMB8
regulation of peptide hormone secretion (GO:0090276),2/73,0.8859324931436037,1,0,0,0.547945205479452,0.06636412280550928,ITPR2;GCK
positive regulation of cytokine secretion (GO:0050715),2/73,0.8859324931436037,1,0,0,0.547945205479452,0.06636412280550928,CD14;CRLF2
protein processing (GO:0016485),3/101,0.8864097011888528,1,0,0,0.594059405940594,0.07162931796059352,PSENEN;CLN3;PCSK6
metal ion transport (GO:0030001),3/101,0.8864097011888528,1,0,0,0.594059405940594,0.07162931796059352,KCNA2;KCNMB4;SLC17A2
positive regulation of cell motility (GO:2000147),6/179,0.8885227601225182,1,0,0,0.6703910614525139,0.07923688181265258,WNT5B;TAC4;SNAI2;SEMA3F;GTSE1;CCL26
cardiac ventricle morphogenesis (GO:0003208),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,PKP2
mitotic metaphase plate congression (GO:0007080),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,CDCA8
male gonad development (GO:0008584),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,AKR1C3
development of primary male sexual characteristics (GO:0046546),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,AKR1C3
positive regulation of interleukin-6 production (GO:0032755),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,IL6
substantia nigra development (GO:0021762),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,ZNF148
nucleobase-containing compound catabolic process (GO:0034655),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,ENTPD3
branching morphogenesis of an epithelial tube (GO:0048754),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,MET
digestive tract development (GO:0048565),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,RARRES2
nitrogen compound transport (GO:0071705),2/74,0.8904734986911036,1,0,0,0.5405405405405406,0.06270374958254536,CUBN;RHBG
MAPK cascade (GO:0000165),10/278,0.8935099822519456,1,0,0,0.7194244604316546,0.08100559163077616,IKBKB;ANGPT1;FGF18;IL2RB;GFRA1;UBA52;GRIN2B;MET;PSMB8;SPTBN2
positive regulation of angiogenesis (GO:0045766),3/103,0.8941493670111881,1,0,0,0.5825242718446602,0.06517423722567385,FGF18;DLL1;PIK3R6
negative regulation of phosphorylation (GO:0042326),2/75,0.8948461559431564,1,0,0,0.5333333333333333,0.0592551830845253,PRKN;WWTR1
gland development (GO:0048732),2/75,0.8948461559431564,1,0,0,0.5333333333333333,0.0592551830845253,SOX2;MET
purine ribonucleotide biosynthetic process (GO:0009152),2/75,0.8948461559431564,1,0,0,0.5333333333333333,0.0592551830845253,GUCY2C;PANK2
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),15/396,0.8955197756487819,1,0,0,0.7575757575757576,0.08359922300402568,PSENEN;ANGPT1;HPN;PXN;ADRB2;GRIN2B;FGFRL1;FOXO1;FES;FGF18;LCP2;UBA52;ATP6V0D2;MPZL1;POLR2L
regulation of focal adhesion assembly (GO:0051893),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,ACVRL1
adherens junction organization (GO:0034332),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,NECTIN3
detection of chemical stimulus involved in sensory perception of taste (GO:0050912),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,TAS1R2
amide biosynthetic process (GO:0043604),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,SGMS2
regulation of dendrite morphogenesis (GO:0048814),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,ADGRB3
positive regulation of macroautophagy (GO:0016239),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,ADRB2
positive regulation of interleukin-8 production (GO:0032757),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,CD14
negative regulation of type I interferon production (GO:0032480),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,UBA52
heart contraction (GO:0060047),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,CASQ2
protein N-linked glycosylation via asparagine (GO:0018279),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,DDOST
mitotic nuclear envelope disassembly (GO:0007077),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,NUP37
metaphase plate congression (GO:0051310),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,CDCA8
regulation of steroid biosynthetic process (GO:0050810),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,AKR1C3
posttranscriptional regulation of gene expression (GO:0010608),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,GRM5
positive regulation of actin filament bundle assembly (GO:0032233),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,PXN
Fc-epsilon receptor signaling pathway (GO:0038095),6/182,0.89732663940776,1,0,0,0.6593406593406593,0.07142989233734502,NFKBIA;IKBKB;UBE2D2;LCP2;UBA52;PSMB8
monovalent inorganic cation transport (GO:0015672),3/104,0.8978388517991447,1,0,0,0.5769230769230769,0.0621719302632217,KCNA2;KCNMB4;SLC17A2
peptide metabolic process (GO:0006518),3/104,0.8978388517991447,1,0,0,0.5769230769230769,0.0621719302632217,HSPA8;GSTA3;GSTA1
double-strand break repair via homologous recombination (GO:0000724),2/76,0.8990559259149057,1,0,0,0.5263157894736842,0.056005282852014004,GEN1;AP5S1
positive regulation of JNK cascade (GO:0046330),2/76,0.8990559259149057,1,0,0,0.5263157894736842,0.056005282852014004,DUSP15;AGER
positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition (GO:0051437),2/76,0.8990559259149057,1,0,0,0.5263157894736842,0.056005282852014004,UBA52;PSMB8
Fc receptor signaling pathway (GO:0038093),6/183,0.9001260483165906,1,0,0,0.6557377049180327,0.06899703067496876,NFKBIA;IKBKB;UBE2D2;LCP2;UBA52;PSMB8
nicotinamide nucleotide metabolic process (GO:0046496),1/45,0.9008174591944802,1,0,0,0.4444444444444444,0.046423395514619575,GCK
peptidyl-asparagine modification (GO:0018196),1/45,0.9008174591944802,1,0,0,0.4444444444444444,0.046423395514619575,DDOST
nucleus organization (GO:0006997),1/45,0.9008174591944802,1,0,0,0.4444444444444444,0.046423395514619575,ANKLE1
metal ion homeostasis (GO:0055065),1/45,0.9008174591944802,1,0,0,0.4444444444444444,0.046423395514619575,WFS1
peptidyl-tyrosine autophosphorylation (GO:0038083),1/45,0.9008174591944802,1,0,0,0.4444444444444444,0.046423395514619575,FES
negative regulation of ossification (GO:0030279),1/45,0.9008174591944802,1,0,0,0.4444444444444444,0.046423395514619575,LRP4
regulation of mitotic cell cycle phase transition (GO:1901990),6/184,0.9028597323328255,1,0,0,0.6521739130434782,0.06664439531119919,ID2;CEP164;CNTRL;UBA52;PSMB8;PAFAH1B1
negative regulation of ubiquitin protein ligase activity (GO:1904667),2/77,0.9031081450221422,1,0,0,0.5194805194805194,0.05294180301649679,UBA52;PSMB8
regulation of cytokinesis (GO:0032465),2/77,0.9031081450221422,1,0,0,0.5194805194805194,0.05294180301649679,KIF13A;TAS1R2
protein targeting (GO:0006605),4/133,0.9046524128561665,1,0,0,0.6015037593984962,0.060273373383263405,AP4M1;TMEM50B;SRPRA;AP1M2
protein phosphorylation (GO:0006468),18/470,0.9048067935974611,1,0,0,0.7659574468085106,0.07662166913226941,ACVRL1;MORC3;PRKCH;IKBKB;RPS6KA4;MOS;ERN1;LATS1;PPP4R1;RELN;LATS2;IRAK2;FES;FASTK;RPS6KA1;ULK3;MAP3K21;PSKH1
positive regulation of cellular catabolic process (GO:0031331),3/106,0.9048723287754362,1,0,0,0.5660377358490566,0.05658193494921566,PFKFB3;APOA4;FOXO1
protein complex disassembly (GO:0043241),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,CLN3
interleukin-12-mediated signaling pathway (GO:0035722),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,BOLA2
regulation of G1/S transition of mitotic cell cycle (GO:2000045),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,ID2
cartilage development (GO:0051216),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,WNT5B
cellular response to interleukin-12 (GO:0071349),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,BOLA2
"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,NDUFA6
negative regulation of autophagy (GO:0010507),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,MET
adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189),2/78,0.9070080241695482,1,0,0,0.5128205128205128,0.0500533240880421,ABCA1;ADRB2
negative regulation of inflammatory response (GO:0050728),2/78,0.9070080241695482,1,0,0,0.5128205128205128,0.0500533240880421,RORA;PPARD
positive regulation of epithelial cell proliferation (GO:0050679),3/107,0.9082222841413132,1,0,0,0.5607476635514018,0.053981004122237344,HPN;NME1;CCL26
negative regulation of response to external stimulus (GO:0032102),3/107,0.9082222841413132,1,0,0,0.5607476635514018,0.053981004122237344,MAPKBP1;RORA;PPARD
regulation of protein secretion (GO:0050708),3/107,0.9082222841413132,1,0,0,0.5607476635514018,0.053981004122237344,ITPR2;ARFIP1;GCK
negative regulation of JAK-STAT cascade (GO:0046426),1/47,0.9105090567783704,1,0,0,0.42553191489361697,0.03989422673431822,BCL3
fatty acid biosynthetic process (GO:0006633),1/47,0.9105090567783704,1,0,0,0.42553191489361697,0.03989422673431822,ELOVL4
cellular response to heat (GO:0034605),1/47,0.9105090567783704,1,0,0,0.42553191489361697,0.03989422673431822,HSPA8
positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),1/47,0.9105090567783704,1,0,0,0.42553191489361697,0.03989422673431822,ACVRL1
phagocytosis (GO:0006909),4/135,0.9106439683988242,1,0,0,0.5925925925925926,0.055468605725438686,TMX3;GSN;BIN2;CD14
mitochondrial transport (GO:0006839),4/135,0.9106439683988242,1,0,0,0.5925925925925926,0.055468605725438686,PRKN;SLC25A17;SLC25A11;TIMM50
negative regulation of mitotic cell cycle phase transition (GO:1901991),2/79,0.9107606472852537,1,0,0,0.5063291139240506,0.047329191130890166,UBA52;PSMB8
peptidyl-tyrosine phosphorylation (GO:0018108),2/79,0.9107606472852537,1,0,0,0.5063291139240506,0.047329191130890166,RELN;FES
anaphase-promoting complex-dependent catabolic process (GO:0031145),2/79,0.9107606472852537,1,0,0,0.5063291139240506,0.047329191130890166,UBA52;PSMB8
cell-cell junction assembly (GO:0007043),2/79,0.9107606472852537,1,0,0,0.5063291139240506,0.047329191130890166,PKP2;CRB3
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),2/79,0.9107606472852537,1,0,0,0.5063291139240506,0.047329191130890166,HSP90AB1;UBA52
negative regulation of hydrolase activity (GO:0051346),3/108,0.9114649563237461,1,0,0,0.5555555555555555,0.051501184313357255,PPP1R12A;WDR81;CCDC8
regulation of GTPase activity (GO:0043087),6/188,0.9131597476168598,1,0,0,0.6382978723404255,0.0579858151181627,DOCK10;DNMBP;RGS1;OCRL;EVI5L;CCL26
endocytosis (GO:0006897),9/263,0.9139369295123392,1,0,0,0.6844106463878327,0.061592656530010545,CUBN;CLN3;CD163;HEATR5A;RHOU;CD14;CD36;ADRB2;SCARF1
regulation of hydrolase activity (GO:0051336),2/80,0.9143709716133156,1,0,0,0.5,0.04475945641757651,OCRL;PAFAH1B1
regulation of protein serine/threonine kinase activity (GO:0071900),2/80,0.9143709716133156,1,0,0,0.5,0.04475945641757651,CCNG1;ADRB2
negative regulation of mitotic cell cycle (GO:0045930),1/48,0.914994048233663,1,0,0,0.41666666666666663,0.03701571599601437,HECA
cytoplasmic microtubule organization (GO:0031122),1/48,0.914994048233663,1,0,0,0.41666666666666663,0.03701571599601437,CCDC88A
regulation of epithelial cell migration (GO:0010632),1/48,0.914994048233663,1,0,0,0.41666666666666663,0.03701571599601437,PTPRR
regulation of mitochondrion organization (GO:0010821),1/48,0.914994048233663,1,0,0,0.41666666666666663,0.03701571599601437,PRKN
positive regulation of protein modification process (GO:0031401),5/163,0.9150605393003802,1,0,0,0.6134969325153374,0.05445708756164863,CD74;RARRES2;BRAT1;FLOT1;AGER
positive regulation of transferase activity (GO:0051347),4/137,0.9162983017532836,1,0,0,0.583941605839416,0.05104426883901789,CD74;HSP90AB1;TIE1;MET
macroautophagy (GO:0016236),3/110,0.9176399007049346,1,0,0,0.5454545454545454,0.04688194382454664,PRKN;CLN3;UBA52
positive regulation of establishment of protein localization to mitochondrion (GO:1903749),3/110,0.9176399007049346,1,0,0,0.5454545454545454,0.04688194382454664,UGCG;RHOU;TP73
positive regulation of protein targeting to mitochondrion (GO:1903955),2/81,0.9178438273168302,1,0,0,0.49382716049382713,0.042334827448253703,UGCG;RHOU
negative regulation of cell cycle process (GO:0010948),2/81,0.9178438273168302,1,0,0,0.49382716049382713,0.042334827448253703,HSP90AB1;STAG2
positive regulation of protein catabolic process (GO:0045732),2/81,0.9178438273168302,1,0,0,0.49382716049382713,0.042334827448253703,PRKN;FOXO1
cilium movement (GO:0003341),1/49,0.919254474341766,1,0,0,0.4081632653061224,0.034364200583535946,RSPH9
establishment of protein localization to mitochondrion (GO:0072655),1/49,0.919254474341766,1,0,0,0.4081632653061224,0.034364200583535946,TIMM50
gonad development (GO:0008406),1/49,0.919254474341766,1,0,0,0.4081632653061224,0.034364200583535946,AKR1C3
plasma membrane bounded cell projection assembly (GO:0120031),8/241,0.9193661993761398,1,0,0,0.6639004149377593,0.05581461249509647,CCDC88A;EHD3;GSN;RFX4;CEP164;CEP83;BBS9;OCRL
sensory perception of smell (GO:0007608),8/241,0.9193661993761398,1,0,0,0.6639004149377593,0.05581461249509647,OR7G2;OR2T4;OR2T27;OR2D3;OR13J1;OR8D1;OR10AD1;OR2T5
regulation of anatomical structure morphogenesis (GO:0022603),2/82,0.9211839178855769,1,0,0,0.4878048780487805,0.04004661901274316,IL6;DLL1
mitotic sister chromatid segregation (GO:0000070),2/82,0.9211839178855769,1,0,0,0.4878048780487805,0.04004661901274316,AKAP8L;CDCA8
positive regulation of ubiquitin protein ligase activity (GO:1904668),2/82,0.9211839178855769,1,0,0,0.4878048780487805,0.04004661901274316,UBA52;PSMB8
positive regulation of protein secretion (GO:0050714),2/82,0.9211839178855769,1,0,0,0.4878048780487805,0.04004661901274316,IL6;GCK
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),2/82,0.9211839178855769,1,0,0,0.4878048780487805,0.04004661901274316,ACVRL1;HSP90AB1
ephrin receptor signaling pathway (GO:0048013),2/82,0.9211839178855769,1,0,0,0.4878048780487805,0.04004661901274316,PSENEN;GRIN2B
C-terminal protein amino acid modification (GO:0018410),2/82,0.9211839178855769,1,0,0,0.4878048780487805,0.04004661901274316,LY6K;LINC00598
cellular response to growth factor stimulus (GO:0071363),4/139,0.9216307962341534,1,0,0,0.5755395683453237,0.04697011427115409,ERN1;ACVRL1;TWF2;SNAI2
neuron differentiation (GO:0030182),4/139,0.9216307962341534,1,0,0,0.5755395683453237,0.04697011427115409,WNT5B;LMX1A;ID2;ID1
positive regulation of GTPase activity (GO:0043547),6/192,0.9224978058129646,1,0,0,0.625,0.050418925995509435,DOCK10;DNMBP;RGS1;EVI5L;TBC1D16;CCL26
regulation of bone mineralization (GO:0030500),1/50,0.9233015685863551,1,0,0,0.39999999999999997,0.03191974852547144,TXLNG
negative regulation of viral genome replication (GO:0045071),1/50,0.9233015685863551,1,0,0,0.39999999999999997,0.03191974852547144,PRKN
heart morphogenesis (GO:0003007),1/50,0.9233015685863551,1,0,0,0.39999999999999997,0.03191974852547144,ACVRL1
receptor internalization (GO:0031623),1/50,0.9233015685863551,1,0,0,0.39999999999999997,0.03191974852547144,CD36
regulation of exocytosis (GO:0017157),1/51,0.9271460027962314,1,0,0,0.39215686274509803,0.029664402156312095,UNC13D
carboxylic acid transport (GO:0046942),1/51,0.9271460027962314,1,0,0,0.39215686274509803,0.029664402156312095,SLC16A2
regulation of cellular amine metabolic process (GO:0033238),1/51,0.9271460027962314,1,0,0,0.39215686274509803,0.029664402156312095,PSMB8
regulation of telomere maintenance via telomerase (GO:0032210),1/51,0.9271460027962314,1,0,0,0.39215686274509803,0.029664402156312095,PIF1
regulation of cellular amino acid metabolic process (GO:0006521),1/51,0.9271460027962314,1,0,0,0.39215686274509803,0.029664402156312095,PSMB8
activation of GTPase activity (GO:0090630),2/84,0.9274839879498789,1,0,0,0.47619047619047616,0.035847499197840214,EVI5L;TBC1D16
mitochondrial ATP synthesis coupled electron transport (GO:0042775),2/85,0.9304527474425885,1,0,0,0.47058823529411764,0.03392187580644571,NDUFA6;COX6A1
positive regulation of ossification (GO:0045778),1/52,0.9307979155856723,1,0,0,0.38461538461538464,0.027581956513803345,IL6
regulation of calcium ion transport (GO:0051924),1/52,0.9307979155856723,1,0,0,0.38461538461538464,0.027581956513803345,WFS1
regulation of cell-matrix adhesion (GO:0001952),1/52,0.9307979155856723,1,0,0,0.38461538461538464,0.027581956513803345,CD36
positive regulation of nervous system development (GO:0051962),1/52,0.9307979155856723,1,0,0,0.38461538461538464,0.027581956513803345,RELN
positive regulation of cell-substrate adhesion (GO:0010811),1/52,0.9307979155856723,1,0,0,0.38461538461538464,0.027581956513803345,CD36
positive regulation of secretion by cell (GO:1903532),1/52,0.9307979155856723,1,0,0,0.38461538461538464,0.027581956513803345,UNC13D
regulation of macroautophagy (GO:0016241),3/116,0.9338791037872658,1,0,0,0.5172413793103448,0.035383597412689746,ERN1;RRAGB;ATP6V0D2
positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),1/53,0.9342669389173686,1,0,0,0.3773584905660377,0.02565776594269266,INS-IGF2
negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845),1/53,0.9342669389173686,1,0,0,0.3773584905660377,0.02565776594269266,UBA52
positive regulation of protein import into nucleus (GO:0042307),1/53,0.9342669389173686,1,0,0,0.3773584905660377,0.02565776594269266,IL6
calcium ion homeostasis (GO:0055074),2/87,0.9360487418513352,1,0,0,0.45977011494252873,0.03038516286569491,WFS1;CCR2
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000060),2/87,0.9360487418513352,1,0,0,0.45977011494252873,0.03038516286569491,UBA52;PSMB8
skeletal system development (GO:0001501),4/146,0.937973433221828,1,0,0,0.547945205479452,0.035086933242870315,TRAPPC2;SHOX;PITX1;PAX1
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),2/88,0.9386840239616273,1,0,0,0.45454545454545453,0.028761981412220677,PRKN;HSP90AB1
inflammatory response (GO:0006954),8/252,0.9395070827321969,1,0,0,0.6349206349206349,0.039618997667003886,IKBKB;CRP;IL6;CXCL9;TAC4;TNFRSF10B;CXCL5;CCL26
positive regulation of cysteine-type endopeptidase activity (GO:2001056),1/55,0.9406924613791231,1,0,0,0.3636363636363636,0.022232368682920493,GRIN2B
negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),1/55,0.9406924613791231,1,0,0,0.3636363636363636,0.022232368682920493,UBA52
positive regulation of DNA biosynthetic process (GO:2000573),1/55,0.9406924613791231,1,0,0,0.3636363636363636,0.022232368682920493,HSP90AB1
positive regulation of B cell activation (GO:0050871),3/119,0.9408414997698965,1,0,0,0.5042016806722689,0.030746516803698005,SASH3;CD74;IL6
peptidyl-threonine modification (GO:0018210),2/89,0.9412159961600209,1,0,0,0.449438202247191,0.02722814686661418,GALNT15;PSKH1
protein autophosphorylation (GO:0046777),5/175,0.9413694544389155,1,0,0,0.5714285714285714,0.034525484282291394,ERN1;MOS;FES;ULK3;MAP3K21
organonitrogen compound catabolic process (GO:1901565),1/56,0.9436659121708673,1,0,0,0.3571428571428571,0.020708243598219184,CLN3
phosphatidylinositol-mediated signaling (GO:0048015),1/56,0.9436659121708673,1,0,0,0.3571428571428571,0.020708243598219184,PIK3R6
negative regulation of cellular catabolic process (GO:0031330),1/56,0.9436659121708673,1,0,0,0.3571428571428571,0.020708243598219184,MET
autophagosome organization (GO:1905037),1/56,0.9436659121708673,1,0,0,0.3571428571428571,0.020708243598219184,ULK3
glycosaminoglycan catabolic process (GO:0006027),1/56,0.9436659121708673,1,0,0,0.3571428571428571,0.020708243598219184,SDC4
negative regulation of cell migration (GO:0030336),3/121,0.9450990402667404,1,0,0,0.49586776859504134,0.027999447503273347,ACVRL1;PTPRR;ROBO1
regulation of protein catabolic process (GO:0042176),2/91,0.9459848142593618,1,0,0,0.43956043956043955,0.024408247313871943,PRKN;FOXO1
regulation of neurogenesis (GO:0050767),1/57,0.9464904210788941,1,0,0,0.3508771929824561,0.01929629078749377,DLL1
protein homotetramerization (GO:0051289),1/57,0.9464904210788941,1,0,0,0.3508771929824561,0.01929629078749377,HSD17B10
positive regulation of apoptotic process (GO:0043065),10/307,0.9465050681271432,1,0,0,0.6514657980456026,0.03581690797977292,PSENEN;LATS1;IL6;PLEKHG2;LATS2;ARHGEF19;ATF6;UBA52;FOXO1;IP6K2
autophagosome assembly (GO:0000045),1/58,0.9491734416512021,1,0,0,0.3448275862068965,0.017987494665677846,ULK3
positive regulation of cell morphogenesis involved in differentiation (GO:0010770),1/58,0.9491734416512021,1,0,0,0.3448275862068965,0.017987494665677846,ROBO1
positive regulation of intracellular protein transport (GO:0090316),4/152,0.9494463614039064,1,0,0,0.5263157894736842,0.02730328512521963,UGCG;RHOU;ANP32B;GTSE1
regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),1/59,0.95172205472190885,1,0,0,0.3389830508474576,0.01677364276098951,ACVRL1
cell morphogenesis (GO:0000902),1/59,0.95172205472190885,1,0,0,0.3389830508474576,0.01677364276098951,RELN
respiratory electron transport chain (GO:0022904),2/94,0.9524527851404014,1,0,0,0.42553191489361697,0.02072967770905844,NDUFA6;COX6A1
axon development (GO:0061564),2/94,0.9524527851404014,1,0,0,0.42553191489361697,0.02072967770905844,NRCAM;DSCAML1
negative regulation of response to stimulus (GO:0048585),3/127,0.9562226890751985,1,0,0,0.47244094488188976,0.021148561272512884,TERT;TIE1;MET
actin cytoskeleton reorganization (GO:0031532),1/61,0.956442628953957,1,0,0,0.32786885245901637,0.014601466257298934,GSN
negative regulation of viral life cycle (GO:1903901),1/61,0.956442628953957,1,0,0,0.32786885245901637,0.014601466257298934,GSN
protein targeting to membrane (GO:0006612),1/61,0.956442628953957,1,0,0,0.32786885245901637,0.014601466257298934,SRPRA
negative regulation of MAP kinase activity (GO:0043407),1/61,0.956442628953957,1,0,0,0.32786885245901637,0.014601466257298934,TP73
proteolysis (GO:0006508),9/291,0.9578154578835197,1,0,0,0.6185567010309279,0.026659887993880003,PSENEN;CLN3;CAPN9;ASTL;HPN;MMP19;PCSK6;MMP8;SENP1
positive regulation of mitochondrion organization (GO:0010822),3/128,0.9578577572454201,1,0,0,0.46875,0.02018249573547579,PRKN;UGCG;RHOU
cellular response to organonitrogen compound (GO:0071417),2/97,0.9581767039032599,1,0,0,0.41237113402061853,0.017617759662583495,GABRB3;RRAGB
negative regulation of cell motility (GO:2000146),2/97,0.9581767039032599,1,0,0,0.41237113402061853,0.017617759662583495,ACVRL1;ROBO1
mitochondrial respiratory chain complex assembly (GO:0033108),2/97,0.9581767039032599,1,0,0,0.41237113402061853,0.017617759662583495,NDUFA6;COX20
cellular protein catabolic process (GO:0044257),1/62,0.9586270516234485,1,0,0,0.3225806451612903,0.013630055718159003,PRKN
negative regulation of peptidase activity (GO:0010466),1/62,0.9586270516234485,1,0,0,0.3225806451612903,0.013630055718159003,SERPINB6
NADH dehydrogenase complex assembly (GO:0010257),1/64,0.9626730196391721,1,0,0,0.3125,0.011887958847229707,NDUFA6
mitochondrial respiratory chain complex I biogenesis (GO:0097031),1/64,0.9626730196391721,1,0,0,0.3125,0.011887958847229707,NDUFA6
mitochondrial respiratory chain complex I assembly (GO:0032981),1/64,0.9626730196391721,1,0,0,0.3125,0.011887958847229707,NDUFA6
positive regulation of cell adhesion (GO:0045785),1/64,0.9626730196391721,1,0,0,0.3125,0.011887958847229707,SIRPG
negative regulation of intracellular signal transduction (GO:1902532),4/161,0.9630441635519674,1,0,0,0.49689440993788814,0.018711059800898308,MAPKBP1;PDE3B;RORA;AJUBA
cellular divalent inorganic cation homeostasis (GO:0072503),2/101,0.9647890418591292,1,0,0,0.396039603960396,0.014196360797659355,SLC39A14;CCR2
neuron projection morphogenesis (GO:0048812),4/163,0.9655642038568073,1,0,0,0.49079754601226994,0.017198861980518405,DOCK10;LRP4;NRCAM;DSCAML1
regulation of protein kinase B signaling (GO:0051896),4/163,0.9655642038568073,1,0,0,0.49079754601226994,0.017198861980518405,ANGPT1;FGF18;AKR1C3;MET
positive regulation of cell migration (GO:0030335),6/221,0.9675462294069075,1,0,0,0.5429864253393665,0.01791424772145804,WNT5B;SNAI2;SEMA3F;GTSE1;CCR2;CCL26
plasma membrane invagination (GO:0099024),2/103,0.9677062755799263,1,0,0,0.38834951456310673,0.01274822216284486,GSN;BIN2
positive regulation of endothelial cell proliferation (GO:0001938),1/67,0.9680129340715097,1,0,0,0.29850746268656714,0.00970442691065804,CCL26
regulation of TOR signaling (GO:0032006),1/67,0.9680129340715097,1,0,0,0.29850746268656714,0.00970442691065804,RRAGB
extrinsic apoptotic signaling pathway (GO:0097191),1/67,0.9680129340715097,1,0,0,0.29850746268656714,0.00970442691065804,TNFRSF10B
positive regulation of vasculature development (GO:1904018),2/104,0.9690762134019278,1,0,0,0.38461538461538464,0.0120815456087189,FGF18;PIK3R6
"phagocytosis, engulfment (GO:0006911)",2/104,0.9690762134019278,1,0,0,0.38461538461538464,0.0120815456087189,GSN;BIN2
regulation of cell proliferation (GO:0042127),27/740,0.9691267914897549,1,0,0,0.7297297297297297,0.02288419872364372,ACVRL1;CXCL9;EPO;REG1B;SIRPG;CHD5;DUSP15;DLL1;CXCL5;CIAO1;UTP20;CD33;WWTR1;PBRM1;PRMT1;AKR1C3;OSM;TNFRSF10B;NME1;CCDC88A;RNF126;IL6;INS-IGF2;FES;DNAJA3;IFNK;CRLF2
response to interferon-gamma (GO:0034341),1/68,0.9696175495526317,1,0,0,0.2941176470588235,0.009074577660222398,CCL26
peptidyl-threonine phosphorylation (GO:0018107),1/68,0.9696175495526317,1,0,0,0.2941176470588235,0.009074577660222398,PSKH1
cellular response to DNA damage stimulus (GO:0006974),10/329,0.9696227885559765,1,0,0,0.60790273556231,0.018752681394908044,MSH6;RBM14;APEX1;BRAT1;BCL3;USP28;MICA;FOXO1;FANCG;TP73
vascular endothelial growth factor receptor signaling pathway (GO:0048010),1/70,0.972589533427257,1,0,0,0.2857142857142857,0.007940897858985217,PXN
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),1/70,0.972589533427257,1,0,0,0.2857142857142857,0.007940897858985217,PRKN
Rab protein signal transduction (GO:0032482),1/70,0.972589533427257,1,0,0,0.2857142857142857,0.007940897858985217,RAB4B
neuropeptide signaling pathway (GO:0007218),1/70,0.972589533427257,1,0,0,0.2857142857142857,0.007940897858985217,NXPH2
interferon-gamma-mediated signaling pathway (GO:0060333),1/70,0.972589533427257,1,0,0,0.2857142857142857,0.007940897858985217,IRF9
inorganic cation transmembrane transport (GO:0098662),3/140,0.9734908104308518,1,0,0,0.42857142857142855,0.011514383115519571,SLC30A6;SCN10A;SLC39A14
regulation of protein activation cascade (GO:2000257),2/108,0.9740164985643297,1,0,0,0.37037037037037035,0.009750754261227252,C4B;C1QB
negative regulation of signal transduction (GO:0009968),8/283,0.9745050862135625,1,0,0,0.5653710247349822,0.014601012433797954,NXN;TIE1;ULK3;SNAI2;CHAC1;APCDD1;UBA52;MET
double-strand break repair (GO:0006302),3/141,0.9745089388889377,1,0,0,0.42553191489361697,0.010987909481436438,GEN1;DDX1;AP5S1
circulatory system development (GO:0072359),2/109,0.9751270159817813,1,0,0,0.3669724770642202,0.009243135290725672,NXN;PKP2
regulation of complement activation (GO:0030449),2/109,0.9751270159817813,1,0,0,0.3669724770642202,0.009243135290725672,C4B;C1QB
antigen receptor-mediated signaling pathway (GO:0050851),7/257,0.9751987540050975,1,0,0,0.5447470817120622,0.01368076649657973,IKBKB;NFKBIA;UBE2D2;LCP2;RBCK1;UBA52;PSMB8
cell-cell junction organization (GO:0045216),1/72,0.9752710378445755,1,0,0,0.27777777777777773,0.006955516411879717,NECTIN3
protein N-linked glycosylation (GO:0006487),1/73,0.9765118358730951,1,0,0,0.273972602739726,0.0065118926107079,DDOST
canonical Wnt signaling pathway (GO:0060070),1/73,0.9765118358730951,1,0,0,0.273972602739726,0.0065118926107079,SNAI2
positive regulation of proteasomal protein catabolic process (GO:1901800),1/73,0.9765118358730951,1,0,0,0.273972602739726,0.0065118926107079,PRKN
positive regulation of epithelial cell migration (GO:0010634),1/74,0.9776904281936729,1,0,0,0.2702702702702703,0.00609789044447976,ANGPT1
negative regulation of cellular amide metabolic process (GO:0034249),1/75,0.9788099305759348,1,0,0,0.26666666666666666,0.005711413813620137,CNOT2
C-terminal protein lipidation (GO:0006501),1/75,0.9788099305759348,1,0,0,0.26666666666666666,0.005711413813620137,LY6K
cAMP-mediated signaling (GO:0019933),1/75,0.9788099305759348,1,0,0,0.26666666666666666,0.005711413813620137,ABCA1
regulation of humoral immune response (GO:0002920),2/113,0.9791273621981581,1,0,0,0.35398230088495575,0.007466743623819164,C4B;C1QB
positive regulation of apoptotic signaling pathway (GO:2001235),1/76,0.9798733026216075,1,0,0,0.2631578947368421,0.005350525977491548,GSN
regulation of protein kinase activity (GO:0045859),3/147,0.9798793347088299,1,0,0,0.4081632653061224,0.008296262345513448,WWTR1;RELN;LCP2
regulation of immune effector process (GO:0002697),2/114,0.9800255952144739,1,0,0,0.3508771929824561,0.007079505295714906,C4B;C1QB
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),1/77,0.9808833558575986,1,0,0,0.2597402597402597,0.00501343630948899,UBA52
negative regulation of cell growth (GO:0030308),2/115,0.9808862990126357,1,0,0,0.34782608695652173,0.0067126014891210894,ACVRL1;IP6K2
cellular response to interferon-gamma (GO:0071346),2/116,0.9817109760502318,1,0,0,0.3448275862068965,0.006364943341352885,IRF9;CCL26
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),1/80,0.9836196507462239,1,0,0,0.25,0.004128997611953673,INS-IGF2
BMP signaling pathway (GO:0030509),1/81,0.9844418345091214,1,0,0,0.24691358024691357,0.003871719481130927,ACVRL1
negative regulation of growth (GO:0045926),2/120,0.9846775335112893,1,0,0,0.3333333333333333,0.005147022851847904,ACVRL1;IP6K2
establishment of protein localization to membrane (GO:0090150),1/83,0.9859645609779344,1,0,0,0.24096385542168675,0.0034059921056594548,KIF13A
negative regulation of endopeptidase activity (GO:0010951),1/83,0.9859645609779344,1,0,0,0.24096385542168675,0.0034059921056594548,SERPINB6
"complement activation, classical pathway (GO:0006958)",2/123,0.9865898138019685,1,0,0,0.3252032520325203,0.004390541392766967,CRP;C1QB
humoral immune response mediated by circulating immunoglobulin (GO:0002455),2/125,0.9877333512529541,1,0,0,0.32,0.0039496016179910295,CRP;C1QB
regulation of immune response (GO:0050776),6/251,0.987735052144464,1,0,0,0.4780876494023904,0.005899975956737849,TREML1;NCR2;ICAM3;CD226;CD33;MICA
calcium ion transmembrane transport (GO:0070588),1/86,0.9879740196694372,1,0,0,0.23255813953488372,0.0028136924328252115,GRIN2B
cytoskeleton organization (GO:0007010),2/126,0.9882689055470334,1,0,0,0.31746031746031744,0.0037461735428357327,RHOU;AJUBA
cellular response to BMP stimulus (GO:0071773),1/87,0.9885777887454201,1,0,0,0.22988505747126436,0.002640907067682,ACVRL1
vesicle organization (GO:0016050),2/127,0.9887816352200313,1,0,0,0.31496062992125984,0.0035533118886497796,STX7;VAMP3
divalent metal ion transport (GO:0070838),1/88,0.9891512672040396,1,0,0,0.22727272727272727,0.002479093046554197,CATSPER4
negative regulation of kinase activity (GO:0033673),1/91,0.9907047643496917,1,0,0,0.21978021978021978,0.002052462844095697,WWTR1
cellular response to organic substance (GO:0071310),2/133,0.9914288561400509,1,0,0,0.3007518796992481,0.0025888984552419132,TWF2;PTPN9
cellular response to organic cyclic compound (GO:0071407),2/135,0.9921672304002093,1,0,0,0.2962962962962963,0.002329957591894398,GABRB3;RORA
transmembrane transport (GO:0055085),10/378,0.9923273318104171,1,0,0,0.5291005291005291,0.004075266953879567,GABRB3;SLC22A23;CLCA3P;CASQ2;HTR3D;ZACN;ATP6V0D2;UBA52;ABCC11;PSMB8
regulation of B cell activation (GO:0050864),1/95,0.9924358915832194,1,0,0,0.21052631578947367,0.0015984971305800805,IL6
cellular metal ion homeostasis (GO:0006875),1/96,0.9928157700996559,1,0,0,0.20833333333333331,0.0015021168229316978,CCR2
heart development (GO:0007507),2/149,0.9958502577635029,1,0,0,0.2684563758389262,0.0011163426338827505,SOX18;PKP2
negative regulation of protein kinase activity (GO:0006469),1/109,0.9963236252556655,1,0,0,0.1834862385321101,6.758071960977404e-4,WWTR1
Ras protein signal transduction (GO:0007265),4/223,0.9963895238275712,1,0,0,0.35874439461883406,0.0012975819452181977,RAB4B;RHOU;USP28;RHOBTB2
calcium ion transport (GO:0006816),1/118,0.9976881532998332,1,0,0,0.1694915254237288,3.922920582310045e-4,CATSPER4
negative regulation of protein phosphorylation (GO:0001933),2/178,0.9989102637859273,1,0,0,0.2247191011235955,2.4501806928015936e-4,PRKN;WWTR1
Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),1/133,0.99893267616922,1,0,0,0.15037593984962405,1.6058553781593565e-4,HSP90AB1
Fc-gamma receptor signaling pathway (GO:0038094),1/134,0.99898625000142,1,0,0,0.14925373134328357,1.5138271502198073e-4,HSP90AB1
Fc receptor mediated stimulatory signaling pathway (GO:0002431),1/135,0.9990371293746406,1,0,0,0.14814814814814814,1.427162197126682e-4,HSP90AB1
spermatogenesis (GO:0007283),1/153,0.9996182906586515,1,0,0,0.13071895424836602,4.9906171359877866e-5,SPAG11B
male gamete generation (GO:0048232),1/154,0.9996373660858319,1,0,0,0.12987012987012986,4.710385477222948e-5,SPAG11B
